date generated: 2020-09-10
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## A1BG -0.3065476
## A1BG-AS1 0.2667380
## A1CF -0.1889397
## A2M -0.4487032
## A2M-AS1 -0.9062206
## A2ML1 1.1221162
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 2400 |
num_genes_in_profile | 21631 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8419 |
num_profile_genes_not_in_sets | 13212 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used: GMT file of genesets: ReactomePathways.gmt
Gene sets metrics | |
---|---|
num_genesets | 2400 |
num_genesets_excluded | 1039 |
num_genesets_included | 1361 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Top N= 100 gene sets
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
IRAK4 deficiency (TLR2/4) | 10 | 2.19e-06 | 0.864 | 3.11e-05 |
MyD88 deficiency (TLR2/4) | 10 | 2.19e-06 | 0.864 | 3.11e-05 |
Peptide chain elongation | 88 | 5.06e-36 | -0.771 | 6.88e-34 |
Eukaryotic Translation Elongation | 93 | 1.44e-37 | -0.767 | 2.18e-35 |
Selenocysteine synthesis | 92 | 1.36e-35 | -0.750 | 1.68e-33 |
Viral mRNA Translation | 88 | 6.76e-34 | -0.747 | 6.14e-32 |
Formation of a pool of free 40S subunits | 100 | 4.05e-38 | -0.746 | 6.88e-36 |
Eukaryotic Translation Termination | 92 | 3.30e-34 | -0.734 | 3.21e-32 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 1.52e-05 | 0.721 | 1.79e-04 |
alpha-linolenic acid (ALA) metabolism | 12 | 1.52e-05 | 0.721 | 1.79e-04 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 94 | 1.58e-32 | -0.708 | 1.20e-30 |
Translocation of ZAP-70 to Immunological synapse | 24 | 1.98e-09 | -0.707 | 5.09e-08 |
L13a-mediated translational silencing of Ceruloplasmin expression | 110 | 7.55e-35 | -0.678 | 8.56e-33 |
GTP hydrolysis and joining of the 60S ribosomal subunit | 111 | 1.11e-34 | -0.674 | 1.16e-32 |
Response of EIF2AK4 (GCN2) to amino acid deficiency | 100 | 3.17e-31 | -0.672 | 2.27e-29 |
Formation of the ternary complex, and subsequently, the 43S complex | 51 | 1.92e-16 | -0.665 | 8.41e-15 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 11 | 1.55e-04 | 0.659 | 1.33e-03 |
Regulation of TLR by endogenous ligand | 11 | 2.34e-04 | 0.641 | 1.88e-03 |
Major pathway of rRNA processing in the nucleolus and cytosol | 180 | 6.06e-50 | -0.641 | 2.06e-47 |
Cap-dependent Translation Initiation | 118 | 2.65e-33 | -0.640 | 2.12e-31 |
Eukaryotic Translation Initiation | 118 | 2.65e-33 | -0.640 | 2.12e-31 |
rRNA processing in the nucleus and cytosol | 190 | 7.19e-52 | -0.636 | 4.89e-49 |
Selenoamino acid metabolism | 114 | 2.44e-30 | -0.620 | 1.58e-28 |
RHO GTPases Activate ROCKs | 18 | 6.30e-06 | 0.615 | 8.41e-05 |
Uptake and function of anthrax toxins | 10 | 8.17e-04 | 0.611 | 4.92e-03 |
Activation of the pre-replicative complex | 32 | 2.71e-09 | -0.607 | 6.59e-08 |
MET activates RAP1 and RAC1 | 10 | 1.02e-03 | 0.600 | 5.89e-03 |
rRNA processing | 217 | 2.08e-51 | -0.593 | 9.44e-49 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 114 | 1.63e-27 | -0.588 | 9.23e-26 |
Nonsense-Mediated Decay (NMD) | 114 | 1.63e-27 | -0.588 | 9.23e-26 |
rRNA modification in the nucleus and cytosol | 59 | 5.93e-15 | -0.587 | 2.45e-13 |
SRP-dependent cotranslational protein targeting to membrane | 111 | 1.23e-26 | -0.586 | 6.19e-25 |
Translation initiation complex formation | 58 | 1.23e-14 | -0.585 | 4.80e-13 |
Nucleobase biosynthesis | 13 | 2.88e-04 | -0.581 | 2.22e-03 |
Influenza Viral RNA Transcription and Replication | 135 | 5.44e-31 | -0.576 | 3.70e-29 |
Ribosomal scanning and start codon recognition | 58 | 3.26e-14 | -0.576 | 1.20e-12 |
Hyaluronan uptake and degradation | 12 | 5.72e-04 | 0.574 | 3.74e-03 |
Unwinding of DNA | 12 | 5.97e-04 | -0.572 | 3.87e-03 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 59 | 2.93e-14 | -0.572 | 1.11e-12 |
NOTCH4 Activation and Transmission of Signal to the Nucleus | 10 | 1.74e-03 | 0.572 | 8.87e-03 |
VLDLR internalisation and degradation | 12 | 6.42e-04 | 0.569 | 4.06e-03 |
PD-1 signaling | 28 | 2.24e-07 | -0.565 | 4.12e-06 |
Platelet sensitization by LDL | 16 | 1.04e-04 | 0.560 | 9.47e-04 |
DNA strand elongation | 32 | 4.60e-08 | -0.558 | 1.01e-06 |
Processive synthesis on the lagging strand | 15 | 2.00e-04 | -0.555 | 1.67e-03 |
Lagging Strand Synthesis | 20 | 2.12e-05 | -0.549 | 2.41e-04 |
Gap junction trafficking | 13 | 6.40e-04 | 0.547 | 4.06e-03 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 11 | 1.79e-03 | 0.544 | 9.07e-03 |
RHO GTPases Activate WASPs and WAVEs | 35 | 3.78e-08 | 0.537 | 8.44e-07 |
Advanced glycosylation endproduct receptor signaling | 12 | 1.28e-03 | 0.537 | 7.01e-03 |
PCNA-Dependent Long Patch Base Excision Repair | 21 | 2.52e-05 | -0.531 | 2.77e-04 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 13 | 9.51e-04 | 0.529 | 5.58e-03 |
Removal of the Flap Intermediate | 14 | 6.35e-04 | -0.527 | 4.06e-03 |
Erythrocytes take up carbon dioxide and release oxygen | 12 | 1.58e-03 | 0.527 | 8.15e-03 |
O2/CO2 exchange in erythrocytes | 12 | 1.58e-03 | 0.527 | 8.15e-03 |
SLBP independent Processing of Histone Pre-mRNAs | 10 | 4.33e-03 | -0.521 | 1.78e-02 |
WNT5A-dependent internalization of FZD4 | 13 | 1.18e-03 | 0.519 | 6.60e-03 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 1.17e-05 | -0.517 | 1.47e-04 |
Retrograde neurotrophin signalling | 12 | 2.17e-03 | 0.511 | 1.06e-02 |
Prolonged ERK activation events | 13 | 1.51e-03 | 0.508 | 7.99e-03 |
Purine ribonucleoside monophosphate biosynthesis | 10 | 5.45e-03 | -0.507 | 2.19e-02 |
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 11 | 3.87e-03 | -0.503 | 1.64e-02 |
Influenza Infection | 154 | 4.36e-27 | -0.503 | 2.28e-25 |
Signal transduction by L1 | 20 | 1.05e-04 | 0.501 | 9.53e-04 |
Erythropoietin activates RAS | 13 | 1.81e-03 | 0.500 | 9.12e-03 |
Synthesis of Leukotrienes (LT) and Eoxins (EX) | 15 | 8.51e-04 | 0.497 | 5.08e-03 |
Activation of ATR in response to replication stress | 37 | 2.01e-07 | -0.494 | 3.75e-06 |
Telomere C-strand (Lagging Strand) Synthesis | 34 | 6.34e-07 | -0.493 | 1.04e-05 |
Phosphorylation of CD3 and TCR zeta chains | 27 | 1.07e-05 | -0.489 | 1.38e-04 |
RHO GTPases activate CIT | 18 | 3.25e-04 | 0.489 | 2.45e-03 |
Generation of second messenger molecules | 38 | 2.64e-07 | -0.482 | 4.67e-06 |
Pre-NOTCH Processing in Golgi | 18 | 4.08e-04 | 0.481 | 2.89e-03 |
Heme degradation | 10 | 8.89e-03 | 0.478 | 3.20e-02 |
BBSome-mediated cargo-targeting to cilium | 22 | 1.14e-04 | -0.475 | 1.02e-03 |
Golgi Cisternae Pericentriolar Stack Reorganization | 14 | 2.08e-03 | 0.475 | 1.03e-02 |
Diseases associated with the TLR signaling cascade | 23 | 7.99e-05 | 0.475 | 7.55e-04 |
Diseases of Immune System | 23 | 7.99e-05 | 0.475 | 7.55e-04 |
RHO GTPases activate IQGAPs | 11 | 6.80e-03 | 0.471 | 2.58e-02 |
EPHB-mediated forward signaling | 32 | 4.14e-06 | 0.470 | 5.69e-05 |
RHO GTPases Activate NADPH Oxidases | 21 | 2.04e-04 | 0.468 | 1.68e-03 |
Telomere C-strand synthesis initiation | 13 | 3.50e-03 | -0.468 | 1.51e-02 |
Sema4D in semaphorin signaling | 22 | 1.52e-04 | 0.466 | 1.32e-03 |
COPI-independent Golgi-to-ER retrograde traffic | 33 | 5.41e-06 | 0.457 | 7.29e-05 |
Cargo concentration in the ER | 30 | 1.48e-05 | 0.457 | 1.79e-04 |
Sema4D induced cell migration and growth-cone collapse | 19 | 5.82e-04 | 0.456 | 3.79e-03 |
Leading Strand Synthesis | 14 | 3.29e-03 | -0.454 | 1.45e-02 |
Polymerase switching | 14 | 3.29e-03 | -0.454 | 1.45e-02 |
Signaling by Erythropoietin | 24 | 1.26e-04 | 0.452 | 1.13e-03 |
GPVI-mediated activation cascade | 31 | 1.49e-05 | 0.449 | 1.79e-04 |
Neutrophil degranulation | 458 | 3.16e-61 | 0.449 | 4.30e-58 |
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 11 | 1.02e-02 | 0.447 | 3.63e-02 |
RHO GTPases activate PAKs | 20 | 5.38e-04 | 0.447 | 3.59e-03 |
Hyaluronan metabolism | 15 | 2.74e-03 | 0.447 | 1.24e-02 |
Translation | 295 | 9.42e-40 | -0.446 | 2.14e-37 |
Frs2-mediated activation | 11 | 1.05e-02 | 0.445 | 3.69e-02 |
Regulated proteolysis of p75NTR | 11 | 1.09e-02 | 0.443 | 3.78e-02 |
Translesion synthesis by REV1 | 16 | 2.21e-03 | -0.442 | 1.07e-02 |
Trafficking of GluR2-containing AMPA receptors | 12 | 8.28e-03 | 0.440 | 3.01e-02 |
AKT phosphorylates targets in the cytosol | 14 | 4.65e-03 | 0.437 | 1.89e-02 |
Mucopolysaccharidoses | 11 | 1.22e-02 | 0.437 | 4.12e-02 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
IRAK4 deficiency (TLR2/4) | 10 | 2.19e-06 | 0.864000 | 3.11e-05 |
MyD88 deficiency (TLR2/4) | 10 | 2.19e-06 | 0.864000 | 3.11e-05 |
Peptide chain elongation | 88 | 5.06e-36 | -0.771000 | 6.88e-34 |
Eukaryotic Translation Elongation | 93 | 1.44e-37 | -0.767000 | 2.18e-35 |
Selenocysteine synthesis | 92 | 1.36e-35 | -0.750000 | 1.68e-33 |
Viral mRNA Translation | 88 | 6.76e-34 | -0.747000 | 6.14e-32 |
Formation of a pool of free 40S subunits | 100 | 4.05e-38 | -0.746000 | 6.88e-36 |
Eukaryotic Translation Termination | 92 | 3.30e-34 | -0.734000 | 3.21e-32 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 1.52e-05 | 0.721000 | 1.79e-04 |
alpha-linolenic acid (ALA) metabolism | 12 | 1.52e-05 | 0.721000 | 1.79e-04 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 94 | 1.58e-32 | -0.708000 | 1.20e-30 |
Translocation of ZAP-70 to Immunological synapse | 24 | 1.98e-09 | -0.707000 | 5.09e-08 |
L13a-mediated translational silencing of Ceruloplasmin expression | 110 | 7.55e-35 | -0.678000 | 8.56e-33 |
GTP hydrolysis and joining of the 60S ribosomal subunit | 111 | 1.11e-34 | -0.674000 | 1.16e-32 |
Response of EIF2AK4 (GCN2) to amino acid deficiency | 100 | 3.17e-31 | -0.672000 | 2.27e-29 |
Formation of the ternary complex, and subsequently, the 43S complex | 51 | 1.92e-16 | -0.665000 | 8.41e-15 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 11 | 1.55e-04 | 0.659000 | 1.33e-03 |
Regulation of TLR by endogenous ligand | 11 | 2.34e-04 | 0.641000 | 1.88e-03 |
Major pathway of rRNA processing in the nucleolus and cytosol | 180 | 6.06e-50 | -0.641000 | 2.06e-47 |
Cap-dependent Translation Initiation | 118 | 2.65e-33 | -0.640000 | 2.12e-31 |
Eukaryotic Translation Initiation | 118 | 2.65e-33 | -0.640000 | 2.12e-31 |
rRNA processing in the nucleus and cytosol | 190 | 7.19e-52 | -0.636000 | 4.89e-49 |
Selenoamino acid metabolism | 114 | 2.44e-30 | -0.620000 | 1.58e-28 |
RHO GTPases Activate ROCKs | 18 | 6.30e-06 | 0.615000 | 8.41e-05 |
Uptake and function of anthrax toxins | 10 | 8.17e-04 | 0.611000 | 4.92e-03 |
Activation of the pre-replicative complex | 32 | 2.71e-09 | -0.607000 | 6.59e-08 |
MET activates RAP1 and RAC1 | 10 | 1.02e-03 | 0.600000 | 5.89e-03 |
rRNA processing | 217 | 2.08e-51 | -0.593000 | 9.44e-49 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 114 | 1.63e-27 | -0.588000 | 9.23e-26 |
Nonsense-Mediated Decay (NMD) | 114 | 1.63e-27 | -0.588000 | 9.23e-26 |
rRNA modification in the nucleus and cytosol | 59 | 5.93e-15 | -0.587000 | 2.45e-13 |
SRP-dependent cotranslational protein targeting to membrane | 111 | 1.23e-26 | -0.586000 | 6.19e-25 |
Translation initiation complex formation | 58 | 1.23e-14 | -0.585000 | 4.80e-13 |
Nucleobase biosynthesis | 13 | 2.88e-04 | -0.581000 | 2.22e-03 |
Influenza Viral RNA Transcription and Replication | 135 | 5.44e-31 | -0.576000 | 3.70e-29 |
Ribosomal scanning and start codon recognition | 58 | 3.26e-14 | -0.576000 | 1.20e-12 |
Hyaluronan uptake and degradation | 12 | 5.72e-04 | 0.574000 | 3.74e-03 |
Unwinding of DNA | 12 | 5.97e-04 | -0.572000 | 3.87e-03 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 59 | 2.93e-14 | -0.572000 | 1.11e-12 |
NOTCH4 Activation and Transmission of Signal to the Nucleus | 10 | 1.74e-03 | 0.572000 | 8.87e-03 |
VLDLR internalisation and degradation | 12 | 6.42e-04 | 0.569000 | 4.06e-03 |
PD-1 signaling | 28 | 2.24e-07 | -0.565000 | 4.12e-06 |
Platelet sensitization by LDL | 16 | 1.04e-04 | 0.560000 | 9.47e-04 |
DNA strand elongation | 32 | 4.60e-08 | -0.558000 | 1.01e-06 |
Processive synthesis on the lagging strand | 15 | 2.00e-04 | -0.555000 | 1.67e-03 |
Lagging Strand Synthesis | 20 | 2.12e-05 | -0.549000 | 2.41e-04 |
Gap junction trafficking | 13 | 6.40e-04 | 0.547000 | 4.06e-03 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 11 | 1.79e-03 | 0.544000 | 9.07e-03 |
RHO GTPases Activate WASPs and WAVEs | 35 | 3.78e-08 | 0.537000 | 8.44e-07 |
Advanced glycosylation endproduct receptor signaling | 12 | 1.28e-03 | 0.537000 | 7.01e-03 |
PCNA-Dependent Long Patch Base Excision Repair | 21 | 2.52e-05 | -0.531000 | 2.77e-04 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 13 | 9.51e-04 | 0.529000 | 5.58e-03 |
Removal of the Flap Intermediate | 14 | 6.35e-04 | -0.527000 | 4.06e-03 |
Erythrocytes take up carbon dioxide and release oxygen | 12 | 1.58e-03 | 0.527000 | 8.15e-03 |
O2/CO2 exchange in erythrocytes | 12 | 1.58e-03 | 0.527000 | 8.15e-03 |
SLBP independent Processing of Histone Pre-mRNAs | 10 | 4.33e-03 | -0.521000 | 1.78e-02 |
WNT5A-dependent internalization of FZD4 | 13 | 1.18e-03 | 0.519000 | 6.60e-03 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 1.17e-05 | -0.517000 | 1.47e-04 |
Retrograde neurotrophin signalling | 12 | 2.17e-03 | 0.511000 | 1.06e-02 |
Prolonged ERK activation events | 13 | 1.51e-03 | 0.508000 | 7.99e-03 |
Purine ribonucleoside monophosphate biosynthesis | 10 | 5.45e-03 | -0.507000 | 2.19e-02 |
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 11 | 3.87e-03 | -0.503000 | 1.64e-02 |
Influenza Infection | 154 | 4.36e-27 | -0.503000 | 2.28e-25 |
Signal transduction by L1 | 20 | 1.05e-04 | 0.501000 | 9.53e-04 |
Erythropoietin activates RAS | 13 | 1.81e-03 | 0.500000 | 9.12e-03 |
Synthesis of Leukotrienes (LT) and Eoxins (EX) | 15 | 8.51e-04 | 0.497000 | 5.08e-03 |
Activation of ATR in response to replication stress | 37 | 2.01e-07 | -0.494000 | 3.75e-06 |
Telomere C-strand (Lagging Strand) Synthesis | 34 | 6.34e-07 | -0.493000 | 1.04e-05 |
Phosphorylation of CD3 and TCR zeta chains | 27 | 1.07e-05 | -0.489000 | 1.38e-04 |
RHO GTPases activate CIT | 18 | 3.25e-04 | 0.489000 | 2.45e-03 |
Generation of second messenger molecules | 38 | 2.64e-07 | -0.482000 | 4.67e-06 |
Pre-NOTCH Processing in Golgi | 18 | 4.08e-04 | 0.481000 | 2.89e-03 |
Heme degradation | 10 | 8.89e-03 | 0.478000 | 3.20e-02 |
BBSome-mediated cargo-targeting to cilium | 22 | 1.14e-04 | -0.475000 | 1.02e-03 |
Golgi Cisternae Pericentriolar Stack Reorganization | 14 | 2.08e-03 | 0.475000 | 1.03e-02 |
Diseases associated with the TLR signaling cascade | 23 | 7.99e-05 | 0.475000 | 7.55e-04 |
Diseases of Immune System | 23 | 7.99e-05 | 0.475000 | 7.55e-04 |
RHO GTPases activate IQGAPs | 11 | 6.80e-03 | 0.471000 | 2.58e-02 |
EPHB-mediated forward signaling | 32 | 4.14e-06 | 0.470000 | 5.69e-05 |
RHO GTPases Activate NADPH Oxidases | 21 | 2.04e-04 | 0.468000 | 1.68e-03 |
Telomere C-strand synthesis initiation | 13 | 3.50e-03 | -0.468000 | 1.51e-02 |
Sema4D in semaphorin signaling | 22 | 1.52e-04 | 0.466000 | 1.32e-03 |
COPI-independent Golgi-to-ER retrograde traffic | 33 | 5.41e-06 | 0.457000 | 7.29e-05 |
Cargo concentration in the ER | 30 | 1.48e-05 | 0.457000 | 1.79e-04 |
Sema4D induced cell migration and growth-cone collapse | 19 | 5.82e-04 | 0.456000 | 3.79e-03 |
Leading Strand Synthesis | 14 | 3.29e-03 | -0.454000 | 1.45e-02 |
Polymerase switching | 14 | 3.29e-03 | -0.454000 | 1.45e-02 |
Signaling by Erythropoietin | 24 | 1.26e-04 | 0.452000 | 1.13e-03 |
GPVI-mediated activation cascade | 31 | 1.49e-05 | 0.449000 | 1.79e-04 |
Neutrophil degranulation | 458 | 3.16e-61 | 0.449000 | 4.30e-58 |
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 11 | 1.02e-02 | 0.447000 | 3.63e-02 |
RHO GTPases activate PAKs | 20 | 5.38e-04 | 0.447000 | 3.59e-03 |
Hyaluronan metabolism | 15 | 2.74e-03 | 0.447000 | 1.24e-02 |
Translation | 295 | 9.42e-40 | -0.446000 | 2.14e-37 |
Frs2-mediated activation | 11 | 1.05e-02 | 0.445000 | 3.69e-02 |
Regulated proteolysis of p75NTR | 11 | 1.09e-02 | 0.443000 | 3.78e-02 |
Translesion synthesis by REV1 | 16 | 2.21e-03 | -0.442000 | 1.07e-02 |
Trafficking of GluR2-containing AMPA receptors | 12 | 8.28e-03 | 0.440000 | 3.01e-02 |
AKT phosphorylates targets in the cytosol | 14 | 4.65e-03 | 0.437000 | 1.89e-02 |
Mucopolysaccharidoses | 11 | 1.22e-02 | 0.437000 | 4.12e-02 |
Detoxification of Reactive Oxygen Species | 32 | 2.51e-05 | 0.430000 | 2.77e-04 |
Metabolism of non-coding RNA | 53 | 6.30e-08 | -0.429000 | 1.30e-06 |
snRNP Assembly | 53 | 6.30e-08 | -0.429000 | 1.30e-06 |
RHO GTPases activate PKNs | 48 | 3.53e-07 | 0.425000 | 6.00e-06 |
Gap junction trafficking and regulation | 15 | 4.41e-03 | 0.425000 | 1.81e-02 |
Regulation of IFNG signaling | 14 | 6.27e-03 | 0.422000 | 2.43e-02 |
Recycling pathway of L1 | 26 | 2.57e-04 | 0.414000 | 2.03e-03 |
Translesion synthesis by POLI | 17 | 3.35e-03 | -0.411000 | 1.47e-02 |
Negative regulation of MET activity | 18 | 2.58e-03 | 0.410000 | 1.18e-02 |
Polymerase switching on the C-strand of the telomere | 26 | 2.94e-04 | -0.410000 | 2.25e-03 |
RNA Polymerase I Promoter Opening | 19 | 2.22e-03 | 0.405000 | 1.07e-02 |
Dissolution of Fibrin Clot | 12 | 1.51e-02 | 0.405000 | 4.93e-02 |
ERKs are inactivated | 13 | 1.17e-02 | 0.404000 | 4.00e-02 |
Regulation of signaling by CBL | 18 | 3.09e-03 | 0.403000 | 1.38e-02 |
tRNA modification in the nucleus and cytosol | 43 | 5.03e-06 | -0.402000 | 6.85e-05 |
Insulin receptor recycling | 21 | 1.49e-03 | 0.400000 | 7.93e-03 |
MAP2K and MAPK activation | 34 | 5.66e-05 | 0.399000 | 5.54e-04 |
Extension of Telomeres | 51 | 9.09e-07 | -0.397000 | 1.44e-05 |
IRAK1 recruits IKK complex | 10 | 3.02e-02 | 0.396000 | 8.52e-02 |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 10 | 3.02e-02 | 0.396000 | 8.52e-02 |
Integrin signaling | 22 | 1.34e-03 | 0.395000 | 7.29e-03 |
RORA activates gene expression | 18 | 3.76e-03 | 0.394000 | 1.61e-02 |
Interactions of Vpr with host cellular proteins | 37 | 3.43e-05 | -0.394000 | 3.70e-04 |
Resolution of Abasic Sites (AP sites) | 37 | 4.22e-05 | -0.389000 | 4.35e-04 |
Translesion synthesis by POLK | 17 | 5.73e-03 | -0.387000 | 2.26e-02 |
VxPx cargo-targeting to cilium | 19 | 3.50e-03 | 0.387000 | 1.51e-02 |
Signaling by high-kinase activity BRAF mutants | 31 | 2.02e-04 | 0.386000 | 1.68e-03 |
Rev-mediated nuclear export of HIV RNA | 35 | 7.89e-05 | -0.386000 | 7.55e-04 |
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 14 | 1.27e-02 | -0.385000 | 4.25e-02 |
mRNA decay by 3' to 5' exoribonuclease | 16 | 7.70e-03 | -0.385000 | 2.86e-02 |
Regulation of expression of SLITs and ROBOs | 159 | 6.82e-17 | -0.383000 | 3.09e-15 |
Signaling by Leptin | 10 | 3.66e-02 | 0.382000 | 9.82e-02 |
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | 21 | 2.48e-03 | 0.381000 | 1.15e-02 |
Neurodegenerative Diseases | 21 | 2.48e-03 | 0.381000 | 1.15e-02 |
Chondroitin sulfate biosynthesis | 12 | 2.22e-02 | 0.381000 | 6.68e-02 |
G-protein beta:gamma signalling | 29 | 3.86e-04 | 0.381000 | 2.79e-03 |
Processive synthesis on the C-strand of the telomere | 19 | 4.06e-03 | -0.381000 | 1.70e-02 |
Gap-filling DNA repair synthesis and ligation in GG-NER | 25 | 9.91e-04 | -0.380000 | 5.79e-03 |
Interactions of Rev with host cellular proteins | 37 | 6.52e-05 | -0.379000 | 6.34e-04 |
Collagen degradation | 29 | 4.12e-04 | 0.379000 | 2.90e-03 |
tRNA Aminoacylation | 42 | 2.27e-05 | -0.378000 | 2.56e-04 |
Postmitotic nuclear pore complex (NPC) reformation | 27 | 6.85e-04 | -0.377000 | 4.22e-03 |
Mitochondrial tRNA aminoacylation | 21 | 2.83e-03 | -0.376000 | 1.27e-02 |
Sealing of the nuclear envelope (NE) by ESCRT-III | 25 | 1.13e-03 | 0.376000 | 6.37e-03 |
p130Cas linkage to MAPK signaling for integrins | 11 | 3.09e-02 | 0.376000 | 8.65e-02 |
Endosomal Sorting Complex Required For Transport (ESCRT) | 29 | 4.77e-04 | 0.375000 | 3.25e-03 |
Vpr-mediated nuclear import of PICs | 34 | 1.62e-04 | -0.374000 | 1.38e-03 |
Glycogen breakdown (glycogenolysis) | 13 | 1.99e-02 | 0.373000 | 6.13e-02 |
Mitochondrial translation elongation | 91 | 8.68e-10 | -0.372000 | 2.32e-08 |
Pentose phosphate pathway | 13 | 2.07e-02 | 0.370000 | 6.30e-02 |
tRNA processing in the nucleus | 59 | 9.95e-07 | -0.368000 | 1.56e-05 |
Budding and maturation of HIV virion | 26 | 1.18e-03 | 0.367000 | 6.60e-03 |
ROS and RNS production in phagocytes | 31 | 4.06e-04 | 0.367000 | 2.89e-03 |
Spry regulation of FGF signaling | 16 | 1.13e-02 | 0.366000 | 3.90e-02 |
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 22 | 2.99e-03 | 0.366000 | 1.34e-02 |
Transferrin endocytosis and recycling | 26 | 1.25e-03 | 0.365000 | 6.94e-03 |
HDMs demethylate histones | 22 | 3.02e-03 | 0.365000 | 1.35e-02 |
EPH-Ephrin signaling | 79 | 2.09e-08 | 0.365000 | 4.82e-07 |
COPI-mediated anterograde transport | 78 | 2.88e-08 | 0.363000 | 6.53e-07 |
Beta-catenin phosphorylation cascade | 17 | 9.56e-03 | 0.363000 | 3.43e-02 |
Smooth Muscle Contraction | 31 | 4.74e-04 | 0.363000 | 3.25e-03 |
Early Phase of HIV Life Cycle | 14 | 1.88e-02 | -0.363000 | 5.84e-02 |
Signaling by RAF1 mutants | 34 | 2.62e-04 | 0.362000 | 2.05e-03 |
Interleukin-3, Interleukin-5 and GM-CSF signaling | 40 | 8.08e-05 | 0.360000 | 7.58e-04 |
Diseases of DNA repair | 10 | 4.87e-02 | -0.360000 | 1.21e-01 |
Folding of actin by CCT/TriC | 10 | 4.90e-02 | -0.360000 | 1.22e-01 |
Cytosolic tRNA aminoacylation | 24 | 2.30e-03 | -0.359000 | 1.09e-02 |
Mitochondrial translation termination | 91 | 3.55e-09 | -0.358000 | 8.47e-08 |
Recognition of DNA damage by PCNA-containing replication complex | 30 | 6.95e-04 | -0.358000 | 4.24e-03 |
Mitochondrial translation initiation | 91 | 3.68e-09 | -0.358000 | 8.63e-08 |
NEP/NS2 Interacts with the Cellular Export Machinery | 32 | 4.77e-04 | -0.357000 | 3.25e-03 |
Metabolism of amine-derived hormones | 10 | 5.10e-02 | -0.356000 | 1.26e-01 |
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 14 | 2.13e-02 | -0.355000 | 6.43e-02 |
Growth hormone receptor signaling | 20 | 5.93e-03 | 0.355000 | 2.32e-02 |
InlB-mediated entry of Listeria monocytogenes into host cell | 12 | 3.35e-02 | 0.354000 | 9.15e-02 |
Mismatch Repair | 15 | 1.78e-02 | -0.353000 | 5.60e-02 |
Intraflagellar transport | 39 | 1.35e-04 | -0.353000 | 1.19e-03 |
Nuclear import of Rev protein | 34 | 3.66e-04 | -0.353000 | 2.72e-03 |
FOXO-mediated transcription of cell death genes | 16 | 1.50e-02 | 0.351000 | 4.91e-02 |
COPII-mediated vesicle transport | 65 | 1.07e-06 | 0.350000 | 1.66e-05 |
Mitochondrial translation | 97 | 2.66e-09 | -0.350000 | 6.59e-08 |
BMAL1:CLOCK,NPAS2 activates circadian gene expression | 25 | 2.61e-03 | 0.348000 | 1.19e-02 |
RNA Polymerase I Transcription Initiation | 47 | 3.98e-05 | -0.346000 | 4.14e-04 |
Interleukin-6 signaling | 10 | 5.85e-02 | 0.346000 | 1.38e-01 |
ER to Golgi Anterograde Transport | 129 | 1.91e-11 | 0.342000 | 6.05e-10 |
Post-translational protein phosphorylation | 70 | 7.43e-07 | 0.342000 | 1.19e-05 |
Regulation of IFNA signaling | 12 | 4.03e-02 | 0.342000 | 1.07e-01 |
tRNA processing | 134 | 8.34e-12 | -0.342000 | 2.83e-10 |
Regulation of cholesterol biosynthesis by SREBP (SREBF) | 55 | 1.17e-05 | 0.342000 | 1.47e-04 |
RNA Polymerase I Transcription Termination | 30 | 1.23e-03 | -0.341000 | 6.81e-03 |
Notch-HLH transcription pathway | 28 | 1.79e-03 | 0.341000 | 9.07e-03 |
Platelet Aggregation (Plug Formation) | 28 | 1.83e-03 | 0.340000 | 9.18e-03 |
activated TAK1 mediates p38 MAPK activation | 19 | 1.03e-02 | 0.340000 | 3.65e-02 |
Signal regulatory protein family interactions | 12 | 4.17e-02 | 0.340000 | 1.10e-01 |
Beta-oxidation of very long chain fatty acids | 10 | 6.34e-02 | 0.339000 | 1.46e-01 |
Removal of the Flap Intermediate from the C-strand | 17 | 1.56e-02 | -0.339000 | 5.03e-02 |
LDL clearance | 18 | 1.31e-02 | 0.338000 | 4.36e-02 |
Termination of translesion DNA synthesis | 32 | 1.09e-03 | -0.334000 | 6.22e-03 |
Adenylate cyclase inhibitory pathway | 11 | 5.99e-02 | 0.328000 | 1.41e-01 |
EPHA-mediated growth cone collapse | 13 | 4.09e-02 | 0.327000 | 1.08e-01 |
HDR through MMEJ (alt-NHEJ) | 10 | 7.32e-02 | -0.327000 | 1.63e-01 |
ADP signalling through P2Y purinoceptor 1 | 21 | 9.78e-03 | 0.326000 | 3.49e-02 |
G beta:gamma signalling through PI3Kgamma | 22 | 8.21e-03 | 0.326000 | 3.00e-02 |
Pyrimidine salvage | 10 | 7.49e-02 | 0.325000 | 1.66e-01 |
trans-Golgi Network Vesicle Budding | 69 | 3.01e-06 | 0.325000 | 4.22e-05 |
Activation of gene expression by SREBF (SREBP) | 42 | 2.86e-04 | 0.323000 | 2.21e-03 |
Export of Viral Ribonucleoproteins from Nucleus | 33 | 1.39e-03 | -0.322000 | 7.46e-03 |
RNA Polymerase III Chain Elongation | 18 | 1.82e-02 | -0.322000 | 5.69e-02 |
TBC/RABGAPs | 45 | 1.90e-04 | 0.322000 | 1.59e-03 |
GRB2:SOS provides linkage to MAPK signaling for Integrins | 12 | 5.56e-02 | 0.319000 | 1.33e-01 |
Energy dependent regulation of mTOR by LKB1-AMPK | 27 | 4.14e-03 | 0.319000 | 1.72e-02 |
Paradoxical activation of RAF signaling by kinase inactive BRAF | 38 | 6.83e-04 | 0.318000 | 4.22e-03 |
Signaling by RAS mutants | 38 | 6.83e-04 | 0.318000 | 4.22e-03 |
Signaling by moderate kinase activity BRAF mutants | 38 | 6.83e-04 | 0.318000 | 4.22e-03 |
Signaling downstream of RAS mutants | 38 | 6.83e-04 | 0.318000 | 4.22e-03 |
DNA methylation | 20 | 1.37e-02 | 0.318000 | 4.53e-02 |
RAF activation | 32 | 1.97e-03 | 0.316000 | 9.83e-03 |
RAB GEFs exchange GTP for GDP on RABs | 88 | 3.07e-07 | 0.316000 | 5.28e-06 |
Pre-NOTCH Expression and Processing | 65 | 1.10e-05 | 0.315000 | 1.41e-04 |
Clathrin-mediated endocytosis | 127 | 8.71e-10 | 0.315000 | 2.32e-08 |
Transport of the SLBP Dependant Mature mRNA | 36 | 1.09e-03 | -0.315000 | 6.22e-03 |
Transport of the SLBP independent Mature mRNA | 35 | 1.28e-03 | -0.314000 | 7.01e-03 |
Signal amplification | 28 | 4.16e-03 | 0.313000 | 1.72e-02 |
Gastrin-CREB signalling pathway via PKC and MAPK | 14 | 4.34e-02 | 0.312000 | 1.13e-01 |
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | 12 | 6.18e-02 | 0.311000 | 1.43e-01 |
Diseases of hemostasis | 12 | 6.18e-02 | 0.311000 | 1.43e-01 |
Transport of Ribonucleoproteins into the Host Nucleus | 32 | 2.36e-03 | -0.311000 | 1.11e-02 |
Lysosome Vesicle Biogenesis | 32 | 2.44e-03 | 0.310000 | 1.14e-02 |
Synthesis of PC | 24 | 8.72e-03 | 0.309000 | 3.15e-02 |
Pre-NOTCH Transcription and Translation | 49 | 1.82e-04 | 0.309000 | 1.55e-03 |
PPARA activates gene expression | 104 | 5.50e-08 | 0.308000 | 1.17e-06 |
Signalling to ERKs | 32 | 2.54e-03 | 0.308000 | 1.17e-02 |
Thrombin signalling through proteinase activated receptors (PARs) | 27 | 5.61e-03 | 0.308000 | 2.23e-02 |
PKA activation in glucagon signalling | 14 | 4.67e-02 | 0.307000 | 1.18e-01 |
RNA Polymerase III Transcription Initiation From Type 1 Promoter | 28 | 4.96e-03 | -0.307000 | 2.00e-02 |
Diseases of programmed cell death | 23 | 1.09e-02 | 0.307000 | 3.78e-02 |
RHO GTPases activate KTN1 | 11 | 7.89e-02 | 0.306000 | 1.72e-01 |
RAB geranylgeranylation | 60 | 4.39e-05 | 0.305000 | 4.46e-04 |
Dual Incision in GG-NER | 41 | 8.66e-04 | -0.301000 | 5.14e-03 |
Mitochondrial protein import | 64 | 3.50e-05 | -0.299000 | 3.75e-04 |
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 81 | 3.26e-06 | 0.299000 | 4.53e-05 |
CD22 mediated BCR regulation | 59 | 7.14e-05 | -0.299000 | 6.89e-04 |
Common Pathway of Fibrin Clot Formation | 14 | 5.37e-02 | 0.298000 | 1.30e-01 |
Regulation of lipid metabolism by PPARalpha | 106 | 1.33e-07 | 0.296000 | 2.56e-06 |
GAB1 signalosome | 15 | 4.79e-02 | 0.295000 | 1.19e-01 |
Metabolism of RNA | 685 | 1.65e-39 | -0.294000 | 3.21e-37 |
Fanconi Anemia Pathway | 36 | 2.26e-03 | -0.294000 | 1.08e-02 |
MET activates RAS signaling | 10 | 1.08e-01 | 0.294000 | 2.15e-01 |
G beta:gamma signalling through CDC42 | 17 | 3.62e-02 | 0.293000 | 9.75e-02 |
GABA receptor activation | 35 | 2.73e-03 | 0.293000 | 1.24e-02 |
Golgi Associated Vesicle Biogenesis | 55 | 1.83e-04 | 0.292000 | 1.55e-03 |
Transport to the Golgi and subsequent modification | 155 | 3.74e-10 | 0.291000 | 1.16e-08 |
Glycosphingolipid metabolism | 36 | 2.50e-03 | 0.291000 | 1.15e-02 |
NS1 Mediated Effects on Host Pathways | 40 | 1.45e-03 | -0.291000 | 7.73e-03 |
Translesion Synthesis by POLH | 18 | 3.30e-02 | -0.290000 | 9.06e-02 |
Semaphorin interactions | 57 | 1.53e-04 | 0.290000 | 1.32e-03 |
MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 92 | 1.56e-06 | 0.290000 | 2.28e-05 |
Toll Like Receptor 2 (TLR2) Cascade | 92 | 1.56e-06 | 0.290000 | 2.28e-05 |
Toll Like Receptor TLR1:TLR2 Cascade | 92 | 1.56e-06 | 0.290000 | 2.28e-05 |
Toll Like Receptor TLR6:TLR2 Cascade | 92 | 1.56e-06 | 0.290000 | 2.28e-05 |
Homologous DNA Pairing and Strand Exchange | 42 | 1.16e-03 | -0.290000 | 6.52e-03 |
Cargo recognition for clathrin-mediated endocytosis | 90 | 2.04e-06 | 0.290000 | 2.95e-05 |
Suppression of phagosomal maturation | 12 | 8.26e-02 | 0.289000 | 1.79e-01 |
Misspliced GSK3beta mutants stabilize beta-catenin | 15 | 5.30e-02 | 0.289000 | 1.28e-01 |
S33 mutants of beta-catenin aren't phosphorylated | 15 | 5.30e-02 | 0.289000 | 1.28e-01 |
S37 mutants of beta-catenin aren't phosphorylated | 15 | 5.30e-02 | 0.289000 | 1.28e-01 |
S45 mutants of beta-catenin aren't phosphorylated | 15 | 5.30e-02 | 0.289000 | 1.28e-01 |
T41 mutants of beta-catenin aren't phosphorylated | 15 | 5.30e-02 | 0.289000 | 1.28e-01 |
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | 15 | 5.30e-02 | 0.289000 | 1.28e-01 |
Caspase activation via extrinsic apoptotic signalling pathway | 25 | 1.26e-02 | 0.288000 | 4.24e-02 |
Platelet activation, signaling and aggregation | 221 | 1.64e-13 | 0.288000 | 5.86e-12 |
Activation of GABAB receptors | 30 | 6.39e-03 | 0.288000 | 2.46e-02 |
GABA B receptor activation | 30 | 6.39e-03 | 0.288000 | 2.46e-02 |
Signaling by MET | 61 | 1.02e-04 | 0.288000 | 9.39e-04 |
ATF6 (ATF6-alpha) activates chaperone genes | 10 | 1.15e-01 | 0.288000 | 2.24e-01 |
EGFR downregulation | 27 | 9.76e-03 | 0.287000 | 3.49e-02 |
Rab regulation of trafficking | 121 | 4.86e-08 | 0.287000 | 1.05e-06 |
Dectin-2 family | 19 | 3.03e-02 | 0.287000 | 8.53e-02 |
Biotin transport and metabolism | 11 | 1.02e-01 | -0.285000 | 2.09e-01 |
RNA Polymerase III Transcription Initiation From Type 2 Promoter | 27 | 1.04e-02 | -0.285000 | 3.68e-02 |
Post-chaperonin tubulin folding pathway | 19 | 3.18e-02 | 0.285000 | 8.79e-02 |
Apoptosis induced DNA fragmentation | 10 | 1.20e-01 | 0.284000 | 2.31e-01 |
Plasma lipoprotein assembly | 10 | 1.21e-01 | 0.283000 | 2.31e-01 |
Golgi-to-ER retrograde transport | 111 | 2.50e-07 | 0.283000 | 4.54e-06 |
Response to elevated platelet cytosolic Ca2+ | 110 | 2.85e-07 | 0.283000 | 4.96e-06 |
Plasma lipoprotein remodeling | 18 | 3.77e-02 | 0.283000 | 1.01e-01 |
SUMOylation of immune response proteins | 11 | 1.05e-01 | 0.283000 | 2.13e-01 |
Presynaptic phase of homologous DNA pairing and strand exchange | 39 | 2.28e-03 | -0.282000 | 1.08e-02 |
Scavenging by Class A Receptors | 11 | 1.05e-01 | 0.282000 | 2.13e-01 |
Response of Mtb to phagocytosis | 22 | 2.24e-02 | 0.281000 | 6.72e-02 |
SUMOylation of SUMOylation proteins | 35 | 4.04e-03 | -0.281000 | 1.70e-02 |
Signaling by ROBO receptors | 199 | 8.54e-12 | -0.281000 | 2.83e-10 |
Late endosomal microautophagy | 30 | 7.81e-03 | 0.281000 | 2.87e-02 |
Transcriptional Regulation by E2F6 | 34 | 4.63e-03 | -0.281000 | 1.89e-02 |
RUNX3 regulates NOTCH signaling | 14 | 6.92e-02 | 0.281000 | 1.57e-01 |
ATF6 (ATF6-alpha) activates chaperones | 12 | 9.25e-02 | 0.281000 | 1.95e-01 |
rRNA processing in the mitochondrion | 27 | 1.17e-02 | -0.280000 | 4.00e-02 |
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | 32 | 6.07e-03 | -0.280000 | 2.37e-02 |
Regulation of Glucokinase by Glucokinase Regulatory Protein | 32 | 6.07e-03 | -0.280000 | 2.37e-02 |
TNFs bind their physiological receptors | 25 | 1.53e-02 | -0.280000 | 4.98e-02 |
DARPP-32 events | 22 | 2.31e-02 | 0.280000 | 6.88e-02 |
Rap1 signalling | 13 | 8.18e-02 | 0.279000 | 1.78e-01 |
Platelet degranulation | 106 | 7.37e-07 | 0.278000 | 1.19e-05 |
NOTCH3 Intracellular Domain Regulates Transcription | 20 | 3.15e-02 | 0.278000 | 8.75e-02 |
ADP signalling through P2Y purinoceptor 12 | 18 | 4.24e-02 | 0.276000 | 1.11e-01 |
G beta:gamma signalling through BTK | 15 | 6.41e-02 | 0.276000 | 1.47e-01 |
L1CAM interactions | 85 | 1.25e-05 | 0.274000 | 1.56e-04 |
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 12 | 1.01e-01 | 0.273000 | 2.09e-01 |
Membrane Trafficking | 558 | 2.21e-28 | 0.273000 | 1.37e-26 |
Degradation of the extracellular matrix | 78 | 3.14e-05 | 0.273000 | 3.42e-04 |
Toll Like Receptor 4 (TLR4) Cascade | 121 | 2.61e-07 | 0.271000 | 4.67e-06 |
Glutamate and glutamine metabolism | 12 | 1.04e-01 | -0.271000 | 2.13e-01 |
G1/S-Specific Transcription | 29 | 1.20e-02 | -0.269000 | 4.07e-02 |
Regulation of FZD by ubiquitination | 15 | 7.17e-02 | -0.269000 | 1.60e-01 |
Assembly of active LPL and LIPC lipase complexes | 10 | 1.43e-01 | 0.267000 | 2.64e-01 |
Signaling by BRAF and RAF fusions | 57 | 4.86e-04 | 0.267000 | 3.29e-03 |
XBP1(S) activates chaperone genes | 47 | 1.53e-03 | 0.267000 | 8.06e-03 |
Transcriptional regulation of granulopoiesis | 46 | 1.73e-03 | 0.267000 | 8.87e-03 |
The NLRP3 inflammasome | 15 | 7.36e-02 | 0.267000 | 1.64e-01 |
SUMOylation of RNA binding proteins | 47 | 1.56e-03 | -0.267000 | 8.14e-03 |
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | 14 | 8.42e-02 | 0.267000 | 1.81e-01 |
Presynaptic function of Kainate receptors | 18 | 5.03e-02 | 0.266000 | 1.25e-01 |
Transcriptional regulation of white adipocyte differentiation | 77 | 5.40e-05 | 0.266000 | 5.33e-04 |
Amyloid fiber formation | 51 | 1.02e-03 | 0.266000 | 5.89e-03 |
SHC1 events in EGFR signaling | 12 | 1.11e-01 | 0.265000 | 2.19e-01 |
Innate Immune System | 967 | 2.26e-44 | 0.265000 | 6.16e-42 |
Glucagon signaling in metabolic regulation | 27 | 1.72e-02 | 0.265000 | 5.46e-02 |
Antigen processing-Cross presentation | 97 | 6.61e-06 | 0.265000 | 8.74e-05 |
EPH-ephrin mediated repulsion of cells | 40 | 3.78e-03 | 0.265000 | 1.61e-02 |
Translocation of SLC2A4 (GLUT4) to the plasma membrane | 48 | 1.54e-03 | 0.264000 | 8.06e-03 |
Activation of G protein gated Potassium channels | 19 | 4.62e-02 | 0.264000 | 1.17e-01 |
G protein gated Potassium channels | 19 | 4.62e-02 | 0.264000 | 1.17e-01 |
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | 19 | 4.62e-02 | 0.264000 | 1.17e-01 |
Plasma lipoprotein assembly, remodeling, and clearance | 53 | 8.83e-04 | 0.264000 | 5.21e-03 |
NOTCH2 intracellular domain regulates transcription | 11 | 1.33e-01 | 0.262000 | 2.48e-01 |
Signaling by NTRKs | 116 | 1.18e-06 | 0.261000 | 1.81e-05 |
ERK/MAPK targets | 22 | 3.40e-02 | 0.261000 | 9.29e-02 |
Membrane binding and targetting of GAG proteins | 13 | 1.05e-01 | 0.260000 | 2.13e-01 |
Synthesis And Processing Of GAG, GAGPOL Polyproteins | 13 | 1.05e-01 | 0.260000 | 2.13e-01 |
Metabolism of steroid hormones | 20 | 4.50e-02 | 0.259000 | 1.16e-01 |
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 15 | 8.29e-02 | 0.259000 | 1.79e-01 |
Activated NOTCH1 Transmits Signal to the Nucleus | 27 | 2.00e-02 | 0.259000 | 6.14e-02 |
Signaling by NTRK1 (TRKA) | 101 | 7.13e-06 | 0.258000 | 9.33e-05 |
MET promotes cell motility | 26 | 2.28e-02 | 0.258000 | 6.82e-02 |
Toll-like Receptor Cascades | 143 | 1.03e-07 | 0.258000 | 2.05e-06 |
IRE1alpha activates chaperones | 49 | 1.82e-03 | 0.257000 | 9.13e-03 |
Integration of energy metabolism | 86 | 3.88e-05 | 0.257000 | 4.10e-04 |
NOTCH4 Intracellular Domain Regulates Transcription | 17 | 6.77e-02 | 0.256000 | 1.54e-01 |
G beta:gamma signalling through PLC beta | 17 | 6.83e-02 | 0.255000 | 1.55e-01 |
PINK1-PRKN Mediated Mitophagy | 21 | 4.29e-02 | -0.255000 | 1.12e-01 |
Glycogen metabolism | 23 | 3.46e-02 | 0.255000 | 9.36e-02 |
Transport of Mature mRNAs Derived from Intronless Transcripts | 43 | 3.88e-03 | -0.255000 | 1.64e-02 |
Infection with Mycobacterium tuberculosis | 26 | 2.48e-02 | 0.254000 | 7.25e-02 |
VEGFA-VEGFR2 Pathway | 92 | 2.49e-05 | 0.254000 | 2.77e-04 |
Intra-Golgi traffic | 43 | 4.02e-03 | 0.253000 | 1.70e-02 |
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 33 | 1.17e-02 | 0.253000 | 4.00e-02 |
Transport of Mature mRNA Derived from an Intronless Transcript | 42 | 4.56e-03 | -0.253000 | 1.87e-02 |
MyD88 dependent cascade initiated on endosome | 89 | 3.92e-05 | 0.252000 | 4.10e-04 |
Toll Like Receptor 7/8 (TLR7/8) Cascade | 89 | 3.92e-05 | 0.252000 | 4.10e-04 |
Defects in vitamin and cofactor metabolism | 21 | 4.55e-02 | -0.252000 | 1.16e-01 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 88 | 4.58e-05 | 0.251000 | 4.62e-04 |
Long-term potentiation | 14 | 1.04e-01 | -0.251000 | 2.13e-01 |
Endogenous sterols | 17 | 7.45e-02 | 0.250000 | 1.65e-01 |
AMER1 mutants destabilize the destruction complex | 14 | 1.06e-01 | 0.250000 | 2.13e-01 |
APC truncation mutants have impaired AXIN binding | 14 | 1.06e-01 | 0.250000 | 2.13e-01 |
AXIN missense mutants destabilize the destruction complex | 14 | 1.06e-01 | 0.250000 | 2.13e-01 |
AXIN mutants destabilize the destruction complex, activating WNT signaling | 14 | 1.06e-01 | 0.250000 | 2.13e-01 |
Truncations of AMER1 destabilize the destruction complex | 14 | 1.06e-01 | 0.250000 | 2.13e-01 |
truncated APC mutants destabilize the destruction complex | 14 | 1.06e-01 | 0.250000 | 2.13e-01 |
Transport of Mature mRNA derived from an Intron-Containing Transcript | 72 | 2.57e-04 | -0.249000 | 2.03e-03 |
Triglyceride catabolism | 16 | 8.46e-02 | 0.249000 | 1.82e-01 |
Plasma lipoprotein clearance | 29 | 2.04e-02 | 0.249000 | 6.21e-02 |
Carboxyterminal post-translational modifications of tubulin | 26 | 2.87e-02 | 0.248000 | 8.15e-02 |
Classical antibody-mediated complement activation | 69 | 3.73e-04 | -0.248000 | 2.74e-03 |
Oncogenic MAPK signaling | 73 | 2.75e-04 | 0.246000 | 2.14e-03 |
Transcription of E2F targets under negative control by DREAM complex | 19 | 6.32e-02 | -0.246000 | 1.46e-01 |
Interleukin-27 signaling | 11 | 1.58e-01 | 0.246000 | 2.79e-01 |
Signaling by SCF-KIT | 40 | 7.14e-03 | 0.246000 | 2.68e-02 |
HuR (ELAVL1) binds and stabilizes mRNA | 10 | 1.78e-01 | 0.246000 | 3.08e-01 |
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 16 | 9.01e-02 | 0.245000 | 1.91e-01 |
Assembly Of The HIV Virion | 15 | 1.01e-01 | 0.244000 | 2.09e-01 |
RNA Polymerase III Transcription Termination | 23 | 4.30e-02 | -0.244000 | 1.12e-01 |
Interleukin-15 signaling | 14 | 1.15e-01 | 0.243000 | 2.24e-01 |
Activation of Matrix Metalloproteinases | 23 | 4.37e-02 | 0.243000 | 1.13e-01 |
Calnexin/calreticulin cycle | 26 | 3.21e-02 | 0.243000 | 8.84e-02 |
Nuclear Pore Complex (NPC) Disassembly | 36 | 1.18e-02 | -0.242000 | 4.02e-02 |
Translation of Replicase and Assembly of the Replication Transcription Complex | 12 | 1.47e-01 | 0.242000 | 2.69e-01 |
RUNX3 regulates p14-ARF | 10 | 1.86e-01 | 0.241000 | 3.17e-01 |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 32 | 1.81e-02 | 0.241000 | 5.68e-02 |
Thromboxane signalling through TP receptor | 20 | 6.17e-02 | 0.241000 | 1.43e-01 |
Butyrophilin (BTN) family interactions | 10 | 1.86e-01 | -0.241000 | 3.17e-01 |
Myogenesis | 21 | 5.60e-02 | 0.241000 | 1.33e-01 |
G-protein activation | 23 | 4.60e-02 | 0.240000 | 1.17e-01 |
Interleukin-1 signaling | 97 | 4.38e-05 | 0.240000 | 4.46e-04 |
HDR through Single Strand Annealing (SSA) | 37 | 1.16e-02 | -0.240000 | 3.97e-02 |
Amino acids regulate mTORC1 | 50 | 3.38e-03 | 0.240000 | 1.47e-02 |
Metabolism of porphyrins | 22 | 5.21e-02 | 0.239000 | 1.28e-01 |
Formation of the cornified envelope | 21 | 5.84e-02 | 0.239000 | 1.38e-01 |
Platelet homeostasis | 69 | 6.38e-04 | 0.238000 | 4.06e-03 |
Diseases of carbohydrate metabolism | 29 | 2.70e-02 | 0.237000 | 7.77e-02 |
Scavenging of heme from plasma | 71 | 5.61e-04 | -0.237000 | 3.69e-03 |
Creation of C4 and C2 activators | 71 | 5.62e-04 | -0.237000 | 3.69e-03 |
SUMOylation of chromatin organization proteins | 57 | 2.03e-03 | -0.236000 | 1.01e-02 |
Toll Like Receptor 9 (TLR9) Cascade | 93 | 8.40e-05 | 0.236000 | 7.83e-04 |
Interleukin receptor SHC signaling | 23 | 5.11e-02 | 0.235000 | 1.26e-01 |
Surfactant metabolism | 21 | 6.35e-02 | 0.234000 | 1.46e-01 |
Packaging Of Telomere Ends | 20 | 7.06e-02 | 0.234000 | 1.58e-01 |
Interleukin-10 signaling | 34 | 1.86e-02 | 0.233000 | 5.80e-02 |
FCGR activation | 76 | 4.56e-04 | -0.233000 | 3.17e-03 |
HDR through Homologous Recombination (HRR) | 66 | 1.12e-03 | -0.232000 | 6.36e-03 |
IKK complex recruitment mediated by RIP1 | 23 | 5.52e-02 | 0.231000 | 1.33e-01 |
MTOR signalling | 38 | 1.39e-02 | 0.231000 | 4.58e-02 |
RIP-mediated NFkB activation via ZBP1 | 17 | 9.98e-02 | 0.231000 | 2.08e-01 |
Metabolism of steroids | 119 | 1.42e-05 | 0.230000 | 1.76e-04 |
RET signaling | 32 | 2.46e-02 | 0.230000 | 7.23e-02 |
Cellular response to hypoxia | 71 | 8.35e-04 | 0.229000 | 5.01e-03 |
Disassembly of the destruction complex and recruitment of AXIN to the membrane | 29 | 3.27e-02 | 0.229000 | 8.98e-02 |
Glycogen synthesis | 13 | 1.54e-01 | 0.228000 | 2.77e-01 |
Bile acid and bile salt metabolism | 29 | 3.33e-02 | 0.228000 | 9.12e-02 |
HDACs deacetylate histones | 47 | 6.77e-03 | 0.228000 | 2.57e-02 |
Chromosome Maintenance | 105 | 5.30e-05 | -0.228000 | 5.26e-04 |
Signaling by NOTCH3 | 42 | 1.05e-02 | 0.228000 | 3.69e-02 |
Formation of apoptosome | 11 | 1.90e-01 | 0.228000 | 3.20e-01 |
Regulation of the apoptosome activity | 11 | 1.90e-01 | 0.228000 | 3.20e-01 |
Aquaporin-mediated transport | 37 | 1.64e-02 | 0.228000 | 5.25e-02 |
Signaling by VEGF | 100 | 8.60e-05 | 0.227000 | 7.96e-04 |
Opioid Signalling | 75 | 6.72e-04 | 0.227000 | 4.22e-03 |
Intra-Golgi and retrograde Golgi-to-ER traffic | 179 | 1.62e-07 | 0.227000 | 3.06e-06 |
MyD88 cascade initiated on plasma membrane | 82 | 3.87e-04 | 0.227000 | 2.79e-03 |
Toll Like Receptor 10 (TLR10) Cascade | 82 | 3.87e-04 | 0.227000 | 2.79e-03 |
Toll Like Receptor 5 (TLR5) Cascade | 82 | 3.87e-04 | 0.227000 | 2.79e-03 |
Defects in cobalamin (B12) metabolism | 13 | 1.57e-01 | -0.227000 | 2.79e-01 |
Cytochrome c-mediated apoptotic response | 13 | 1.58e-01 | 0.226000 | 2.79e-01 |
Negative regulation of FGFR1 signaling | 24 | 5.51e-02 | 0.226000 | 1.33e-01 |
DNA Damage Bypass | 47 | 7.76e-03 | -0.224000 | 2.86e-02 |
NR1H2 and NR1H3-mediated signaling | 39 | 1.54e-02 | 0.224000 | 5.00e-02 |
Signaling by cytosolic FGFR1 fusion mutants | 18 | 1.01e-01 | 0.224000 | 2.09e-01 |
HSP90 chaperone cycle for steroid hormone receptors (SHR) | 36 | 2.04e-02 | 0.223000 | 6.22e-02 |
Interleukin-1 family signaling | 124 | 1.75e-05 | 0.223000 | 2.02e-04 |
Chemokine receptors bind chemokines | 37 | 1.89e-02 | -0.223000 | 5.86e-02 |
Retinoid metabolism and transport | 24 | 5.91e-02 | 0.223000 | 1.39e-01 |
Sphingolipid metabolism | 77 | 7.38e-04 | 0.222000 | 4.49e-03 |
Nucleotide salvage | 21 | 7.88e-02 | 0.222000 | 1.72e-01 |
Constitutive Signaling by AKT1 E17K in Cancer | 25 | 5.55e-02 | 0.221000 | 1.33e-01 |
Gluconeogenesis | 28 | 4.27e-02 | 0.221000 | 1.11e-01 |
ER-Phagosome pathway | 82 | 5.52e-04 | 0.221000 | 3.66e-03 |
Asparagine N-linked glycosylation | 269 | 4.67e-10 | 0.221000 | 1.38e-08 |
ZBP1(DAI) mediated induction of type I IFNs | 20 | 8.78e-02 | 0.220000 | 1.87e-01 |
Josephin domain DUBs | 10 | 2.27e-01 | 0.220000 | 3.65e-01 |
Metabolism of amino acids and derivatives | 324 | 9.44e-12 | -0.220000 | 3.06e-10 |
Oncogene Induced Senescence | 33 | 2.87e-02 | 0.220000 | 8.15e-02 |
Transport of Mature Transcript to Cytoplasm | 81 | 6.35e-04 | -0.220000 | 4.06e-03 |
Vasopressin regulates renal water homeostasis via Aquaporins | 34 | 2.68e-02 | 0.219000 | 7.74e-02 |
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | 38 | 1.93e-02 | -0.219000 | 5.96e-02 |
MyD88-independent TLR4 cascade | 96 | 2.10e-04 | 0.219000 | 1.72e-03 |
TRIF(TICAM1)-mediated TLR4 signaling | 96 | 2.10e-04 | 0.219000 | 1.72e-03 |
Nuclear Events (kinase and transcription factor activation) | 53 | 5.86e-03 | 0.219000 | 2.31e-02 |
Diseases associated with glycosylation precursor biosynthesis | 18 | 1.09e-01 | 0.218000 | 2.16e-01 |
TRAF6 mediated NF-kB activation | 23 | 7.03e-02 | 0.218000 | 1.58e-01 |
NOTCH3 Activation and Transmission of Signal to the Nucleus | 23 | 7.05e-02 | 0.218000 | 1.58e-01 |
Viral Messenger RNA Synthesis | 44 | 1.26e-02 | -0.217000 | 4.25e-02 |
E2F mediated regulation of DNA replication | 22 | 7.79e-02 | -0.217000 | 1.71e-01 |
Adherens junctions interactions | 18 | 1.11e-01 | 0.217000 | 2.19e-01 |
Acyl chain remodelling of PC | 19 | 1.02e-01 | 0.217000 | 2.09e-01 |
Signaling by Hippo | 18 | 1.12e-01 | 0.216000 | 2.19e-01 |
SUMOylation of DNA damage response and repair proteins | 77 | 1.05e-03 | -0.216000 | 6.05e-03 |
Inactivation of APC/C via direct inhibition of the APC/C complex | 21 | 8.68e-02 | -0.216000 | 1.86e-01 |
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | 21 | 8.68e-02 | -0.216000 | 1.86e-01 |
Regulation of insulin secretion | 60 | 3.85e-03 | 0.216000 | 1.64e-02 |
Transport of bile salts and organic acids, metal ions and amine compounds | 55 | 5.70e-03 | 0.215000 | 2.25e-02 |
GRB2 events in EGFR signaling | 11 | 2.17e-01 | 0.215000 | 3.53e-01 |
Signaling by NOTCH | 182 | 6.06e-07 | 0.214000 | 1.01e-05 |
RNA Polymerase III Transcription Initiation | 36 | 2.61e-02 | -0.214000 | 7.58e-02 |
Apoptotic execution phase | 45 | 1.29e-02 | 0.214000 | 4.33e-02 |
TRAF6 mediated IRF7 activation | 15 | 1.52e-01 | 0.213000 | 2.75e-01 |
Potential therapeutics for SARS | 36 | 2.67e-02 | 0.213000 | 7.72e-02 |
Vesicle-mediated transport | 648 | 2.00e-20 | 0.213000 | 9.72e-19 |
Listeria monocytogenes entry into host cells | 17 | 1.29e-01 | 0.213000 | 2.43e-01 |
Synthesis of PIPs at the plasma membrane | 52 | 7.99e-03 | 0.213000 | 2.93e-02 |
Assembly and cell surface presentation of NMDA receptors | 18 | 1.19e-01 | -0.212000 | 2.30e-01 |
Deadenylation-dependent mRNA decay | 53 | 7.56e-03 | -0.212000 | 2.81e-02 |
Activation of BAD and translocation to mitochondria | 15 | 1.56e-01 | 0.212000 | 2.78e-01 |
Biosynthesis of specialized proresolving mediators (SPMs) | 16 | 1.43e-01 | 0.211000 | 2.64e-01 |
Interconversion of nucleotide di- and triphosphates | 27 | 5.78e-02 | -0.211000 | 1.37e-01 |
RNA Polymerase III Transcription Initiation From Type 3 Promoter | 28 | 5.36e-02 | -0.211000 | 1.30e-01 |
Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 13 | 1.89e-01 | 0.210000 | 3.18e-01 |
PLC beta mediated events | 43 | 1.76e-02 | 0.209000 | 5.55e-02 |
Uptake and actions of bacterial toxins | 27 | 6.02e-02 | 0.209000 | 1.41e-01 |
Cytosolic iron-sulfur cluster assembly | 13 | 1.92e-01 | -0.209000 | 3.22e-01 |
COPI-dependent Golgi-to-ER retrograde traffic | 78 | 1.44e-03 | 0.209000 | 7.73e-03 |
Interleukin-37 signaling | 19 | 1.16e-01 | 0.208000 | 2.26e-01 |
G alpha (z) signalling events | 36 | 3.07e-02 | 0.208000 | 8.60e-02 |
DAP12 interactions | 39 | 2.47e-02 | 0.208000 | 7.23e-02 |
MAP kinase activation | 63 | 4.44e-03 | 0.207000 | 1.82e-02 |
Costimulation by the CD28 family | 74 | 2.14e-03 | -0.206000 | 1.05e-02 |
mRNA Splicing - Minor Pathway | 52 | 1.05e-02 | -0.205000 | 3.69e-02 |
Signaling by EGFR | 46 | 1.61e-02 | 0.205000 | 5.18e-02 |
G-protein mediated events | 44 | 1.86e-02 | 0.205000 | 5.80e-02 |
Signaling by Receptor Tyrosine Kinases | 414 | 8.43e-13 | 0.205000 | 2.94e-11 |
Platelet Adhesion to exposed collagen | 13 | 2.01e-01 | 0.205000 | 3.33e-01 |
ER Quality Control Compartment (ERQC) | 21 | 1.06e-01 | 0.204000 | 2.13e-01 |
Glutamate binding, activation of AMPA receptors and synaptic plasticity | 20 | 1.15e-01 | 0.203000 | 2.24e-01 |
Trafficking of AMPA receptors | 20 | 1.15e-01 | 0.203000 | 2.24e-01 |
Signaling by Insulin receptor | 59 | 6.91e-03 | 0.203000 | 2.61e-02 |
Inflammasomes | 20 | 1.17e-01 | 0.203000 | 2.26e-01 |
Processing of SMDT1 | 15 | 1.75e-01 | -0.202000 | 3.03e-01 |
Signaling by NOTCH4 | 78 | 2.27e-03 | 0.200000 | 1.08e-02 |
SARS-CoV Infections | 83 | 1.69e-03 | 0.199000 | 8.68e-03 |
Initiation of Nuclear Envelope (NE) Reformation | 19 | 1.33e-01 | 0.199000 | 2.47e-01 |
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 17 | 1.55e-01 | -0.199000 | 2.78e-01 |
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | 16 | 1.68e-01 | -0.199000 | 2.95e-01 |
Processing of Capped Intron-Containing Pre-mRNA | 238 | 1.29e-07 | -0.199000 | 2.51e-06 |
SUMOylation of ubiquitinylation proteins | 39 | 3.19e-02 | -0.199000 | 8.80e-02 |
Initial triggering of complement | 78 | 2.43e-03 | -0.199000 | 1.14e-02 |
Negative regulation of FGFR3 signaling | 20 | 1.25e-01 | 0.198000 | 2.37e-01 |
Caspase activation via Death Receptors in the presence of ligand | 16 | 1.70e-01 | 0.198000 | 2.97e-01 |
O-linked glycosylation of mucins | 47 | 1.90e-02 | 0.198000 | 5.86e-02 |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 27 | 7.52e-02 | 0.198000 | 1.66e-01 |
RUNX2 regulates bone development | 23 | 1.01e-01 | 0.198000 | 2.09e-01 |
PKA activation | 15 | 1.86e-01 | 0.197000 | 3.17e-01 |
Gap-filling DNA repair synthesis and ligation in TC-NER | 64 | 6.34e-03 | -0.197000 | 2.45e-02 |
RHO GTPase Effectors | 250 | 7.74e-08 | 0.197000 | 1.57e-06 |
Tight junction interactions | 18 | 1.48e-01 | -0.197000 | 2.70e-01 |
Role of LAT2/NTAL/LAB on calcium mobilization | 74 | 3.66e-03 | -0.195000 | 1.57e-02 |
CD28 dependent PI3K/Akt signaling | 22 | 1.13e-01 | -0.195000 | 2.21e-01 |
Regulation of PTEN stability and activity | 66 | 6.11e-03 | 0.195000 | 2.38e-02 |
Carnitine metabolism | 10 | 2.86e-01 | 0.195000 | 4.31e-01 |
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | 17 | 1.65e-01 | -0.194000 | 2.90e-01 |
KSRP (KHSRP) binds and destabilizes mRNA | 17 | 1.66e-01 | -0.194000 | 2.91e-01 |
FCERI mediated Ca+2 mobilization | 89 | 1.57e-03 | -0.194000 | 8.15e-03 |
Signaling by NOTCH1 | 66 | 6.51e-03 | 0.194000 | 2.50e-02 |
FGFR1 mutant receptor activation | 24 | 1.01e-01 | 0.194000 | 2.09e-01 |
Glycogen storage diseases | 13 | 2.27e-01 | 0.194000 | 3.65e-01 |
Metalloprotease DUBs | 21 | 1.25e-01 | 0.193000 | 2.37e-01 |
PIWI-interacting RNA (piRNA) biogenesis | 23 | 1.09e-01 | -0.193000 | 2.16e-01 |
Regulation of localization of FOXO transcription factors | 11 | 2.69e-01 | 0.192000 | 4.12e-01 |
Signaling by PDGFRA extracellular domain mutants | 12 | 2.49e-01 | 0.192000 | 3.89e-01 |
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 12 | 2.49e-01 | 0.192000 | 3.89e-01 |
Ca-dependent events | 29 | 7.34e-02 | 0.192000 | 1.63e-01 |
Cross-presentation of soluble exogenous antigens (endosomes) | 47 | 2.30e-02 | 0.192000 | 6.85e-02 |
APC-Cdc20 mediated degradation of Nek2A | 26 | 9.07e-02 | -0.192000 | 1.92e-01 |
Sialic acid metabolism | 28 | 7.95e-02 | 0.191000 | 1.73e-01 |
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 64 | 8.16e-03 | 0.191000 | 2.99e-02 |
Dual incision in TC-NER | 65 | 7.74e-03 | -0.191000 | 2.86e-02 |
Trafficking and processing of endosomal TLR | 13 | 2.33e-01 | 0.191000 | 3.72e-01 |
TRAF6-mediated induction of TAK1 complex within TLR4 complex | 16 | 1.86e-01 | 0.191000 | 3.17e-01 |
Activation of the AP-1 family of transcription factors | 10 | 2.97e-01 | 0.191000 | 4.42e-01 |
Interleukin-17 signaling | 68 | 6.57e-03 | 0.191000 | 2.51e-02 |
Prostacyclin signalling through prostacyclin receptor | 16 | 1.89e-01 | 0.190000 | 3.18e-01 |
Apoptotic cleavage of cellular proteins | 34 | 5.54e-02 | 0.190000 | 1.33e-01 |
SUMOylation of DNA replication proteins | 46 | 2.61e-02 | -0.190000 | 7.58e-02 |
N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 35 | 5.23e-02 | 0.190000 | 1.28e-01 |
RNA Polymerase II Transcription Termination | 65 | 8.32e-03 | -0.189000 | 3.02e-02 |
MAPK targets/ Nuclear events mediated by MAP kinases | 31 | 6.84e-02 | 0.189000 | 1.55e-01 |
Cell-extracellular matrix interactions | 14 | 2.21e-01 | 0.189000 | 3.58e-01 |
Telomere Maintenance | 80 | 3.48e-03 | -0.189000 | 1.51e-02 |
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 53 | 1.74e-02 | 0.189000 | 5.51e-02 |
Processing of Capped Intronless Pre-mRNA | 28 | 8.38e-02 | -0.189000 | 1.81e-01 |
SARS-CoV-1 Infection | 47 | 2.58e-02 | 0.188000 | 7.52e-02 |
Interleukin-2 family signaling | 38 | 4.53e-02 | 0.188000 | 1.16e-01 |
A tetrasaccharide linker sequence is required for GAG synthesis | 17 | 1.81e-01 | -0.188000 | 3.09e-01 |
Role of phospholipids in phagocytosis | 88 | 2.40e-03 | -0.187000 | 1.13e-02 |
Telomere Extension By Telomerase | 23 | 1.20e-01 | -0.187000 | 2.31e-01 |
Signaling by FGFR1 | 38 | 4.70e-02 | 0.186000 | 1.19e-01 |
Iron uptake and transport | 52 | 2.03e-02 | 0.186000 | 6.20e-02 |
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 17 | 1.85e-01 | 0.186000 | 3.16e-01 |
mRNA Splicing - Major Pathway | 179 | 2.01e-05 | -0.185000 | 2.30e-04 |
Phospholipid metabolism | 186 | 1.46e-05 | 0.184000 | 1.79e-04 |
MHC class II antigen presentation | 101 | 1.39e-03 | 0.184000 | 7.46e-03 |
Toll Like Receptor 3 (TLR3) Cascade | 92 | 2.29e-03 | 0.184000 | 1.08e-02 |
Regulation of HSF1-mediated heat shock response | 79 | 4.76e-03 | -0.184000 | 1.93e-02 |
RNA Polymerase III Abortive And Retractive Initiation | 41 | 4.19e-02 | -0.184000 | 1.10e-01 |
RNA Polymerase III Transcription | 41 | 4.19e-02 | -0.184000 | 1.10e-01 |
PCP/CE pathway | 86 | 3.24e-03 | 0.184000 | 1.44e-02 |
G0 and Early G1 | 27 | 9.91e-02 | -0.183000 | 2.07e-01 |
Metabolism of lipids | 625 | 5.63e-15 | 0.183000 | 2.40e-13 |
mRNA Splicing | 187 | 1.64e-05 | -0.183000 | 1.90e-04 |
Rho GTPase cycle | 126 | 4.00e-04 | 0.183000 | 2.87e-03 |
Signaling by Interleukins | 385 | 7.78e-10 | 0.183000 | 2.16e-08 |
SUMOylation of intracellular receptors | 25 | 1.14e-01 | 0.182000 | 2.24e-01 |
Platelet calcium homeostasis | 21 | 1.48e-01 | 0.182000 | 2.69e-01 |
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | 20 | 1.59e-01 | -0.182000 | 2.80e-01 |
Hedgehog ligand biogenesis | 58 | 1.65e-02 | 0.182000 | 5.27e-02 |
mTORC1-mediated signalling | 23 | 1.31e-01 | 0.182000 | 2.45e-01 |
Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 78 | 5.57e-03 | -0.182000 | 2.22e-02 |
Signaling by Rho GTPases | 367 | 2.45e-09 | 0.181000 | 6.19e-08 |
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 84 | 4.09e-03 | -0.181000 | 1.71e-02 |
PI-3K cascade:FGFR2 | 12 | 2.78e-01 | -0.181000 | 4.22e-01 |
Glycerophospholipid biosynthesis | 107 | 1.29e-03 | 0.180000 | 7.01e-03 |
Glycosaminoglycan metabolism | 94 | 2.57e-03 | 0.180000 | 1.18e-02 |
Synthesis of DNA | 118 | 7.45e-04 | -0.180000 | 4.51e-03 |
Mitochondrial calcium ion transport | 22 | 1.45e-01 | -0.179000 | 2.67e-01 |
PI Metabolism | 80 | 5.58e-03 | 0.179000 | 2.22e-02 |
Striated Muscle Contraction | 23 | 1.37e-01 | 0.179000 | 2.55e-01 |
Cholesterol biosynthesis | 24 | 1.30e-01 | 0.179000 | 2.44e-01 |
FGFR2 mutant receptor activation | 22 | 1.47e-01 | -0.178000 | 2.69e-01 |
Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 25 | 1.23e-01 | 0.178000 | 2.35e-01 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 51 | 2.79e-02 | 0.178000 | 7.98e-02 |
NCAM1 interactions | 23 | 1.40e-01 | -0.178000 | 2.59e-01 |
Formation of Fibrin Clot (Clotting Cascade) | 26 | 1.18e-01 | 0.177000 | 2.28e-01 |
Synthesis of PIPs at the late endosome membrane | 11 | 3.09e-01 | 0.177000 | 4.54e-01 |
Global Genome Nucleotide Excision Repair (GG-NER) | 84 | 5.21e-03 | -0.176000 | 2.10e-02 |
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | 53 | 2.66e-02 | 0.176000 | 7.70e-02 |
Arachidonic acid metabolism | 43 | 4.58e-02 | 0.176000 | 1.17e-01 |
Collagen formation | 66 | 1.36e-02 | 0.176000 | 4.50e-02 |
SUMOylation of DNA methylation proteins | 16 | 2.24e-01 | -0.176000 | 3.62e-01 |
Acyl chain remodelling of PI | 10 | 3.38e-01 | 0.175000 | 4.85e-01 |
Ion channel transport | 133 | 5.22e-04 | 0.174000 | 3.50e-03 |
Synthesis of PIPs at the Golgi membrane | 16 | 2.28e-01 | 0.174000 | 3.66e-01 |
Defective CFTR causes cystic fibrosis | 59 | 2.11e-02 | 0.174000 | 6.41e-02 |
mRNA decay by 5' to 3' exoribonuclease | 15 | 2.45e-01 | -0.174000 | 3.85e-01 |
Elastic fibre formation | 32 | 9.00e-02 | 0.173000 | 1.91e-01 |
Synthesis of IP2, IP, and Ins in the cytosol | 13 | 2.80e-01 | 0.173000 | 4.25e-01 |
Triglyceride metabolism | 25 | 1.35e-01 | 0.173000 | 2.50e-01 |
RUNX1 regulates transcription of genes involved in differentiation of HSCs | 82 | 6.97e-03 | 0.172000 | 2.62e-02 |
Inwardly rectifying K+ channels | 23 | 1.53e-01 | 0.172000 | 2.75e-01 |
Transcriptional regulation of pluripotent stem cells | 19 | 1.94e-01 | 0.172000 | 3.24e-01 |
Effects of PIP2 hydrolysis | 24 | 1.45e-01 | -0.172000 | 2.67e-01 |
Base Excision Repair | 58 | 2.39e-02 | -0.171000 | 7.07e-02 |
Downstream signal transduction | 27 | 1.23e-01 | 0.171000 | 2.35e-01 |
Senescence-Associated Secretory Phenotype (SASP) | 66 | 1.64e-02 | 0.171000 | 5.25e-02 |
Tie2 Signaling | 16 | 2.38e-01 | 0.171000 | 3.77e-01 |
Insulin processing | 21 | 1.76e-01 | 0.170000 | 3.05e-01 |
Signaling by FGFR3 | 31 | 1.01e-01 | 0.170000 | 2.09e-01 |
G alpha (12/13) signalling events | 69 | 1.46e-02 | 0.170000 | 4.79e-02 |
Muscle contraction | 141 | 4.92e-04 | 0.170000 | 3.31e-03 |
Metabolism of fat-soluble vitamins | 28 | 1.20e-01 | 0.170000 | 2.31e-01 |
Synthesis of bile acids and bile salts | 24 | 1.50e-01 | 0.170000 | 2.72e-01 |
Signaling by WNT in cancer | 30 | 1.08e-01 | 0.169000 | 2.15e-01 |
IRF3-mediated induction of type I IFN | 12 | 3.11e-01 | -0.169000 | 4.55e-01 |
EGR2 and SOX10-mediated initiation of Schwann cell myelination | 22 | 1.70e-01 | 0.169000 | 2.97e-01 |
S Phase | 160 | 2.31e-04 | -0.169000 | 1.88e-03 |
MAP3K8 (TPL2)-dependent MAPK1/3 activation | 16 | 2.46e-01 | 0.168000 | 3.87e-01 |
Regulation of ornithine decarboxylase (ODC) | 49 | 4.24e-02 | 0.168000 | 1.11e-01 |
Cobalamin (Cbl, vitamin B12) transport and metabolism | 16 | 2.46e-01 | -0.167000 | 3.87e-01 |
Oxidative Stress Induced Senescence | 79 | 1.01e-02 | 0.167000 | 3.59e-02 |
Phase 4 - resting membrane potential | 10 | 3.60e-01 | 0.167000 | 5.05e-01 |
Cleavage of the damaged purine | 24 | 1.57e-01 | 0.167000 | 2.79e-01 |
Depurination | 24 | 1.57e-01 | 0.167000 | 2.79e-01 |
Recognition and association of DNA glycosylase with site containing an affected purine | 24 | 1.57e-01 | 0.167000 | 2.79e-01 |
Condensation of Prophase Chromosomes | 29 | 1.20e-01 | 0.167000 | 2.31e-01 |
Cellular response to heat stress | 93 | 5.53e-03 | -0.166000 | 2.22e-02 |
Mitophagy | 28 | 1.28e-01 | -0.166000 | 2.42e-01 |
Negative regulation of FGFR4 signaling | 21 | 1.88e-01 | 0.166000 | 3.18e-01 |
Interleukin-6 family signaling | 18 | 2.24e-01 | 0.166000 | 3.62e-01 |
Constitutive Signaling by Overexpressed ERBB2 | 11 | 3.43e-01 | 0.165000 | 4.87e-01 |
Regulation of beta-cell development | 19 | 2.13e-01 | 0.165000 | 3.48e-01 |
Disorders of developmental biology | 12 | 3.23e-01 | 0.165000 | 4.67e-01 |
Loss of function of MECP2 in Rett syndrome | 12 | 3.23e-01 | 0.165000 | 4.67e-01 |
Pervasive developmental disorders | 12 | 3.23e-01 | 0.165000 | 4.67e-01 |
DNA Replication | 125 | 1.50e-03 | -0.164000 | 7.95e-03 |
Regulation of TP53 Activity through Methylation | 19 | 2.16e-01 | -0.164000 | 3.51e-01 |
NOD1/2 Signaling Pathway | 32 | 1.10e-01 | 0.163000 | 2.17e-01 |
Regulation of TP53 Activity through Association with Co-factors | 11 | 3.49e-01 | -0.163000 | 4.93e-01 |
Signaling by Activin | 10 | 3.72e-01 | -0.163000 | 5.14e-01 |
Hh mutants abrogate ligand secretion | 54 | 3.84e-02 | 0.163000 | 1.02e-01 |
Sphingolipid de novo biosynthesis | 41 | 7.38e-02 | 0.161000 | 1.64e-01 |
Programmed Cell Death | 169 | 3.05e-04 | 0.161000 | 2.32e-03 |
TRAF3-dependent IRF activation pathway | 13 | 3.15e-01 | 0.161000 | 4.60e-01 |
Neurotransmitter receptors and postsynaptic signal transmission | 123 | 2.10e-03 | 0.161000 | 1.03e-02 |
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 17 | 2.52e-01 | -0.161000 | 3.92e-01 |
Autophagy | 124 | 2.10e-03 | 0.160000 | 1.03e-02 |
tRNA processing in the mitochondrion | 30 | 1.31e-01 | -0.159000 | 2.45e-01 |
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 20 | 2.17e-01 | -0.159000 | 3.53e-01 |
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 22 | 1.96e-01 | 0.159000 | 3.26e-01 |
Apoptosis | 166 | 4.19e-04 | 0.159000 | 2.94e-03 |
Intrinsic Pathway of Fibrin Clot Formation | 16 | 2.73e-01 | 0.158000 | 4.17e-01 |
Regulation of FOXO transcriptional activity by acetylation | 10 | 3.87e-01 | 0.158000 | 5.28e-01 |
Diseases of signal transduction by growth factor receptors and second messengers | 340 | 5.72e-07 | 0.158000 | 9.60e-06 |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 53 | 4.74e-02 | 0.157000 | 1.19e-01 |
Constitutive Signaling by NOTCH1 PEST Domain Mutants | 53 | 4.74e-02 | 0.157000 | 1.19e-01 |
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 53 | 4.74e-02 | 0.157000 | 1.19e-01 |
Signaling by NOTCH1 PEST Domain Mutants in Cancer | 53 | 4.74e-02 | 0.157000 | 1.19e-01 |
Signaling by NOTCH1 in Cancer | 53 | 4.74e-02 | 0.157000 | 1.19e-01 |
p38MAPK events | 13 | 3.26e-01 | 0.157000 | 4.70e-01 |
Constitutive Signaling by EGFRvIII | 14 | 3.09e-01 | 0.157000 | 4.54e-01 |
Signaling by EGFRvIII in Cancer | 14 | 3.09e-01 | 0.157000 | 4.54e-01 |
VEGFR2 mediated vascular permeability | 27 | 1.58e-01 | 0.157000 | 2.79e-01 |
Signaling by Non-Receptor Tyrosine Kinases | 48 | 6.06e-02 | 0.157000 | 1.41e-01 |
Signaling by PTK6 | 48 | 6.06e-02 | 0.157000 | 1.41e-01 |
Potassium Channels | 63 | 3.16e-02 | 0.157000 | 8.77e-02 |
Hemostasis | 548 | 3.99e-10 | 0.156000 | 1.21e-08 |
Metabolism of Angiotensinogen to Angiotensins | 11 | 3.71e-01 | 0.156000 | 5.13e-01 |
G1/S Transition | 130 | 2.21e-03 | -0.155000 | 1.07e-02 |
Synaptic adhesion-like molecules | 14 | 3.17e-01 | 0.154000 | 4.62e-01 |
Regulation of activated PAK-2p34 by proteasome mediated degradation | 48 | 6.53e-02 | 0.154000 | 1.49e-01 |
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | 11 | 3.77e-01 | -0.154000 | 5.19e-01 |
Defective B3GALT6 causes EDSP2 and SEMDJL1 | 11 | 3.80e-01 | -0.153000 | 5.20e-01 |
RA biosynthesis pathway | 13 | 3.41e-01 | -0.153000 | 4.87e-01 |
Vitamin B5 (pantothenate) metabolism | 17 | 2.77e-01 | 0.152000 | 4.22e-01 |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 13 | 3.43e-01 | 0.152000 | 4.87e-01 |
Stimuli-sensing channels | 73 | 2.55e-02 | 0.151000 | 7.44e-02 |
Synthesis, secretion, and deacylation of Ghrelin | 12 | 3.67e-01 | -0.150000 | 5.09e-01 |
Immune System | 1893 | 2.18e-27 | 0.150000 | 1.19e-25 |
Degradation of DVL | 54 | 5.61e-02 | 0.150000 | 1.33e-01 |
Establishment of Sister Chromatid Cohesion | 11 | 3.89e-01 | -0.150000 | 5.29e-01 |
Interleukin-4 and Interleukin-13 signaling | 92 | 1.30e-02 | 0.150000 | 4.33e-02 |
Assembly of collagen fibrils and other multimeric structures | 42 | 9.28e-02 | 0.150000 | 1.95e-01 |
APC/C:Cdc20 mediated degradation of Cyclin B | 24 | 2.05e-01 | -0.150000 | 3.37e-01 |
Nucleotide Excision Repair | 110 | 6.75e-03 | -0.150000 | 2.57e-02 |
Formation of Incision Complex in GG-NER | 43 | 9.14e-02 | -0.149000 | 1.93e-01 |
SHC1 events in ERBB2 signaling | 17 | 2.89e-01 | 0.148000 | 4.34e-01 |
Signaling by WNT | 253 | 4.93e-05 | 0.148000 | 4.94e-04 |
ISG15 antiviral mechanism | 72 | 3.02e-02 | -0.148000 | 8.52e-02 |
p75 NTR receptor-mediated signalling | 89 | 1.61e-02 | 0.148000 | 5.18e-02 |
Olfactory Signaling Pathway | 58 | 5.21e-02 | 0.147000 | 1.28e-01 |
Interleukin-20 family signaling | 17 | 2.93e-01 | 0.147000 | 4.37e-01 |
Transmission across Chemical Synapses | 172 | 8.85e-04 | 0.147000 | 5.21e-03 |
Caspase-mediated cleavage of cytoskeletal proteins | 12 | 3.81e-01 | 0.146000 | 5.21e-01 |
Cilium Assembly | 181 | 6.95e-04 | -0.146000 | 4.24e-03 |
Beta-catenin independent WNT signaling | 136 | 3.27e-03 | 0.146000 | 1.45e-02 |
Defective B4GALT7 causes EDS, progeroid type | 11 | 4.03e-01 | -0.145000 | 5.43e-01 |
Citric acid cycle (TCA cycle) | 22 | 2.40e-01 | 0.145000 | 3.79e-01 |
Synthesis of IP3 and IP4 in the cytosol | 22 | 2.40e-01 | 0.145000 | 3.79e-01 |
Inositol phosphate metabolism | 42 | 1.05e-01 | 0.145000 | 2.13e-01 |
Regulation of KIT signaling | 15 | 3.32e-01 | 0.145000 | 4.78e-01 |
Factors involved in megakaryocyte development and platelet production | 116 | 7.17e-03 | 0.145000 | 2.68e-02 |
Hedgehog 'on' state | 75 | 3.07e-02 | 0.144000 | 8.60e-02 |
NGF-stimulated transcription | 31 | 1.64e-01 | 0.144000 | 2.89e-01 |
Nuclear Envelope Breakdown | 53 | 6.95e-02 | -0.144000 | 1.57e-01 |
Regulation of TP53 Activity through Acetylation | 29 | 1.80e-01 | -0.144000 | 3.09e-01 |
Signaling by FGFR3 in disease | 13 | 3.69e-01 | -0.144000 | 5.11e-01 |
Signaling by FGFR3 point mutants in cancer | 13 | 3.69e-01 | -0.144000 | 5.11e-01 |
ABC transporters in lipid homeostasis | 14 | 3.51e-01 | -0.144000 | 4.96e-01 |
FCGR3A-mediated IL10 synthesis | 99 | 1.34e-02 | -0.144000 | 4.45e-02 |
Binding and Uptake of Ligands by Scavenger Receptors | 92 | 1.75e-02 | -0.143000 | 5.52e-02 |
Peroxisomal lipid metabolism | 27 | 1.99e-01 | 0.143000 | 3.30e-01 |
SHC-mediated cascade:FGFR2 | 12 | 3.93e-01 | -0.142000 | 5.33e-01 |
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 36 | 1.39e-01 | 0.142000 | 2.58e-01 |
Negative regulation of NOTCH4 signaling | 54 | 7.02e-02 | 0.142000 | 1.58e-01 |
Degradation of GLI1 by the proteasome | 57 | 6.35e-02 | 0.142000 | 1.46e-01 |
Vif-mediated degradation of APOBEC3G | 52 | 7.88e-02 | 0.141000 | 1.72e-01 |
Other semaphorin interactions | 16 | 3.31e-01 | 0.141000 | 4.76e-01 |
GP1b-IX-V activation signalling | 10 | 4.42e-01 | 0.140000 | 5.81e-01 |
Glyoxylate metabolism and glycine degradation | 24 | 2.34e-01 | -0.140000 | 3.73e-01 |
mRNA 3'-end processing | 56 | 6.95e-02 | -0.140000 | 1.57e-01 |
ABC transporter disorders | 70 | 4.25e-02 | 0.140000 | 1.11e-01 |
Acetylcholine Neurotransmitter Release Cycle | 11 | 4.21e-01 | -0.140000 | 5.61e-01 |
Retrograde transport at the Trans-Golgi-Network | 49 | 9.02e-02 | 0.140000 | 1.91e-01 |
Negative regulation of MAPK pathway | 42 | 1.17e-01 | 0.140000 | 2.26e-01 |
Extracellular matrix organization | 219 | 3.70e-04 | 0.140000 | 2.74e-03 |
Signaling by FGFR1 in disease | 31 | 1.81e-01 | 0.139000 | 3.09e-01 |
The role of Nef in HIV-1 replication and disease pathogenesis | 28 | 2.04e-01 | 0.139000 | 3.37e-01 |
CaM pathway | 27 | 2.12e-01 | 0.139000 | 3.47e-01 |
Calmodulin induced events | 27 | 2.12e-01 | 0.139000 | 3.47e-01 |
Glutathione conjugation | 26 | 2.21e-01 | 0.139000 | 3.58e-01 |
Peroxisomal protein import | 57 | 7.04e-02 | 0.139000 | 1.58e-01 |
Chaperonin-mediated protein folding | 84 | 2.83e-02 | 0.138000 | 8.08e-02 |
TICAM1, RIP1-mediated IKK complex recruitment | 19 | 2.99e-01 | 0.138000 | 4.44e-01 |
Negative regulation of NMDA receptor-mediated neuronal transmission | 14 | 3.73e-01 | -0.137000 | 5.14e-01 |
FGFR2 alternative splicing | 25 | 2.36e-01 | -0.137000 | 3.75e-01 |
C-type lectin receptors (CLRs) | 128 | 7.55e-03 | 0.137000 | 2.81e-02 |
UCH proteinases | 86 | 2.86e-02 | 0.137000 | 8.15e-02 |
Phosphorylation of the APC/C | 20 | 2.92e-01 | -0.136000 | 4.37e-01 |
The phototransduction cascade | 25 | 2.40e-01 | -0.136000 | 3.79e-01 |
Signaling by NOTCH2 | 30 | 1.98e-01 | 0.136000 | 3.29e-01 |
The canonical retinoid cycle in rods (twilight vision) | 10 | 4.57e-01 | 0.136000 | 5.91e-01 |
Metabolism of carbohydrates | 244 | 2.62e-04 | 0.136000 | 2.05e-03 |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 18 | 3.21e-01 | 0.135000 | 4.66e-01 |
Fatty acyl-CoA biosynthesis | 34 | 1.73e-01 | 0.135000 | 3.01e-01 |
Protein methylation | 15 | 3.66e-01 | -0.135000 | 5.08e-01 |
TGF-beta receptor signaling activates SMADs | 32 | 1.87e-01 | 0.135000 | 3.17e-01 |
Protein folding | 90 | 2.73e-02 | 0.135000 | 7.84e-02 |
Apoptotic factor-mediated response | 18 | 3.23e-01 | 0.134000 | 4.67e-01 |
Activation of HOX genes during differentiation | 68 | 5.56e-02 | 0.134000 | 1.33e-01 |
Activation of anterior HOX genes in hindbrain development during early embryogenesis | 68 | 5.56e-02 | 0.134000 | 1.33e-01 |
Activation of kainate receptors upon glutamate binding | 26 | 2.39e-01 | 0.134000 | 3.78e-01 |
HS-GAG biosynthesis | 20 | 3.02e-01 | 0.133000 | 4.48e-01 |
Nicotinate metabolism | 25 | 2.49e-01 | 0.133000 | 3.89e-01 |
Lysine catabolism | 11 | 4.47e-01 | 0.132000 | 5.83e-01 |
Neuronal System | 258 | 2.50e-04 | 0.132000 | 2.00e-03 |
Acyl chain remodelling of PG | 11 | 4.49e-01 | 0.132000 | 5.84e-01 |
TCF dependent signaling in response to WNT | 165 | 3.49e-03 | 0.132000 | 1.51e-02 |
NOTCH1 Intracellular Domain Regulates Transcription | 44 | 1.30e-01 | 0.132000 | 2.45e-01 |
Transport of small molecules | 557 | 1.08e-07 | 0.132000 | 2.12e-06 |
Formation of the beta-catenin:TCF transactivating complex | 46 | 1.23e-01 | 0.131000 | 2.35e-01 |
TNFR1-induced proapoptotic signaling | 12 | 4.32e-01 | -0.131000 | 5.71e-01 |
CDC6 association with the ORC:origin complex | 11 | 4.53e-01 | -0.131000 | 5.86e-01 |
CD209 (DC-SIGN) signaling | 20 | 3.12e-01 | 0.131000 | 4.56e-01 |
DNA Damage/Telomere Stress Induced Senescence | 44 | 1.34e-01 | 0.131000 | 2.50e-01 |
Signaling by FGFR4 | 31 | 2.09e-01 | 0.130000 | 3.43e-01 |
Transcriptional regulation by RUNX2 | 101 | 2.37e-02 | 0.130000 | 7.00e-02 |
Antiviral mechanism by IFN-stimulated genes | 80 | 4.44e-02 | -0.130000 | 1.15e-01 |
Unblocking of NMDA receptors, glutamate binding and activation | 12 | 4.36e-01 | -0.130000 | 5.74e-01 |
Adrenaline,noradrenaline inhibits insulin secretion | 24 | 2.71e-01 | 0.130000 | 4.14e-01 |
Xenobiotics | 11 | 4.56e-01 | -0.130000 | 5.90e-01 |
Regulation of Apoptosis | 51 | 1.10e-01 | 0.129000 | 2.17e-01 |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 52 | 1.07e-01 | 0.129000 | 2.14e-01 |
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 14 | 4.03e-01 | 0.129000 | 5.42e-01 |
PECAM1 interactions | 12 | 4.39e-01 | 0.129000 | 5.77e-01 |
Transcriptional regulation by RUNX3 | 90 | 3.44e-02 | 0.129000 | 9.34e-02 |
Degradation of GLI2 by the proteasome | 56 | 9.69e-02 | 0.128000 | 2.03e-01 |
Metabolic disorders of biological oxidation enzymes | 25 | 2.68e-01 | 0.128000 | 4.11e-01 |
Keratinization | 32 | 2.10e-01 | 0.128000 | 3.45e-01 |
Alpha-protein kinase 1 signaling pathway | 11 | 4.62e-01 | 0.128000 | 5.96e-01 |
E3 ubiquitin ligases ubiquitinate target proteins | 52 | 1.10e-01 | 0.128000 | 2.18e-01 |
DNA Replication Pre-Initiation | 82 | 4.52e-02 | -0.128000 | 1.16e-01 |
cGMP effects | 13 | 4.25e-01 | 0.128000 | 5.65e-01 |
Regulation of MECP2 expression and activity | 28 | 2.42e-01 | 0.128000 | 3.82e-01 |
Transport of vitamins, nucleosides, and related molecules | 33 | 2.05e-01 | 0.128000 | 3.37e-01 |
Signaling by FGFR2 in disease | 32 | 2.12e-01 | -0.127000 | 3.47e-01 |
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 80 | 4.92e-02 | 0.127000 | 1.22e-01 |
Extra-nuclear estrogen signaling | 67 | 7.23e-02 | 0.127000 | 1.62e-01 |
Cell recruitment (pro-inflammatory response) | 22 | 3.03e-01 | 0.127000 | 4.49e-01 |
Purinergic signaling in leishmaniasis infection | 22 | 3.03e-01 | 0.127000 | 4.49e-01 |
Cellular Senescence | 144 | 8.71e-03 | 0.127000 | 3.15e-02 |
Gene expression (Transcription) | 1326 | 1.11e-14 | -0.126000 | 4.43e-13 |
Signaling by PDGF | 44 | 1.48e-01 | 0.126000 | 2.69e-01 |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 182 | 3.37e-03 | -0.126000 | 1.47e-02 |
Cytosolic sulfonation of small molecules | 19 | 3.42e-01 | 0.126000 | 4.87e-01 |
Response of EIF2AK1 (HRI) to heme deficiency | 14 | 4.15e-01 | 0.126000 | 5.54e-01 |
Regulation of Complement cascade | 95 | 3.42e-02 | -0.126000 | 9.32e-02 |
RUNX2 regulates osteoblast differentiation | 18 | 3.56e-01 | 0.126000 | 5.00e-01 |
Complement cascade | 99 | 3.13e-02 | -0.125000 | 8.70e-02 |
Macroautophagy | 110 | 2.33e-02 | 0.125000 | 6.92e-02 |
Signal Transduction | 1882 | 2.53e-19 | 0.125000 | 1.19e-17 |
G alpha (s) signalling events | 141 | 1.07e-02 | 0.124000 | 3.74e-02 |
Interleukin-12 signaling | 44 | 1.54e-01 | 0.124000 | 2.77e-01 |
Depolymerisation of the Nuclear Lamina | 15 | 4.05e-01 | 0.124000 | 5.44e-01 |
Regulation of RUNX3 expression and activity | 55 | 1.11e-01 | 0.124000 | 2.19e-01 |
Inhibition of DNA recombination at telomere | 35 | 2.05e-01 | 0.124000 | 3.37e-01 |
Intracellular signaling by second messengers | 271 | 4.61e-04 | 0.124000 | 3.18e-03 |
Keratan sulfate/keratin metabolism | 27 | 2.66e-01 | 0.124000 | 4.09e-01 |
Interleukin-12 family signaling | 53 | 1.20e-01 | 0.123000 | 2.31e-01 |
CLEC7A (Dectin-1) signaling | 96 | 3.67e-02 | 0.123000 | 9.82e-02 |
CRMPs in Sema3A signaling | 14 | 4.26e-01 | 0.123000 | 5.66e-01 |
Translation of structural proteins | 28 | 2.61e-01 | 0.123000 | 4.03e-01 |
PTEN Regulation | 138 | 1.30e-02 | 0.122000 | 4.34e-02 |
PIP3 activates AKT signaling | 239 | 1.12e-03 | 0.122000 | 6.36e-03 |
ATF4 activates genes in response to endoplasmic reticulum stress | 25 | 2.90e-01 | -0.122000 | 4.34e-01 |
Cell death signalling via NRAGE, NRIF and NADE | 70 | 7.76e-02 | 0.122000 | 1.71e-01 |
AUF1 (hnRNP D0) binds and destabilizes mRNA | 53 | 1.25e-01 | 0.122000 | 2.37e-01 |
Circadian Clock | 67 | 8.49e-02 | 0.122000 | 1.82e-01 |
Protein ubiquitination | 72 | 7.48e-02 | 0.121000 | 1.66e-01 |
Deubiquitination | 241 | 1.27e-03 | 0.121000 | 6.99e-03 |
DNA Repair | 289 | 4.35e-04 | -0.120000 | 3.04e-03 |
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 26 | 2.90e-01 | -0.120000 | 4.34e-01 |
VEGFR2 mediated cell proliferation | 18 | 3.79e-01 | 0.120000 | 5.20e-01 |
Degradation of cysteine and homocysteine | 12 | 4.73e-01 | 0.120000 | 6.07e-01 |
Fatty acid metabolism | 152 | 1.09e-02 | 0.120000 | 3.78e-02 |
Degradation of beta-catenin by the destruction complex | 83 | 6.01e-02 | 0.119000 | 1.41e-01 |
Regulation of RAS by GAPs | 66 | 9.41e-02 | 0.119000 | 1.98e-01 |
Class I MHC mediated antigen processing & presentation | 349 | 1.35e-04 | 0.119000 | 1.19e-03 |
Activation of NF-kappaB in B cells | 65 | 9.75e-02 | 0.119000 | 2.04e-01 |
Tryptophan catabolism | 12 | 4.76e-01 | 0.119000 | 6.09e-01 |
Collagen biosynthesis and modifying enzymes | 48 | 1.55e-01 | 0.119000 | 2.78e-01 |
Ubiquitin-dependent degradation of Cyclin D | 50 | 1.50e-01 | 0.118000 | 2.72e-01 |
Ion transport by P-type ATPases | 42 | 1.88e-01 | 0.117000 | 3.18e-01 |
FCERI mediated MAPK activation | 90 | 5.57e-02 | -0.117000 | 1.33e-01 |
Regulation of innate immune responses to cytosolic DNA | 14 | 4.51e-01 | -0.116000 | 5.85e-01 |
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 50 | 1.56e-01 | 0.116000 | 2.78e-01 |
p53-Independent DNA Damage Response | 50 | 1.56e-01 | 0.116000 | 2.78e-01 |
p53-Independent G1/S DNA damage checkpoint | 50 | 1.56e-01 | 0.116000 | 2.78e-01 |
Defective B3GAT3 causes JDSSDHD | 11 | 5.05e-01 | -0.116000 | 6.35e-01 |
The role of GTSE1 in G2/M progression after G2 checkpoint | 58 | 1.29e-01 | 0.115000 | 2.43e-01 |
HSF1 activation | 26 | 3.10e-01 | -0.115000 | 4.54e-01 |
RNA Polymerase I Promoter Clearance | 66 | 1.06e-01 | -0.115000 | 2.13e-01 |
RNA Polymerase I Transcription | 66 | 1.06e-01 | -0.115000 | 2.13e-01 |
TP53 Regulates Transcription of Caspase Activators and Caspases | 11 | 5.10e-01 | -0.115000 | 6.39e-01 |
Cleavage of the damaged pyrimidine | 29 | 2.87e-01 | 0.114000 | 4.31e-01 |
Depyrimidination | 29 | 2.87e-01 | 0.114000 | 4.31e-01 |
Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 29 | 2.87e-01 | 0.114000 | 4.31e-01 |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 16 | 4.30e-01 | 0.114000 | 5.69e-01 |
Regulation of TP53 Activity through Phosphorylation | 88 | 6.46e-02 | -0.114000 | 1.48e-01 |
Heparan sulfate/heparin (HS-GAG) metabolism | 37 | 2.32e-01 | 0.114000 | 3.70e-01 |
DAG and IP3 signaling | 33 | 2.60e-01 | 0.113000 | 4.02e-01 |
Biosynthesis of DHA-derived SPMs | 14 | 4.63e-01 | 0.113000 | 5.97e-01 |
Methylation | 12 | 4.99e-01 | -0.113000 | 6.29e-01 |
Regulation of TP53 Activity | 151 | 1.68e-02 | -0.113000 | 5.33e-02 |
Degradation of AXIN | 53 | 1.56e-01 | 0.113000 | 2.78e-01 |
Signaling by TGF-beta Receptor Complex | 72 | 9.86e-02 | 0.113000 | 2.06e-01 |
Inactivation, recovery and regulation of the phototransduction cascade | 24 | 3.40e-01 | -0.112000 | 4.87e-01 |
Elevation of cytosolic Ca2+ levels | 12 | 5.00e-01 | 0.112000 | 6.30e-01 |
Homology Directed Repair | 110 | 4.17e-02 | -0.112000 | 1.10e-01 |
Insulin receptor signalling cascade | 39 | 2.25e-01 | 0.112000 | 3.63e-01 |
Processing and activation of SUMO | 10 | 5.39e-01 | -0.112000 | 6.66e-01 |
Signaling by PDGFR in disease | 19 | 3.98e-01 | 0.112000 | 5.37e-01 |
Generic Transcription Pathway | 1077 | 5.38e-10 | -0.112000 | 1.56e-08 |
Deadenylation of mRNA | 22 | 3.63e-01 | -0.112000 | 5.08e-01 |
ECM proteoglycans | 35 | 2.53e-01 | 0.112000 | 3.93e-01 |
Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 30 | 2.90e-01 | 0.112000 | 4.34e-01 |
Repression of WNT target genes | 14 | 4.70e-01 | -0.112000 | 6.04e-01 |
Other interleukin signaling | 18 | 4.13e-01 | 0.111000 | 5.52e-01 |
ESR-mediated signaling | 162 | 1.46e-02 | 0.111000 | 4.80e-02 |
MAPK6/MAPK4 signaling | 82 | 8.26e-02 | 0.111000 | 1.79e-01 |
GLI3 is processed to GLI3R by the proteasome | 57 | 1.48e-01 | 0.111000 | 2.69e-01 |
Synthesis of PIPs at the early endosome membrane | 16 | 4.44e-01 | 0.110000 | 5.83e-01 |
FOXO-mediated transcription | 58 | 1.47e-01 | 0.110000 | 2.69e-01 |
Gene Silencing by RNA | 87 | 7.73e-02 | -0.110000 | 1.70e-01 |
Signaling by ERBB4 | 44 | 2.09e-01 | 0.110000 | 3.43e-01 |
PERK regulates gene expression | 30 | 3.00e-01 | -0.109000 | 4.46e-01 |
Asymmetric localization of PCP proteins | 60 | 1.44e-01 | 0.109000 | 2.66e-01 |
Signaling by GPCR | 536 | 1.59e-05 | 0.109000 | 1.86e-04 |
Formation of TC-NER Pre-Incision Complex | 53 | 1.70e-01 | -0.109000 | 2.97e-01 |
Death Receptor Signalling | 132 | 3.10e-02 | 0.109000 | 8.66e-02 |
Negative regulation of the PI3K/AKT network | 87 | 7.98e-02 | 0.109000 | 1.74e-01 |
Positive epigenetic regulation of rRNA expression | 62 | 1.39e-01 | -0.109000 | 2.58e-01 |
DNA Double-Strand Break Repair | 135 | 2.98e-02 | -0.108000 | 8.46e-02 |
Ras activation upon Ca2+ influx through NMDA receptor | 15 | 4.70e-01 | -0.108000 | 6.04e-01 |
TP53 Regulates Metabolic Genes | 84 | 8.83e-02 | 0.108000 | 1.88e-01 |
FRS-mediated FGFR2 signaling | 14 | 4.87e-01 | -0.107000 | 6.19e-01 |
Cytochrome P450 - arranged by substrate type | 34 | 2.81e-01 | 0.107000 | 4.25e-01 |
Signaling by Nuclear Receptors | 218 | 6.89e-03 | 0.106000 | 2.61e-02 |
RNA Polymerase II Transcription | 1196 | 7.42e-10 | -0.106000 | 2.10e-08 |
Activation of SMO | 13 | 5.09e-01 | 0.106000 | 6.39e-01 |
Metal ion SLC transporters | 21 | 4.05e-01 | 0.105000 | 5.44e-01 |
NIK-->noncanonical NF-kB signaling | 57 | 1.71e-01 | 0.105000 | 2.97e-01 |
Post-translational protein modification | 1190 | 1.08e-09 | 0.105000 | 2.83e-08 |
Ovarian tumor domain proteases | 37 | 2.69e-01 | 0.105000 | 4.12e-01 |
Class I peroxisomal membrane protein import | 20 | 4.17e-01 | -0.105000 | 5.56e-01 |
Nucleobase catabolism | 28 | 3.37e-01 | 0.105000 | 4.84e-01 |
NF-kB is activated and signals survival | 12 | 5.30e-01 | 0.105000 | 6.58e-01 |
WNT ligand biogenesis and trafficking | 21 | 4.07e-01 | 0.105000 | 5.45e-01 |
Voltage gated Potassium channels | 25 | 3.66e-01 | 0.105000 | 5.08e-01 |
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 27 | 3.47e-01 | -0.104000 | 4.92e-01 |
Receptor Mediated Mitophagy | 11 | 5.49e-01 | 0.104000 | 6.76e-01 |
Cardiac conduction | 92 | 8.40e-02 | 0.104000 | 1.81e-01 |
Signaling by EGFR in Cancer | 23 | 3.89e-01 | 0.104000 | 5.29e-01 |
SUMOylation | 165 | 2.19e-02 | -0.103000 | 6.62e-02 |
NRAGE signals death through JNK | 53 | 1.94e-01 | 0.103000 | 3.24e-01 |
Deposition of new CENPA-containing nucleosomes at the centromere | 40 | 2.60e-01 | -0.103000 | 4.02e-01 |
Nucleosome assembly | 40 | 2.60e-01 | -0.103000 | 4.02e-01 |
O-glycosylation of TSR domain-containing proteins | 27 | 3.57e-01 | -0.102000 | 5.01e-01 |
Dectin-1 mediated noncanonical NF-kB signaling | 58 | 1.80e-01 | 0.102000 | 3.09e-01 |
Organelle biogenesis and maintenance | 269 | 4.21e-03 | -0.101000 | 1.74e-02 |
Base-Excision Repair, AP Site Formation | 31 | 3.29e-01 | 0.101000 | 4.74e-01 |
Cellular hexose transport | 15 | 4.97e-01 | -0.101000 | 6.28e-01 |
Metabolism of polyamines | 57 | 1.88e-01 | 0.101000 | 3.17e-01 |
SLC-mediated transmembrane transport | 180 | 1.98e-02 | 0.101000 | 6.09e-02 |
Unfolded Protein Response (UPR) | 86 | 1.07e-01 | 0.101000 | 2.13e-01 |
Signalling to RAS | 19 | 4.48e-01 | 0.101000 | 5.83e-01 |
Mitotic G1 phase and G1/S transition | 148 | 3.50e-02 | -0.100000 | 9.45e-02 |
DNA Damage Recognition in GG-NER | 38 | 2.86e-01 | -0.100000 | 4.31e-01 |
GPCR downstream signalling | 494 | 1.40e-04 | 0.100000 | 1.23e-03 |
Autodegradation of the E3 ubiquitin ligase COP1 | 49 | 2.26e-01 | 0.099900 | 3.65e-01 |
Nephrin family interactions | 17 | 4.76e-01 | -0.099800 | 6.09e-01 |
Purine catabolism | 16 | 4.92e-01 | -0.099200 | 6.25e-01 |
DAP12 signaling | 28 | 3.65e-01 | 0.098900 | 5.08e-01 |
G alpha (q) signalling events | 131 | 5.23e-02 | 0.098200 | 1.28e-01 |
Cristae formation | 31 | 3.44e-01 | -0.098100 | 4.89e-01 |
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | 36 | 3.10e-01 | 0.097800 | 4.54e-01 |
SIRT1 negatively regulates rRNA expression | 24 | 4.07e-01 | 0.097700 | 5.46e-01 |
Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 11 | 5.75e-01 | 0.097600 | 7.01e-01 |
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | 10 | 5.93e-01 | -0.097500 | 7.17e-01 |
Transcriptional Regulation by MECP2 | 47 | 2.48e-01 | 0.097400 | 3.89e-01 |
Aberrant regulation of mitotic exit in cancer due to RB1 defects | 20 | 4.51e-01 | -0.097300 | 5.85e-01 |
SUMO E3 ligases SUMOylate target proteins | 159 | 3.45e-02 | -0.097200 | 9.35e-02 |
MASTL Facilitates Mitotic Progression | 10 | 5.95e-01 | 0.097100 | 7.17e-01 |
Defective EXT1 causes exostoses 1, TRPS2 and CHDS | 10 | 5.95e-01 | -0.097000 | 7.17e-01 |
Defective EXT2 causes exostoses 2 | 10 | 5.95e-01 | -0.097000 | 7.17e-01 |
Resolution of D-loop Structures through Holliday Junction Intermediates | 32 | 3.43e-01 | -0.096900 | 4.87e-01 |
Vpu mediated degradation of CD4 | 50 | 2.39e-01 | 0.096200 | 3.79e-01 |
Negative regulation of FGFR2 signaling | 23 | 4.26e-01 | 0.095800 | 5.66e-01 |
NOTCH2 Activation and Transmission of Signal to the Nucleus | 20 | 4.60e-01 | 0.095500 | 5.93e-01 |
Leishmania infection | 245 | 1.01e-02 | 0.095500 | 3.58e-02 |
PKA-mediated phosphorylation of CREB | 17 | 4.98e-01 | 0.095000 | 6.28e-01 |
Meiotic synapsis | 45 | 2.70e-01 | 0.095000 | 4.13e-01 |
Epigenetic regulation of gene expression | 103 | 9.73e-02 | -0.094600 | 2.04e-01 |
Nuclear signaling by ERBB4 | 24 | 4.25e-01 | 0.094200 | 5.65e-01 |
Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 22 | 4.45e-01 | 0.094000 | 5.83e-01 |
Metabolism of nucleotides | 86 | 1.32e-01 | -0.094000 | 2.46e-01 |
p75NTR signals via NF-kB | 15 | 5.31e-01 | 0.093500 | 6.58e-01 |
Signaling by FGFR2 IIIa TM | 18 | 4.93e-01 | -0.093400 | 6.25e-01 |
Peptide ligand-binding receptors | 92 | 1.24e-01 | 0.092800 | 2.36e-01 |
Pexophagy | 11 | 5.94e-01 | 0.092800 | 7.17e-01 |
TP53 Regulates Transcription of DNA Repair Genes | 61 | 2.14e-01 | -0.092000 | 3.49e-01 |
Heme biosynthesis | 14 | 5.51e-01 | 0.091900 | 6.79e-01 |
Integrin cell surface interactions | 52 | 2.53e-01 | 0.091600 | 3.93e-01 |
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 104 | 1.07e-01 | -0.091400 | 2.14e-01 |
Recruitment of NuMA to mitotic centrosomes | 80 | 1.61e-01 | -0.090700 | 2.83e-01 |
Metabolism of cofactors | 19 | 4.95e-01 | 0.090500 | 6.26e-01 |
Fcgamma receptor (FCGR) dependent phagocytosis | 147 | 5.88e-02 | 0.090300 | 1.38e-01 |
FLT3 Signaling | 244 | 1.52e-02 | 0.090200 | 4.96e-02 |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 72 | 1.88e-01 | 0.089600 | 3.18e-01 |
PI-3K cascade:FGFR4 | 10 | 6.25e-01 | -0.089200 | 7.41e-01 |
Anchoring of the basal body to the plasma membrane | 97 | 1.29e-01 | -0.089100 | 2.43e-01 |
Ub-specific processing proteases | 170 | 4.52e-02 | 0.089000 | 1.16e-01 |
Termination of O-glycan biosynthesis | 16 | 5.39e-01 | 0.088700 | 6.66e-01 |
Processing of DNA double-strand break ends | 71 | 1.98e-01 | -0.088400 | 3.28e-01 |
Mitotic Telophase/Cytokinesis | 13 | 5.83e-01 | 0.088000 | 7.08e-01 |
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 17 | 5.31e-01 | 0.087800 | 6.58e-01 |
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 17 | 5.31e-01 | 0.087800 | 6.58e-01 |
Branched-chain amino acid catabolism | 21 | 4.86e-01 | -0.087700 | 6.19e-01 |
Stabilization of p53 | 54 | 2.66e-01 | 0.087400 | 4.09e-01 |
Mitotic Prometaphase | 185 | 4.05e-02 | -0.087400 | 1.07e-01 |
Ca2+ pathway | 57 | 2.57e-01 | 0.086800 | 3.98e-01 |
Condensation of Prometaphase Chromosomes | 11 | 6.18e-01 | 0.086800 | 7.37e-01 |
Pregnenolone biosynthesis | 10 | 6.36e-01 | 0.086500 | 7.52e-01 |
FRS-mediated FGFR1 signaling | 14 | 5.77e-01 | 0.086100 | 7.02e-01 |
MAPK1/MAPK3 signaling | 235 | 2.31e-02 | 0.086000 | 6.88e-02 |
MAPK family signaling cascades | 269 | 1.56e-02 | 0.085700 | 5.03e-02 |
Regulation of necroptotic cell death | 14 | 5.80e-01 | -0.085400 | 7.05e-01 |
Mitotic Spindle Checkpoint | 108 | 1.26e-01 | -0.085300 | 2.38e-01 |
Centrosome maturation | 81 | 1.85e-01 | -0.085200 | 3.16e-01 |
Recruitment of mitotic centrosome proteins and complexes | 81 | 1.85e-01 | -0.085200 | 3.16e-01 |
Regulation of PTEN mRNA translation | 13 | 5.96e-01 | 0.084800 | 7.18e-01 |
Downstream signaling of activated FGFR2 | 19 | 5.22e-01 | -0.084800 | 6.51e-01 |
Signaling by Hedgehog | 120 | 1.09e-01 | 0.084800 | 2.16e-01 |
FCERI mediated NF-kB activation | 137 | 8.72e-02 | -0.084600 | 1.86e-01 |
mRNA Capping | 29 | 4.31e-01 | -0.084600 | 5.69e-01 |
Regulation of mRNA stability by proteins that bind AU-rich elements | 87 | 1.74e-01 | 0.084300 | 3.03e-01 |
Synthesis of very long-chain fatty acyl-CoAs | 21 | 5.04e-01 | 0.084200 | 6.34e-01 |
HCMV Early Events | 74 | 2.11e-01 | -0.084100 | 3.46e-01 |
DCC mediated attractive signaling | 13 | 6.00e-01 | -0.084000 | 7.22e-01 |
G alpha (i) signalling events | 244 | 2.46e-02 | 0.083600 | 7.23e-02 |
Regulation of TP53 Expression and Degradation | 36 | 3.86e-01 | -0.083500 | 5.27e-01 |
SHC-mediated cascade:FGFR1 | 12 | 6.18e-01 | 0.083200 | 7.37e-01 |
RAF-independent MAPK1/3 activation | 21 | 5.09e-01 | 0.083200 | 6.39e-01 |
Signaling by NTRK2 (TRKB) | 20 | 5.23e-01 | 0.082500 | 6.52e-01 |
Endosomal/Vacuolar pathway | 12 | 6.22e-01 | -0.082100 | 7.39e-01 |
Intrinsic Pathway for Apoptosis | 52 | 3.06e-01 | 0.082000 | 4.53e-01 |
Laminin interactions | 21 | 5.15e-01 | 0.082000 | 6.45e-01 |
Zinc transporters | 14 | 5.95e-01 | 0.082000 | 7.17e-01 |
Signaling by TGFB family members | 91 | 1.78e-01 | 0.081800 | 3.07e-01 |
SCF-beta-TrCP mediated degradation of Emi1 | 53 | 3.04e-01 | 0.081700 | 4.49e-01 |
CD28 dependent Vav1 pathway | 12 | 6.27e-01 | 0.081100 | 7.42e-01 |
Downstream TCR signaling | 100 | 1.63e-01 | -0.080700 | 2.87e-01 |
HCMV Late Events | 69 | 2.46e-01 | 0.080700 | 3.87e-01 |
RAF/MAP kinase cascade | 230 | 3.61e-02 | 0.080200 | 9.73e-02 |
Transcriptional regulation by RUNX1 | 184 | 6.06e-02 | 0.080200 | 1.41e-01 |
SUMOylation of transcription factors | 16 | 5.79e-01 | 0.080200 | 7.04e-01 |
CLEC7A (Dectin-1) induces NFAT activation | 11 | 6.46e-01 | -0.080100 | 7.61e-01 |
NCAM signaling for neurite out-growth | 43 | 3.65e-01 | -0.079900 | 5.08e-01 |
Interleukin-2 signaling | 11 | 6.49e-01 | 0.079200 | 7.65e-01 |
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 32 | 4.43e-01 | 0.078400 | 5.81e-01 |
Phase I - Functionalization of compounds | 63 | 2.85e-01 | 0.077900 | 4.31e-01 |
ABC-family proteins mediated transport | 93 | 1.96e-01 | 0.077600 | 3.26e-01 |
Collagen chain trimerization | 27 | 4.85e-01 | -0.077600 | 6.19e-01 |
Cytokine Signaling in Immune system | 735 | 3.43e-04 | 0.077600 | 2.56e-03 |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 18 | 5.69e-01 | 0.077500 | 6.94e-01 |
Signaling by Ligand-Responsive EGFR Variants in Cancer | 18 | 5.69e-01 | 0.077500 | 6.94e-01 |
Defective B3GALTL causes Peters-plus syndrome (PpS) | 26 | 4.94e-01 | -0.077400 | 6.26e-01 |
Resolution of D-Loop Structures | 33 | 4.44e-01 | -0.076900 | 5.83e-01 |
RNA Polymerase I Promoter Escape | 47 | 3.62e-01 | -0.076900 | 5.06e-01 |
ADORA2B mediated anti-inflammatory cytokines production | 73 | 2.57e-01 | 0.076800 | 3.98e-01 |
Regulation of TNFR1 signaling | 32 | 4.53e-01 | -0.076600 | 5.86e-01 |
Acyl chain remodelling of PE | 20 | 5.54e-01 | 0.076400 | 6.82e-01 |
Post-translational modification: synthesis of GPI-anchored proteins | 57 | 3.19e-01 | 0.076300 | 4.64e-01 |
Estrogen-dependent gene expression | 99 | 1.93e-01 | 0.075700 | 3.23e-01 |
Regulation of actin dynamics for phagocytic cup formation | 123 | 1.49e-01 | 0.075300 | 2.71e-01 |
Peptide hormone metabolism | 51 | 3.52e-01 | 0.075300 | 4.96e-01 |
PRC2 methylates histones and DNA | 29 | 4.83e-01 | 0.075200 | 6.17e-01 |
Synthesis of PE | 12 | 6.53e-01 | -0.075000 | 7.66e-01 |
ERBB2 Regulates Cell Motility | 10 | 6.82e-01 | 0.074900 | 7.83e-01 |
Nicotinamide salvaging | 14 | 6.31e-01 | 0.074200 | 7.46e-01 |
Signaling by ERBB2 | 44 | 3.95e-01 | 0.074200 | 5.34e-01 |
Pyruvate metabolism | 28 | 4.98e-01 | 0.074100 | 6.28e-01 |
Class B/2 (Secretin family receptors) | 56 | 3.38e-01 | 0.074000 | 4.85e-01 |
Regulation of TP53 Degradation | 35 | 4.51e-01 | -0.073700 | 5.85e-01 |
p53-Dependent G1 DNA Damage Response | 63 | 3.13e-01 | 0.073600 | 4.56e-01 |
p53-Dependent G1/S DNA damage checkpoint | 63 | 3.13e-01 | 0.073600 | 4.56e-01 |
Neurotransmitter release cycle | 39 | 4.27e-01 | 0.073500 | 5.66e-01 |
Activation of RAC1 | 11 | 6.74e-01 | 0.073200 | 7.76e-01 |
G2/M DNA damage checkpoint | 68 | 2.99e-01 | -0.072900 | 4.44e-01 |
Cell junction organization | 59 | 3.40e-01 | 0.071800 | 4.87e-01 |
Cell Cycle | 624 | 2.23e-03 | -0.071700 | 1.07e-02 |
Negative regulators of DDX58/IFIH1 signaling | 34 | 4.75e-01 | -0.070700 | 6.09e-01 |
GABA synthesis, release, reuptake and degradation | 13 | 6.61e-01 | -0.070300 | 7.70e-01 |
Eicosanoid ligand-binding receptors | 13 | 6.61e-01 | -0.070200 | 7.70e-01 |
Glucose metabolism | 84 | 2.66e-01 | 0.070200 | 4.09e-01 |
Regulation of PTEN gene transcription | 59 | 3.54e-01 | 0.069800 | 4.97e-01 |
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 91 | 2.52e-01 | -0.069500 | 3.92e-01 |
Amplification of signal from the kinetochores | 91 | 2.52e-01 | -0.069500 | 3.92e-01 |
p75NTR recruits signalling complexes | 12 | 6.77e-01 | 0.069400 | 7.79e-01 |
HIV Life Cycle | 144 | 1.51e-01 | -0.069400 | 2.73e-01 |
NRIF signals cell death from the nucleus | 15 | 6.43e-01 | 0.069200 | 7.58e-01 |
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 18 | 6.11e-01 | -0.069200 | 7.32e-01 |
Host Interactions of HIV factors | 129 | 1.75e-01 | -0.069200 | 3.03e-01 |
Downstream signaling events of B Cell Receptor (BCR) | 79 | 2.89e-01 | 0.069000 | 4.34e-01 |
Basigin interactions | 23 | 5.68e-01 | -0.068800 | 6.94e-01 |
SHC1 events in ERBB4 signaling | 10 | 7.06e-01 | 0.068800 | 7.97e-01 |
Synthesis of substrates in N-glycan biosythesis | 58 | 3.66e-01 | 0.068700 | 5.08e-01 |
Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 13 | 6.70e-01 | -0.068200 | 7.76e-01 |
Pyruvate metabolism and Citric Acid (TCA) cycle | 52 | 3.97e-01 | 0.068000 | 5.36e-01 |
Cell Cycle Checkpoints | 259 | 6.16e-02 | -0.067500 | 1.43e-01 |
Switching of origins to a post-replicative state | 89 | 2.76e-01 | -0.066900 | 4.20e-01 |
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 36 | 4.88e-01 | 0.066800 | 6.20e-01 |
APC/C:Cdc20 mediated degradation of Securin | 66 | 3.48e-01 | 0.066700 | 4.93e-01 |
Cell-Cell communication | 87 | 2.84e-01 | 0.066400 | 4.30e-01 |
PI3K/AKT Signaling in Cancer | 80 | 3.08e-01 | 0.065900 | 4.54e-01 |
Aflatoxin activation and detoxification | 14 | 6.70e-01 | 0.065700 | 7.76e-01 |
DDX58/IFIH1-mediated induction of interferon-alpha/beta | 63 | 3.74e-01 | 0.064700 | 5.15e-01 |
SCF(Skp2)-mediated degradation of p27/p21 | 60 | 3.87e-01 | 0.064600 | 5.27e-01 |
MicroRNA (miRNA) biogenesis | 24 | 5.85e-01 | -0.064400 | 7.09e-01 |
GPCR ligand binding | 229 | 9.37e-02 | 0.064300 | 1.97e-01 |
RNA polymerase II transcribes snRNA genes | 72 | 3.48e-01 | 0.064000 | 4.93e-01 |
Negative epigenetic regulation of rRNA expression | 65 | 3.78e-01 | -0.063200 | 5.19e-01 |
FCGR3A-mediated phagocytosis | 121 | 2.31e-01 | 0.063000 | 3.70e-01 |
Leishmania phagocytosis | 121 | 2.31e-01 | 0.063000 | 3.70e-01 |
Parasite infection | 121 | 2.31e-01 | 0.063000 | 3.70e-01 |
Regulation of RUNX2 expression and activity | 66 | 3.79e-01 | 0.062600 | 5.20e-01 |
Molecules associated with elastic fibres | 22 | 6.12e-01 | 0.062500 | 7.32e-01 |
Downregulation of SMAD2/3:SMAD4 transcriptional activity | 23 | 6.04e-01 | 0.062500 | 7.25e-01 |
Protein localization | 157 | 1.80e-01 | -0.062000 | 3.09e-01 |
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 21 | 6.24e-01 | 0.061900 | 7.40e-01 |
Resolution of Sister Chromatid Cohesion | 104 | 2.77e-01 | -0.061700 | 4.22e-01 |
TICAM1,TRAF6-dependent induction of TAK1 complex | 11 | 7.23e-01 | 0.061700 | 8.12e-01 |
Autodegradation of Cdh1 by Cdh1:APC/C | 64 | 3.95e-01 | 0.061500 | 5.34e-01 |
Class A/1 (Rhodopsin-like receptors) | 162 | 1.78e-01 | 0.061300 | 3.08e-01 |
G1/S DNA Damage Checkpoints | 65 | 3.94e-01 | 0.061100 | 5.34e-01 |
TRP channels | 17 | 6.63e-01 | 0.061000 | 7.71e-01 |
Sema3A PAK dependent Axon repulsion | 16 | 6.73e-01 | 0.060900 | 7.76e-01 |
B-WICH complex positively regulates rRNA expression | 47 | 4.71e-01 | -0.060800 | 6.05e-01 |
G2/M Checkpoints | 139 | 2.17e-01 | -0.060600 | 3.53e-01 |
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 23 | 6.21e-01 | 0.059500 | 7.39e-01 |
Signaling by the B Cell Receptor (BCR) | 162 | 1.92e-01 | -0.059400 | 3.22e-01 |
Ephrin signaling | 17 | 6.72e-01 | 0.059300 | 7.76e-01 |
Ion homeostasis | 40 | 5.18e-01 | 0.059000 | 6.48e-01 |
EML4 and NUDC in mitotic spindle formation | 95 | 3.21e-01 | -0.058900 | 4.66e-01 |
Regulation of PLK1 Activity at G2/M Transition | 87 | 3.43e-01 | -0.058800 | 4.88e-01 |
Cargo trafficking to the periciliary membrane | 47 | 4.86e-01 | -0.058700 | 6.19e-01 |
RAS processing | 19 | 6.60e-01 | -0.058400 | 7.70e-01 |
mitochondrial fatty acid beta-oxidation of saturated fatty acids | 11 | 7.40e-01 | -0.057800 | 8.26e-01 |
Signaling by FGFR4 in disease | 11 | 7.43e-01 | -0.057100 | 8.27e-01 |
Synthesis of glycosylphosphatidylinositol (GPI) | 17 | 6.84e-01 | -0.057000 | 7.85e-01 |
Downstream signaling of activated FGFR1 | 20 | 6.61e-01 | 0.056700 | 7.70e-01 |
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 43 | 5.21e-01 | 0.056500 | 6.51e-01 |
CDK-mediated phosphorylation and removal of Cdc6 | 71 | 4.11e-01 | 0.056500 | 5.49e-01 |
Transport of inorganic cations/anions and amino acids/oligopeptides | 79 | 3.89e-01 | 0.056100 | 5.29e-01 |
Antigen processing: Ubiquitination & Proteasome degradation | 288 | 1.03e-01 | 0.055800 | 2.12e-01 |
Glycolysis | 67 | 4.33e-01 | 0.055300 | 5.72e-01 |
Interleukin-7 signaling | 21 | 6.64e-01 | 0.054800 | 7.71e-01 |
Polo-like kinase mediated events | 16 | 7.05e-01 | 0.054700 | 7.97e-01 |
Phase II - Conjugation of compounds | 68 | 4.47e-01 | 0.053300 | 5.83e-01 |
Loss of Nlp from mitotic centrosomes | 69 | 4.46e-01 | -0.053100 | 5.83e-01 |
Loss of proteins required for interphase microtubule organization from the centrosome | 69 | 4.46e-01 | -0.053100 | 5.83e-01 |
Metabolism of folate and pterines | 16 | 7.13e-01 | 0.053100 | 8.02e-01 |
Metabolism of nitric oxide: NOS3 activation and regulation | 12 | 7.51e-01 | 0.052900 | 8.33e-01 |
Neddylation | 218 | 1.87e-01 | 0.051800 | 3.17e-01 |
TCR signaling | 121 | 3.28e-01 | -0.051500 | 4.73e-01 |
Metabolism | 1768 | 3.32e-04 | 0.051400 | 2.50e-03 |
Prolactin receptor signaling | 11 | 7.68e-01 | -0.051300 | 8.46e-01 |
Cell Cycle, Mitotic | 502 | 5.21e-02 | -0.050600 | 1.28e-01 |
RNA Pol II CTD phosphorylation and interaction with CE | 27 | 6.52e-01 | -0.050100 | 7.66e-01 |
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 27 | 6.52e-01 | -0.050100 | 7.66e-01 |
Prefoldin mediated transfer of substrate to CCT/TriC | 26 | 6.59e-01 | -0.050000 | 7.70e-01 |
Diseases of metabolism | 190 | 2.35e-01 | 0.050000 | 3.74e-01 |
Developmental Biology | 727 | 2.27e-02 | 0.049600 | 6.80e-02 |
RMTs methylate histone arginines | 37 | 6.02e-01 | -0.049600 | 7.23e-01 |
Maturation of nucleoprotein | 10 | 7.86e-01 | 0.049500 | 8.57e-01 |
Signaling by NODAL | 13 | 7.59e-01 | -0.049200 | 8.39e-01 |
Signaling by BMP | 21 | 7.03e-01 | -0.048000 | 7.96e-01 |
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 75 | 4.77e-01 | 0.047500 | 6.09e-01 |
Metabolism of vitamins and cofactors | 155 | 3.07e-01 | 0.047500 | 4.53e-01 |
HCMV Infection | 96 | 4.23e-01 | 0.047300 | 5.64e-01 |
Orc1 removal from chromatin | 69 | 4.99e-01 | -0.047100 | 6.29e-01 |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 31 | 6.51e-01 | -0.047000 | 7.66e-01 |
Downregulation of ERBB2:ERBB3 signaling | 12 | 7.81e-01 | -0.046400 | 8.52e-01 |
Diseases associated with N-glycosylation of proteins | 17 | 7.42e-01 | -0.046200 | 8.27e-01 |
Phase 2 - plateau phase | 18 | 7.35e-01 | 0.046100 | 8.23e-01 |
Diseases associated with glycosaminoglycan metabolism | 26 | 6.86e-01 | 0.045800 | 7.86e-01 |
HATs acetylate histones | 93 | 4.47e-01 | -0.045600 | 5.83e-01 |
Biological oxidations | 136 | 3.64e-01 | 0.045100 | 5.08e-01 |
TP53 Regulates Transcription of Cell Cycle Genes | 48 | 5.90e-01 | -0.044900 | 7.15e-01 |
PI-3K cascade:FGFR1 | 12 | 7.88e-01 | 0.044900 | 8.58e-01 |
Constitutive Signaling by NOTCH1 HD Domain Mutants | 14 | 7.71e-01 | 0.044900 | 8.48e-01 |
Signaling by NOTCH1 HD Domain Mutants in Cancer | 14 | 7.71e-01 | 0.044900 | 8.48e-01 |
Formation of RNA Pol II elongation complex | 57 | 5.58e-01 | 0.044900 | 6.84e-01 |
RNA Polymerase II Transcription Elongation | 57 | 5.58e-01 | 0.044900 | 6.84e-01 |
CDT1 association with the CDC6:ORC:origin complex | 57 | 5.58e-01 | 0.044800 | 6.84e-01 |
Processing of Intronless Pre-mRNAs | 19 | 7.36e-01 | -0.044700 | 8.23e-01 |
Disorders of transmembrane transporters | 147 | 3.53e-01 | 0.044400 | 4.96e-01 |
Nonhomologous End-Joining (NHEJ) | 42 | 6.21e-01 | 0.044100 | 7.39e-01 |
Adaptive Immune System | 756 | 3.94e-02 | 0.044000 | 1.05e-01 |
Interferon Signaling | 177 | 3.12e-01 | -0.044000 | 4.56e-01 |
Signaling by ERBB2 ECD mutants | 15 | 7.68e-01 | 0.044000 | 8.46e-01 |
Mitotic Prophase | 98 | 4.52e-01 | 0.044000 | 5.85e-01 |
Chondroitin sulfate/dermatan sulfate metabolism | 38 | 6.42e-01 | 0.043500 | 7.58e-01 |
SHC-mediated cascade:FGFR4 | 10 | 8.13e-01 | -0.043200 | 8.80e-01 |
SLC transporter disorders | 77 | 5.13e-01 | -0.043100 | 6.42e-01 |
HIV elongation arrest and recovery | 32 | 6.73e-01 | 0.043100 | 7.76e-01 |
Pausing and recovery of HIV elongation | 32 | 6.73e-01 | 0.043100 | 7.76e-01 |
Late Phase of HIV Life Cycle | 131 | 4.03e-01 | -0.042300 | 5.43e-01 |
Neurexins and neuroligins | 37 | 6.56e-01 | -0.042300 | 7.69e-01 |
Transcriptional regulation by small RNAs | 63 | 5.62e-01 | -0.042300 | 6.88e-01 |
APC/C:Cdc20 mediated degradation of mitotic proteins | 74 | 5.30e-01 | 0.042200 | 6.58e-01 |
Nitric oxide stimulates guanylate cyclase | 16 | 7.72e-01 | 0.041900 | 8.48e-01 |
Disease | 1299 | 1.13e-02 | 0.041900 | 3.89e-02 |
Transcriptional activation of mitochondrial biogenesis | 51 | 6.13e-01 | 0.040900 | 7.33e-01 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 124 | 4.32e-01 | -0.040800 | 5.71e-01 |
RIPK1-mediated regulated necrosis | 16 | 7.79e-01 | 0.040600 | 8.50e-01 |
Regulated Necrosis | 16 | 7.79e-01 | 0.040600 | 8.50e-01 |
TP53 Regulates Transcription of Death Receptors and Ligands | 11 | 8.16e-01 | -0.040500 | 8.82e-01 |
Dopamine Neurotransmitter Release Cycle | 20 | 7.55e-01 | -0.040400 | 8.36e-01 |
Netrin-1 signaling | 40 | 6.61e-01 | 0.040000 | 7.70e-01 |
Cyclin A/B1/B2 associated events during G2/M transition | 25 | 7.30e-01 | 0.039800 | 8.20e-01 |
Mitochondrial Fatty Acid Beta-Oxidation | 36 | 6.80e-01 | -0.039700 | 7.82e-01 |
Gamma carboxylation, hypusine formation and arylsulfatase activation | 34 | 6.89e-01 | -0.039700 | 7.89e-01 |
Interleukin-35 Signalling | 12 | 8.12e-01 | -0.039600 | 8.80e-01 |
TP53 Regulates Transcription of Cell Death Genes | 42 | 6.57e-01 | 0.039600 | 7.69e-01 |
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 72 | 5.65e-01 | 0.039200 | 6.92e-01 |
Hedgehog 'off' state | 92 | 5.28e-01 | 0.038100 | 6.57e-01 |
Purine salvage | 12 | 8.21e-01 | 0.037800 | 8.84e-01 |
Post NMDA receptor activation events | 48 | 6.51e-01 | 0.037700 | 7.66e-01 |
Amino acid transport across the plasma membrane | 23 | 7.54e-01 | 0.037700 | 8.36e-01 |
Visual phototransduction | 59 | 6.18e-01 | 0.037600 | 7.37e-01 |
Glutathione synthesis and recycling | 10 | 8.39e-01 | -0.037100 | 8.99e-01 |
IGF1R signaling cascade | 36 | 7.01e-01 | 0.037000 | 7.94e-01 |
Keratan sulfate biosynthesis | 22 | 7.65e-01 | 0.036700 | 8.44e-01 |
AURKA Activation by TPX2 | 72 | 5.90e-01 | -0.036700 | 7.15e-01 |
Aberrant regulation of mitotic cell cycle due to RB1 defects | 36 | 7.07e-01 | -0.036200 | 7.97e-01 |
Diseases of mitotic cell cycle | 36 | 7.07e-01 | -0.036200 | 7.97e-01 |
TNFR2 non-canonical NF-kB pathway | 95 | 5.43e-01 | -0.036100 | 6.70e-01 |
N-glycan antennae elongation in the medial/trans-Golgi | 21 | 7.75e-01 | 0.036000 | 8.49e-01 |
O-linked glycosylation | 84 | 5.69e-01 | 0.035900 | 6.94e-01 |
Transcriptional Regulation by VENTX | 38 | 7.04e-01 | -0.035600 | 7.96e-01 |
Cyclin D associated events in G1 | 47 | 6.73e-01 | 0.035500 | 7.76e-01 |
G1 Phase | 47 | 6.73e-01 | 0.035500 | 7.76e-01 |
Diseases associated with O-glycosylation of proteins | 49 | 6.67e-01 | -0.035500 | 7.75e-01 |
Chromatin modifying enzymes | 217 | 3.72e-01 | 0.035100 | 5.14e-01 |
Chromatin organization | 217 | 3.72e-01 | 0.035100 | 5.14e-01 |
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 18 | 7.98e-01 | 0.034900 | 8.66e-01 |
Transcription of the HIV genome | 67 | 6.23e-01 | -0.034800 | 7.39e-01 |
Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 71 | 6.13e-01 | 0.034800 | 7.33e-01 |
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 46 | 6.84e-01 | 0.034700 | 7.85e-01 |
Respiratory electron transport | 101 | 5.48e-01 | -0.034600 | 6.76e-01 |
Formation of HIV-1 elongation complex containing HIV-1 Tat | 42 | 6.99e-01 | -0.034500 | 7.93e-01 |
HIV Transcription Elongation | 42 | 6.99e-01 | -0.034500 | 7.93e-01 |
Tat-mediated elongation of the HIV-1 transcript | 42 | 6.99e-01 | -0.034500 | 7.93e-01 |
IRAK2 mediated activation of TAK1 complex | 10 | 8.51e-01 | 0.034400 | 9.06e-01 |
Formation of the Early Elongation Complex | 33 | 7.34e-01 | -0.034200 | 8.22e-01 |
Formation of the HIV-1 Early Elongation Complex | 33 | 7.34e-01 | -0.034200 | 8.22e-01 |
Nef mediated downregulation of MHC class I complex cell surface expression | 10 | 8.52e-01 | -0.034000 | 9.07e-01 |
Downregulation of TGF-beta receptor signaling | 26 | 7.65e-01 | 0.033900 | 8.44e-01 |
CASP8 activity is inhibited | 11 | 8.47e-01 | -0.033500 | 9.03e-01 |
Dimerization of procaspase-8 | 11 | 8.47e-01 | -0.033500 | 9.03e-01 |
Regulation by c-FLIP | 11 | 8.47e-01 | -0.033500 | 9.03e-01 |
HIV Transcription Initiation | 45 | 6.99e-01 | -0.033300 | 7.93e-01 |
RNA Polymerase II HIV Promoter Escape | 45 | 6.99e-01 | -0.033300 | 7.93e-01 |
RNA Polymerase II Promoter Escape | 45 | 6.99e-01 | -0.033300 | 7.93e-01 |
RNA Polymerase II Transcription Initiation | 45 | 6.99e-01 | -0.033300 | 7.93e-01 |
RNA Polymerase II Transcription Initiation And Promoter Clearance | 45 | 6.99e-01 | -0.033300 | 7.93e-01 |
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 45 | 6.99e-01 | -0.033300 | 7.93e-01 |
PI3K events in ERBB2 signaling | 11 | 8.53e-01 | -0.032300 | 9.07e-01 |
NoRC negatively regulates rRNA expression | 62 | 6.60e-01 | -0.032300 | 7.70e-01 |
Signaling by FGFR in disease | 51 | 6.94e-01 | 0.031900 | 7.93e-01 |
GRB2 events in ERBB2 signaling | 11 | 8.61e-01 | -0.030600 | 9.09e-01 |
Acyl chain remodelling of PS | 14 | 8.46e-01 | 0.030000 | 9.03e-01 |
Chaperone Mediated Autophagy | 20 | 8.19e-01 | -0.029600 | 8.83e-01 |
Cellular responses to stress | 499 | 2.59e-01 | -0.029500 | 4.01e-01 |
Formation of ATP by chemiosmotic coupling | 18 | 8.29e-01 | 0.029500 | 8.89e-01 |
Signaling by FGFR | 69 | 6.74e-01 | 0.029300 | 7.76e-01 |
Complex I biogenesis | 55 | 7.09e-01 | -0.029100 | 7.98e-01 |
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | 13 | 8.56e-01 | -0.029000 | 9.08e-01 |
Transcriptional Regulation by TP53 | 351 | 3.52e-01 | -0.028900 | 4.96e-01 |
Mitochondrial iron-sulfur cluster biogenesis | 13 | 8.59e-01 | -0.028500 | 9.08e-01 |
Lewis blood group biosynthesis | 13 | 8.59e-01 | 0.028500 | 9.08e-01 |
Glutamate Neurotransmitter Release Cycle | 20 | 8.30e-01 | -0.027700 | 8.89e-01 |
Anti-inflammatory response favouring Leishmania parasite infection | 169 | 5.34e-01 | -0.027700 | 6.61e-01 |
Leishmania parasite growth and survival | 169 | 5.34e-01 | -0.027700 | 6.61e-01 |
DNA Double Strand Break Response | 47 | 7.43e-01 | 0.027700 | 8.27e-01 |
Pausing and recovery of Tat-mediated HIV elongation | 30 | 7.97e-01 | 0.027100 | 8.66e-01 |
Tat-mediated HIV elongation arrest and recovery | 30 | 7.97e-01 | 0.027100 | 8.66e-01 |
Blood group systems biosynthesis | 17 | 8.47e-01 | 0.027100 | 9.03e-01 |
Meiotic recombination | 38 | 7.76e-01 | 0.026700 | 8.49e-01 |
MECP2 regulates neuronal receptors and channels | 13 | 8.68e-01 | 0.026600 | 9.13e-01 |
HS-GAG degradation | 16 | 8.55e-01 | 0.026300 | 9.08e-01 |
Nuclear Envelope (NE) Reassembly | 69 | 7.08e-01 | 0.026100 | 7.98e-01 |
Fertilization | 12 | 8.77e-01 | 0.025800 | 9.20e-01 |
Activation of BH3-only proteins | 29 | 8.13e-01 | 0.025400 | 8.80e-01 |
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 24 | 8.29e-01 | 0.025400 | 8.89e-01 |
Signaling by ERBB2 TMD/JMD mutants | 17 | 8.57e-01 | -0.025200 | 9.08e-01 |
PKMTs methylate histone lysines | 44 | 7.72e-01 | -0.025200 | 8.48e-01 |
Serotonin Neurotransmitter Release Cycle | 15 | 8.67e-01 | 0.025000 | 9.13e-01 |
Interferon alpha/beta signaling | 57 | 7.47e-01 | 0.024700 | 8.31e-01 |
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 73 | 7.22e-01 | 0.024100 | 8.11e-01 |
Syndecan interactions | 19 | 8.60e-01 | 0.023300 | 9.09e-01 |
FRS-mediated FGFR3 signaling | 11 | 8.94e-01 | 0.023200 | 9.31e-01 |
Signaling by Retinoic Acid | 31 | 8.25e-01 | -0.022900 | 8.86e-01 |
Cellular responses to external stimuli | 505 | 3.81e-01 | -0.022800 | 5.21e-01 |
Cell surface interactions at the vascular wall | 174 | 6.11e-01 | -0.022400 | 7.32e-01 |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | 12 | 8.95e-01 | -0.022000 | 9.31e-01 |
Protein-protein interactions at synapses | 57 | 7.76e-01 | 0.021800 | 8.49e-01 |
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) | 10 | 9.05e-01 | 0.021700 | 9.38e-01 |
Signaling by ERBB2 KD Mutants | 20 | 8.69e-01 | -0.021400 | 9.13e-01 |
Sulfur amino acid metabolism | 23 | 8.61e-01 | 0.021000 | 9.09e-01 |
Signaling by FGFR2 | 60 | 7.84e-01 | -0.020400 | 8.55e-01 |
Constitutive Signaling by Aberrant PI3K in Cancer | 54 | 7.97e-01 | -0.020300 | 8.66e-01 |
Formation of HIV elongation complex in the absence of HIV Tat | 44 | 8.18e-01 | -0.020100 | 8.82e-01 |
Synthesis of PA | 32 | 8.44e-01 | 0.020100 | 9.03e-01 |
RNA Polymerase II Pre-transcription Events | 78 | 7.60e-01 | 0.020000 | 8.39e-01 |
Downstream signaling of activated FGFR4 | 17 | 8.89e-01 | -0.019600 | 9.28e-01 |
Interferon gamma signaling | 83 | 7.59e-01 | -0.019400 | 8.39e-01 |
FRS-mediated FGFR4 signaling | 12 | 9.10e-01 | -0.018800 | 9.42e-01 |
Phase 0 - rapid depolarisation | 28 | 8.64e-01 | -0.018700 | 9.11e-01 |
Formation of tubulin folding intermediates by CCT/TriC | 22 | 8.80e-01 | 0.018600 | 9.21e-01 |
Infectious disease | 723 | 3.99e-01 | -0.018400 | 5.38e-01 |
Activation of NMDA receptors and postsynaptic events | 58 | 8.13e-01 | 0.017900 | 8.80e-01 |
Diseases of glycosylation | 109 | 7.47e-01 | 0.017900 | 8.31e-01 |
The citric acid (TCA) cycle and respiratory electron transport | 172 | 6.94e-01 | -0.017400 | 7.93e-01 |
Cytosolic sensors of pathogen-associated DNA | 62 | 8.16e-01 | -0.017100 | 8.82e-01 |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 37 | 8.57e-01 | 0.017100 | 9.08e-01 |
Glucagon-type ligand receptors | 20 | 8.96e-01 | 0.016800 | 9.31e-01 |
Class C/3 (Metabotropic glutamate/pheromone receptors) | 12 | 9.20e-01 | -0.016700 | 9.47e-01 |
Miscellaneous transport and binding events | 20 | 8.99e-01 | 0.016400 | 9.33e-01 |
FOXO-mediated transcription of cell cycle genes | 15 | 9.14e-01 | -0.016200 | 9.43e-01 |
STING mediated induction of host immune responses | 15 | 9.14e-01 | -0.016000 | 9.43e-01 |
Aggrephagy | 22 | 8.97e-01 | 0.016000 | 9.31e-01 |
N-Glycan antennae elongation | 13 | 9.20e-01 | 0.016000 | 9.47e-01 |
Signaling by NTRK3 (TRKC) | 16 | 9.14e-01 | -0.015600 | 9.43e-01 |
Regulation of RUNX1 Expression and Activity | 18 | 9.09e-01 | 0.015600 | 9.41e-01 |
Antimicrobial peptides | 33 | 8.83e-01 | 0.014900 | 9.23e-01 |
MET activates PTK2 signaling | 15 | 9.22e-01 | 0.014600 | 9.48e-01 |
IRS-related events triggered by IGF1R | 35 | 8.82e-01 | 0.014500 | 9.22e-01 |
Separation of Sister Chromatids | 167 | 7.49e-01 | -0.014400 | 8.31e-01 |
Cyclin E associated events during G1/S transition | 83 | 8.25e-01 | 0.014000 | 8.86e-01 |
Metabolism of proteins | 1715 | 3.50e-01 | 0.013600 | 4.93e-01 |
Fc epsilon receptor (FCERI) signaling | 190 | 7.48e-01 | -0.013500 | 8.31e-01 |
Mitotic Anaphase | 223 | 7.37e-01 | 0.013100 | 8.23e-01 |
Selective autophagy | 58 | 8.71e-01 | -0.012400 | 9.14e-01 |
TNF signaling | 42 | 8.92e-01 | 0.012200 | 9.30e-01 |
Downregulation of ERBB2 signaling | 24 | 9.19e-01 | -0.011900 | 9.47e-01 |
Meiosis | 68 | 8.65e-01 | -0.011900 | 9.11e-01 |
Signaling by ERBB2 in Cancer | 21 | 9.32e-01 | 0.010800 | 9.55e-01 |
Norepinephrine Neurotransmitter Release Cycle | 14 | 9.44e-01 | -0.010800 | 9.66e-01 |
Cell-cell junction organization | 38 | 9.11e-01 | 0.010500 | 9.42e-01 |
Receptor-type tyrosine-protein phosphatases | 12 | 9.50e-01 | 0.010500 | 9.68e-01 |
CTLA4 inhibitory signaling | 21 | 9.34e-01 | 0.010500 | 9.56e-01 |
Metabolism of water-soluble vitamins and cofactors | 109 | 8.54e-01 | 0.010200 | 9.08e-01 |
Lysosphingolipid and LPA receptors | 11 | 9.56e-01 | -0.009620 | 9.74e-01 |
APC/C-mediated degradation of cell cycle proteins | 86 | 8.79e-01 | 0.009490 | 9.21e-01 |
Regulation of mitotic cell cycle | 86 | 8.79e-01 | 0.009490 | 9.21e-01 |
Downstream signaling of activated FGFR3 | 16 | 9.49e-01 | 0.009200 | 9.68e-01 |
M Phase | 360 | 7.73e-01 | 0.008860 | 8.48e-01 |
Mitotic Metaphase and Anaphase | 224 | 8.20e-01 | 0.008840 | 8.83e-01 |
HIV Infection | 224 | 8.23e-01 | -0.008660 | 8.86e-01 |
IL-6-type cytokine receptor ligand interactions | 12 | 9.61e-01 | 0.008150 | 9.77e-01 |
Mitochondrial biogenesis | 88 | 8.97e-01 | -0.008020 | 9.31e-01 |
Cohesin Loading onto Chromatin | 10 | 9.67e-01 | 0.007580 | 9.81e-01 |
Assembly of the pre-replicative complex | 66 | 9.21e-01 | 0.007080 | 9.47e-01 |
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 29 | 9.49e-01 | 0.006810 | 9.68e-01 |
TICAM1-dependent activation of IRF3/IRF7 | 12 | 9.69e-01 | -0.006580 | 9.81e-01 |
Deactivation of the beta-catenin transactivating complex | 36 | 9.46e-01 | 0.006500 | 9.67e-01 |
Non-integrin membrane-ECM interactions | 37 | 9.46e-01 | 0.006400 | 9.67e-01 |
Attenuation phase | 23 | 9.58e-01 | 0.006360 | 9.75e-01 |
Reproduction | 80 | 9.23e-01 | -0.006240 | 9.48e-01 |
G2/M Transition | 180 | 8.88e-01 | -0.006060 | 9.28e-01 |
Cyclin A:Cdk2-associated events at S phase entry | 85 | 9.24e-01 | 0.005970 | 9.49e-01 |
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 14 | 9.70e-01 | -0.005800 | 9.82e-01 |
HSF1-dependent transactivation | 29 | 9.59e-01 | -0.005520 | 9.75e-01 |
Interaction between L1 and Ankyrins | 22 | 9.65e-01 | 0.005380 | 9.80e-01 |
RHO GTPases Activate Formins | 117 | 9.27e-01 | 0.004880 | 9.51e-01 |
Signaling by KIT in disease | 20 | 9.74e-01 | 0.004280 | 9.82e-01 |
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | 20 | 9.74e-01 | 0.004280 | 9.82e-01 |
Kinesins | 39 | 9.64e-01 | 0.004220 | 9.79e-01 |
TNFR1-induced NFkappaB signaling pathway | 25 | 9.74e-01 | -0.003800 | 9.82e-01 |
Axon guidance | 455 | 8.96e-01 | -0.003570 | 9.31e-01 |
SUMOylation of transcription cofactors | 44 | 9.72e-01 | 0.003100 | 9.82e-01 |
PI3K Cascade | 30 | 9.78e-01 | -0.002900 | 9.85e-01 |
CD28 co-stimulation | 33 | 9.77e-01 | -0.002840 | 9.85e-01 |
IRS-mediated signalling | 34 | 9.83e-01 | -0.002090 | 9.88e-01 |
Regulation of APC/C activators between G1/S and early anaphase | 79 | 9.80e-01 | -0.001670 | 9.85e-01 |
Mitotic G2-G2/M phases | 182 | 9.70e-01 | 0.001630 | 9.82e-01 |
Abortive elongation of HIV-1 transcript in the absence of Tat | 23 | 9.90e-01 | 0.001450 | 9.93e-01 |
Association of TriC/CCT with target proteins during biosynthesis | 37 | 9.90e-01 | -0.001170 | 9.93e-01 |
Nuclear Receptor transcription pathway | 36 | 9.90e-01 | 0.001150 | 9.93e-01 |
Regulation of pyruvate dehydrogenase (PDH) complex | 15 | 9.95e-01 | -0.000919 | 9.97e-01 |
Nucleotide-like (purinergic) receptors | 12 | 9.96e-01 | 0.000917 | 9.97e-01 |
Nervous system development | 474 | 9.80e-01 | 0.000685 | 9.85e-01 |
Incretin synthesis, secretion, and inactivation | 10 | 9.99e-01 | -0.000241 | 9.99e-01 |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | 10 | 9.99e-01 | -0.000241 | 9.99e-01 |
IRAK4 deficiency (TLR2/4)
511 | |
---|---|
set | IRAK4 deficiency (TLR2/4) |
setSize | 10 |
pANOVA | 2.19e-06 |
s.dist | 0.864 |
p.adjustANOVA | 3.11e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MYD88 | 11331 |
CD36 | 10947 |
BTK | 10849 |
TLR2 | 10535 |
TLR1 | 10059 |
TLR4 | 9549 |
CD14 | 9466 |
LY96 | 9322 |
TLR6 | 9070 |
TIRAP | 8858 |
GeneID | Gene Rank |
---|---|
MYD88 | 11331 |
CD36 | 10947 |
BTK | 10849 |
TLR2 | 10535 |
TLR1 | 10059 |
TLR4 | 9549 |
CD14 | 9466 |
LY96 | 9322 |
TLR6 | 9070 |
TIRAP | 8858 |
MyD88 deficiency (TLR2/4)
684 | |
---|---|
set | MyD88 deficiency (TLR2/4) |
setSize | 10 |
pANOVA | 2.19e-06 |
s.dist | 0.864 |
p.adjustANOVA | 3.11e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MYD88 | 11331 |
CD36 | 10947 |
BTK | 10849 |
TLR2 | 10535 |
TLR1 | 10059 |
TLR4 | 9549 |
CD14 | 9466 |
LY96 | 9322 |
TLR6 | 9070 |
TIRAP | 8858 |
GeneID | Gene Rank |
---|---|
MYD88 | 11331 |
CD36 | 10947 |
BTK | 10849 |
TLR2 | 10535 |
TLR1 | 10059 |
TLR4 | 9549 |
CD14 | 9466 |
LY96 | 9322 |
TLR6 | 9070 |
TIRAP | 8858 |
Peptide chain elongation
806 | |
---|---|
set | Peptide chain elongation |
setSize | 88 |
pANOVA | 5.06e-36 |
s.dist | -0.771 |
p.adjustANOVA | 6.88e-34 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
EEF1A1 | -9751 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
EEF1A1 | -9751 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
EEF2 | -6279 |
RPL8 | -6101 |
RPLP1 | -6018 |
RPL28 | -3873 |
FAU | -3618 |
UBA52 | -3490 |
RPL39L | -1661 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
RPS9 | 1841 |
RPL3L | 5150 |
RPL26L1 | 6001 |
Eukaryotic Translation Elongation
349 | |
---|---|
set | Eukaryotic Translation Elongation |
setSize | 93 |
pANOVA | 1.44e-37 |
s.dist | -0.767 |
p.adjustANOVA | 2.18e-35 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
EEF1A1 | -9751 |
EEF1B2 | -9732 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
EEF1A1 | -9751 |
EEF1B2 | -9732 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
EEF1G | -9293 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
EEF2 | -6279 |
RPL8 | -6101 |
RPLP1 | -6018 |
EEF1A1P5 | -5877 |
EEF1D | -5664 |
RPL28 | -3873 |
FAU | -3618 |
UBA52 | -3490 |
EEF1A2 | -3246 |
RPL39L | -1661 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
RPS9 | 1841 |
RPL3L | 5150 |
RPL26L1 | 6001 |
Selenocysteine synthesis
1058 | |
---|---|
set | Selenocysteine synthesis |
setSize | 92 |
pANOVA | 1.36e-35 |
s.dist | -0.75 |
p.adjustANOVA | 1.68e-33 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RPS11 | -7975 |
RPL38 | -7968 |
SEPSECS | -7958 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
SECISBP2 | -6992 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
EEFSEC | -6493 |
RPL8 | -6101 |
SARS1 | -6044 |
RPLP1 | -6018 |
PSTK | -5710 |
RPL28 | -3873 |
FAU | -3618 |
UBA52 | -3490 |
RPL39L | -1661 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
RPS9 | 1841 |
RPL3L | 5150 |
RPL26L1 | 6001 |
SEPHS2 | 8084 |
Viral mRNA Translation
1313 | |
---|---|
set | Viral mRNA Translation |
setSize | 88 |
pANOVA | 6.76e-34 |
s.dist | -0.747 |
p.adjustANOVA | 6.14e-32 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
RPL8 | -6101 |
RPLP1 | -6018 |
RPL28 | -3873 |
FAU | -3618 |
UBA52 | -3490 |
GRSF1 | -2923 |
RPL39L | -1661 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
RPS9 | 1841 |
RPL3L | 5150 |
RPL26L1 | 6001 |
DNAJC3 | 9831 |
Formation of a pool of free 40S subunits
391 | |
---|---|
set | Formation of a pool of free 40S subunits |
setSize | 100 |
pANOVA | 4.05e-38 |
s.dist | -0.746 |
p.adjustANOVA | 6.88e-36 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
EIF3B | -9526 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
EIF3B | -9526 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
EIF3E | -9049 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
EIF1AX | -8383 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
EIF3L | -8255 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
EIF3H | -7091 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
EIF3M | -6817 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
EIF3J | -6448 |
RPL8 | -6101 |
RPLP1 | -6018 |
EIF3F | -5200 |
EIF3D | -5158 |
EIF3C | -4716 |
RPL28 | -3873 |
FAU | -3618 |
UBA52 | -3490 |
EIF3G | -2746 |
EIF3I | -2580 |
EIF3K | -2369 |
RPL39L | -1661 |
EIF3A | -1276 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
RPS9 | 1841 |
RPL3L | 5150 |
RPL26L1 | 6001 |
Eukaryotic Translation Termination
351 | |
---|---|
set | Eukaryotic Translation Termination |
setSize | 92 |
pANOVA | 3.3e-34 |
s.dist | -0.734 |
p.adjustANOVA | 3.21e-32 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
N6AMT1 | -9282 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
GSPT2 | -7995 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
RPL8 | -6101 |
RPLP1 | -6018 |
RPL28 | -3873 |
FAU | -3618 |
UBA52 | -3490 |
TRMT112 | -2296 |
GSPT1 | -2025 |
RPL39L | -1661 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
RPS9 | 1841 |
APEH | 4945 |
RPL3L | 5150 |
RPL26L1 | 6001 |
ETF1 | 6835 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism
1328 | |
---|---|
set | alpha-linolenic (omega3) and linoleic (omega6) acid metabolism |
setSize | 12 |
pANOVA | 1.52e-05 |
s.dist | 0.721 |
p.adjustANOVA | 0.000179 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ACSL1 | 11102 |
ACAA1 | 11076 |
FADS1 | 10870 |
ACOT8 | 10822 |
ACOX1 | 10277 |
ELOVL1 | 9841 |
ELOVL3 | 9553 |
HSD17B4 | 8942 |
ABCD1 | 7994 |
FADS2 | 7216 |
ELOVL5 | 5665 |
SCP2 | -1980 |
GeneID | Gene Rank |
---|---|
ACSL1 | 11102 |
ACAA1 | 11076 |
FADS1 | 10870 |
ACOT8 | 10822 |
ACOX1 | 10277 |
ELOVL1 | 9841 |
ELOVL3 | 9553 |
HSD17B4 | 8942 |
ABCD1 | 7994 |
FADS2 | 7216 |
ELOVL5 | 5665 |
SCP2 | -1980 |
alpha-linolenic acid (ALA) metabolism
1329 | |
---|---|
set | alpha-linolenic acid (ALA) metabolism |
setSize | 12 |
pANOVA | 1.52e-05 |
s.dist | 0.721 |
p.adjustANOVA | 0.000179 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ACSL1 | 11102 |
ACAA1 | 11076 |
FADS1 | 10870 |
ACOT8 | 10822 |
ACOX1 | 10277 |
ELOVL1 | 9841 |
ELOVL3 | 9553 |
HSD17B4 | 8942 |
ABCD1 | 7994 |
FADS2 | 7216 |
ELOVL5 | 5665 |
SCP2 | -1980 |
GeneID | Gene Rank |
---|---|
ACSL1 | 11102 |
ACAA1 | 11076 |
FADS1 | 10870 |
ACOT8 | 10822 |
ACOX1 | 10277 |
ELOVL1 | 9841 |
ELOVL3 | 9553 |
HSD17B4 | 8942 |
ABCD1 | 7994 |
FADS2 | 7216 |
ELOVL5 | 5665 |
SCP2 | -1980 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
742 | |
---|---|
set | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) |
setSize | 94 |
pANOVA | 1.58e-32 |
s.dist | -0.708 |
p.adjustANOVA | 1.2e-30 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
NCBP2 | -9631 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
NCBP2 | -9631 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
GSPT2 | -7995 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
RPL8 | -6101 |
RPLP1 | -6018 |
RPL28 | -3873 |
FAU | -3618 |
UBA52 | -3490 |
PABPC1 | -2991 |
GSPT1 | -2025 |
RPL39L | -1661 |
RPS26 | -1154 |
NCBP1 | -942 |
RPS27L | -496 |
RPS4Y1 | 331 |
RPS9 | 1841 |
RPL3L | 5150 |
RPL26L1 | 6001 |
ETF1 | 6835 |
UPF1 | 9103 |
EIF4G1 | 10506 |
Translocation of ZAP-70 to Immunological synapse
1276 | |
---|---|
set | Translocation of ZAP-70 to Immunological synapse |
setSize | 24 |
pANOVA | 1.98e-09 |
s.dist | -0.707 |
p.adjustANOVA | 5.09e-08 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9971 |
TRAC | -9703 |
HLA-DQB2 | -9656 |
LCK | -9556 |
TRBC1 | -9303 |
TRAV29DV5 | -9278 |
CD3E | -9249 |
TRAV19 | -9248 |
HLA-DRA | -9006 |
HLA-DQA2 | -8774 |
ZAP70 | -8755 |
CD247 | -8741 |
HLA-DPB1 | -8397 |
TRBV7-9 | -8303 |
CD3D | -8297 |
HLA-DPA1 | -8217 |
CD3G | -8111 |
CD4 | -6881 |
HLA-DQA1 | -6389 |
TRAV8-4 | -4769 |
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9971 |
TRAC | -9703 |
HLA-DQB2 | -9656 |
LCK | -9556 |
TRBC1 | -9303 |
TRAV29DV5 | -9278 |
CD3E | -9249 |
TRAV19 | -9248 |
HLA-DRA | -9006 |
HLA-DQA2 | -8774 |
ZAP70 | -8755 |
CD247 | -8741 |
HLA-DPB1 | -8397 |
TRBV7-9 | -8303 |
CD3D | -8297 |
HLA-DPA1 | -8217 |
CD3G | -8111 |
CD4 | -6881 |
HLA-DQA1 | -6389 |
TRAV8-4 | -4769 |
HLA-DQB1 | -4459 |
HLA-DRB1 | -334 |
HLA-DRB5 | 748 |
PTPN22 | 6966 |
L13a-mediated translational silencing of Ceruloplasmin expression
587 | |
---|---|
set | L13a-mediated translational silencing of Ceruloplasmin expression |
setSize | 110 |
pANOVA | 7.55e-35 |
s.dist | -0.678 |
p.adjustANOVA | 8.56e-33 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
EIF4A2 | -9593 |
RPS2 | -9591 |
RPL4 | -9549 |
EIF3B | -9526 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
EIF4A2 | -9593 |
RPS2 | -9591 |
RPL4 | -9549 |
EIF3B | -9526 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
EIF3E | -9049 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
EIF1AX | -8383 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
EIF3L | -8255 |
RPL22L1 | -8202 |
EIF4B | -8190 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
EIF3H | -7091 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
EIF3M | -6817 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
EIF3J | -6448 |
RPL8 | -6101 |
RPLP1 | -6018 |
EIF3F | -5200 |
EIF3D | -5158 |
EIF3C | -4716 |
RPL28 | -3873 |
FAU | -3618 |
UBA52 | -3490 |
PABPC1 | -2991 |
EIF3G | -2746 |
EIF3I | -2580 |
EIF3K | -2369 |
RPL39L | -1661 |
EIF2S1 | -1649 |
EIF3A | -1276 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
EIF2S2 | 554 |
EIF4E | 1661 |
RPS9 | 1841 |
EIF2S3 | 2500 |
RPL3L | 5150 |
EIF4A1 | 5541 |
RPL26L1 | 6001 |
EIF4H | 7768 |
EIF4G1 | 10506 |
GTP hydrolysis and joining of the 60S ribosomal subunit
433 | |
---|---|
set | GTP hydrolysis and joining of the 60S ribosomal subunit |
setSize | 111 |
pANOVA | 1.11e-34 |
s.dist | -0.674 |
p.adjustANOVA | 1.16e-32 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
EIF4A2 | -9593 |
RPS2 | -9591 |
RPL4 | -9549 |
EIF3B | -9526 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
EIF4A2 | -9593 |
RPS2 | -9591 |
RPL4 | -9549 |
EIF3B | -9526 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
EIF3E | -9049 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
EIF1AX | -8383 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
EIF3L | -8255 |
RPL22L1 | -8202 |
EIF4B | -8190 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
EIF3H | -7091 |
EIF5B | -6867 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
EIF3M | -6817 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
EIF3J | -6448 |
RPL8 | -6101 |
RPLP1 | -6018 |
EIF3F | -5200 |
EIF3D | -5158 |
EIF3C | -4716 |
RPL28 | -3873 |
FAU | -3618 |
UBA52 | -3490 |
EIF3G | -2746 |
EIF3I | -2580 |
EIF3K | -2369 |
RPL39L | -1661 |
EIF2S1 | -1649 |
EIF3A | -1276 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
EIF2S2 | 554 |
EIF4E | 1661 |
RPS9 | 1841 |
EIF2S3 | 2500 |
EIF5 | 2937 |
RPL3L | 5150 |
EIF4A1 | 5541 |
RPL26L1 | 6001 |
EIF4H | 7768 |
EIF4G1 | 10506 |
Response of EIF2AK4 (GCN2) to amino acid deficiency
1006 | |
---|---|
set | Response of EIF2AK4 (GCN2) to amino acid deficiency |
setSize | 100 |
pANOVA | 3.17e-31 |
s.dist | -0.672 |
p.adjustANOVA | 2.27e-29 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
ASNS | -7772 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
RPL8 | -6101 |
RPLP1 | -6018 |
GCN1 | -5625 |
IMPACT | -5597 |
ATF3 | -4287 |
RPL28 | -3873 |
FAU | -3618 |
UBA52 | -3490 |
RPL39L | -1661 |
EIF2AK4 | -1656 |
EIF2S1 | -1649 |
RPS26 | -1154 |
ATF2 | -657 |
RPS27L | -496 |
ATF4 | -54 |
RPS4Y1 | 331 |
EIF2S2 | 554 |
RPS9 | 1841 |
TRIB3 | 2492 |
EIF2S3 | 2500 |
CEBPG | 4210 |
RPL3L | 5150 |
RPL26L1 | 6001 |
DDIT3 | 6480 |
CEBPB | 11136 |
Formation of the ternary complex, and subsequently, the 43S complex
397 | |
---|---|
set | Formation of the ternary complex, and subsequently, the 43S complex |
setSize | 51 |
pANOVA | 1.92e-16 |
s.dist | -0.665 |
p.adjustANOVA | 8.41e-15 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS3A | -9834 |
RPS27A | -9723 |
RPS6 | -9699 |
RPS25 | -9664 |
RPS2 | -9591 |
EIF3B | -9526 |
RPS20 | -9413 |
RPS23 | -9387 |
RPS3 | -9298 |
RPS12 | -9270 |
RPS27 | -9175 |
RPS7 | -9165 |
EIF3E | -9049 |
RPS5 | -9042 |
RPS15A | -8883 |
RPS8 | -8861 |
RPS13 | -8724 |
RPS4X | -8648 |
RPS29 | -8637 |
RPS16 | -8579 |
GeneID | Gene Rank |
---|---|
RPS3A | -9834 |
RPS27A | -9723 |
RPS6 | -9699 |
RPS25 | -9664 |
RPS2 | -9591 |
EIF3B | -9526 |
RPS20 | -9413 |
RPS23 | -9387 |
RPS3 | -9298 |
RPS12 | -9270 |
RPS27 | -9175 |
RPS7 | -9165 |
EIF3E | -9049 |
RPS5 | -9042 |
RPS15A | -8883 |
RPS8 | -8861 |
RPS13 | -8724 |
RPS4X | -8648 |
RPS29 | -8637 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
EIF1AX | -8383 |
RPS21 | -8330 |
RPS18 | -8321 |
RPS17 | -8281 |
EIF3L | -8255 |
RPS28 | -8083 |
RPS11 | -7975 |
RPS19 | -7806 |
EIF3H | -7091 |
RPS24 | -6818 |
EIF3M | -6817 |
RPS15 | -6703 |
RPSA | -6629 |
EIF3J | -6448 |
EIF3F | -5200 |
EIF3D | -5158 |
EIF3C | -4716 |
FAU | -3618 |
EIF3G | -2746 |
EIF3I | -2580 |
EIF3K | -2369 |
EIF2S1 | -1649 |
EIF3A | -1276 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
EIF2S2 | 554 |
RPS9 | 1841 |
EIF2S3 | 2500 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2
1321 | |
---|---|
set | WNT5A-dependent internalization of FZD2, FZD5 and ROR2 |
setSize | 11 |
pANOVA | 0.000155 |
s.dist | 0.659 |
p.adjustANOVA | 0.00133 |
Top enriched genes
GeneID | Gene Rank |
---|---|
FZD5 | 11440 |
AP2A1 | 11340 |
CLTC | 10304 |
AP2A2 | 10223 |
AP2M1 | 8799 |
AP2S1 | 8045 |
CLTB | 7968 |
CLTA | 7164 |
FZD2 | 5116 |
AP2B1 | 2910 |
ROR1 | 2194 |
GeneID | Gene Rank |
---|---|
FZD5 | 11440 |
AP2A1 | 11340 |
CLTC | 10304 |
AP2A2 | 10223 |
AP2M1 | 8799 |
AP2S1 | 8045 |
CLTB | 7968 |
CLTA | 7164 |
FZD2 | 5116 |
AP2B1 | 2910 |
ROR1 | 2194 |
Regulation of TLR by endogenous ligand
966 | |
---|---|
set | Regulation of TLR by endogenous ligand |
setSize | 11 |
pANOVA | 0.000234 |
s.dist | 0.641 |
p.adjustANOVA | 0.00188 |
Top enriched genes
GeneID | Gene Rank |
---|---|
S100A8 | 11184 |
CD36 | 10947 |
S100A9 | 10613 |
TLR2 | 10535 |
TLR1 | 10059 |
TLR4 | 9549 |
CD14 | 9466 |
LY96 | 9322 |
TLR6 | 9070 |
S100A1 | -688 |
HMGB1 | -6699 |
GeneID | Gene Rank |
---|---|
S100A8 | 11184 |
CD36 | 10947 |
S100A9 | 10613 |
TLR2 | 10535 |
TLR1 | 10059 |
TLR4 | 9549 |
CD14 | 9466 |
LY96 | 9322 |
TLR6 | 9070 |
S100A1 | -688 |
HMGB1 | -6699 |
Major pathway of rRNA processing in the nucleolus and cytosol
624 | |
---|---|
set | Major pathway of rRNA processing in the nucleolus and cytosol |
setSize | 180 |
pANOVA | 6.06e-50 |
s.dist | -0.641 |
p.adjustANOVA | 2.06e-47 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPP40 | -10069 |
NOP58 | -10031 |
RPL23A | -9979 |
GNL3 | -9960 |
RPL3 | -9957 |
FBL | -9942 |
NOL11 | -9932 |
RPL5 | -9881 |
RPS3A | -9834 |
WDR75 | -9823 |
RPL7 | -9765 |
EXOSC2 | -9753 |
TSR1 | -9724 |
RPS27A | -9723 |
UTP4 | -9700 |
RPS6 | -9699 |
RPL14 | -9698 |
LAS1L | -9679 |
RPS25 | -9664 |
RPL22 | -9659 |
GeneID | Gene Rank |
---|---|
RPP40 | -10069 |
NOP58 | -10031 |
RPL23A | -9979 |
GNL3 | -9960 |
RPL3 | -9957 |
FBL | -9942 |
NOL11 | -9932 |
RPL5 | -9881 |
RPS3A | -9834 |
WDR75 | -9823 |
RPL7 | -9765 |
EXOSC2 | -9753 |
TSR1 | -9724 |
RPS27A | -9723 |
UTP4 | -9700 |
RPS6 | -9699 |
RPL14 | -9698 |
LAS1L | -9679 |
RPS25 | -9664 |
RPL22 | -9659 |
NOP14 | -9641 |
BMS1 | -9626 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
NOP56 | -9444 |
RPS20 | -9413 |
RPL13A | -9402 |
WDR43 | -9395 |
RPS23 | -9387 |
EXOSC8 | -9379 |
RPL32 | -9345 |
NCL | -9336 |
DDX47 | -9334 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
UTP15 | -9156 |
RPL11 | -9117 |
RPL17 | -9116 |
WDR46 | -9056 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
TEX10 | -8915 |
RPL36A | -8909 |
NOB1 | -8908 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
MPHOSPH10 | -8840 |
EXOSC9 | -8793 |
NOL9 | -8786 |
RPL31 | -8769 |
EMG1 | -8744 |
RPS13 | -8724 |
RPL26 | -8706 |
RPP25 | -8688 |
RPS4X | -8648 |
RPP30 | -8640 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
UTP6 | -8616 |
RRP9 | -8598 |
RPS16 | -8579 |
RPS14 | -8541 |
SNU13 | -8495 |
RPS10 | -8494 |
EXOSC7 | -8473 |
EXOSC5 | -8394 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
PELP1 | -8232 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RIOK2 | -8079 |
PNO1 | -8004 |
RPS11 | -7975 |
RPL38 | -7968 |
EBNA1BP2 | -7916 |
RPL37 | -7861 |
NOL6 | -7834 |
RPL27 | -7810 |
RPS19 | -7806 |
NIP7 | -7779 |
KRR1 | -7720 |
RCL1 | -7690 |
RPP38 | -7683 |
RPL13 | -7671 |
DCAF13 | -7564 |
RPL41 | -7561 |
RPL36 | -7493 |
EXOSC6 | -7458 |
UTP20 | -7427 |
HEATR1 | -7278 |
IMP4 | -7155 |
PES1 | -7148 |
LTV1 | -7119 |
WDR3 | -7016 |
IMP3 | -6912 |
RPL37A | -6833 |
EXOSC10 | -6829 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
BOP1 | -6593 |
PDCD11 | -6547 |
CSNK1E | -6526 |
RPL8 | -6101 |
RPLP1 | -6018 |
RBM28 | -5712 |
PWP2 | -5423 |
RRP7A | -5246 |
WDR36 | -5072 |
BYSL | -4898 |
RIOK1 | -4858 |
UTP3 | -4821 |
DHX37 | -4742 |
MTREX | -4495 |
RPP21 | -4260 |
DIS3 | -4140 |
RPL28 | -3873 |
WDR18 | -3817 |
FAU | -3618 |
UBA52 | -3490 |
UTP14A | -3323 |
MPHOSPH6 | -3194 |
RRP1 | -3051 |
UTP14C | -2415 |
RPP14 | -2204 |
RPL39L | -1661 |
FTSJ3 | -1199 |
DDX21 | -1198 |
RPS26 | -1154 |
WDR12 | -731 |
RPS27L | -496 |
EXOSC1 | -493 |
RRP36 | -395 |
C1D | -325 |
EXOSC3 | -40 |
UTP11 | -37 |
SENP3 | 78 |
RPS4Y1 | 331 |
FCF1 | 453 |
TBL3 | 739 |
NOC4L | 1606 |
DDX52 | 1795 |
RPS9 | 1841 |
ISG20L2 | 3150 |
UTP18 | 3850 |
DDX49 | 4083 |
NOL12 | 4277 |
RPL3L | 5150 |
RPL26L1 | 6001 |
ERI1 | 6679 |
RIOK3 | 7088 |
CSNK1D | 8475 |
EXOSC4 | 10040 |
XRN2 | 10267 |
SNORD3A | 10596 |
Cap-dependent Translation Initiation
142 | |
---|---|
set | Cap-dependent Translation Initiation |
setSize | 118 |
pANOVA | 2.65e-33 |
s.dist | -0.64 |
p.adjustANOVA | 2.12e-31 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
EIF4A2 | -9593 |
RPS2 | -9591 |
RPL4 | -9549 |
EIF3B | -9526 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
EIF4A2 | -9593 |
RPS2 | -9591 |
RPL4 | -9549 |
EIF3B | -9526 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
EIF3E | -9049 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
EIF1AX | -8383 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
EIF3L | -8255 |
RPL22L1 | -8202 |
EIF4B | -8190 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
EIF3H | -7091 |
EIF5B | -6867 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
EIF3M | -6817 |
RPS15 | -6703 |
EIF2B3 | -6649 |
RPL36AL | -6646 |
RPSA | -6629 |
EIF3J | -6448 |
RPL8 | -6101 |
RPLP1 | -6018 |
EIF2B5 | -5580 |
EIF3F | -5200 |
EIF3D | -5158 |
EIF3C | -4716 |
RPL28 | -3873 |
FAU | -3618 |
UBA52 | -3490 |
PABPC1 | -2991 |
EIF3G | -2746 |
EIF3I | -2580 |
EIF3K | -2369 |
EIF2B1 | -2228 |
RPL39L | -1661 |
EIF2S1 | -1649 |
EIF3A | -1276 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
EIF2S2 | 554 |
EIF4E | 1661 |
RPS9 | 1841 |
EIF2S3 | 2500 |
EIF4EBP1 | 2825 |
EIF5 | 2937 |
EIF2B4 | 4294 |
RPL3L | 5150 |
EIF4A1 | 5541 |
RPL26L1 | 6001 |
EIF2B2 | 7498 |
EIF4H | 7768 |
EIF4G1 | 10506 |
Eukaryotic Translation Initiation
350 | |
---|---|
set | Eukaryotic Translation Initiation |
setSize | 118 |
pANOVA | 2.65e-33 |
s.dist | -0.64 |
p.adjustANOVA | 2.12e-31 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
EIF4A2 | -9593 |
RPS2 | -9591 |
RPL4 | -9549 |
EIF3B | -9526 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
EIF4A2 | -9593 |
RPS2 | -9591 |
RPL4 | -9549 |
EIF3B | -9526 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
EIF3E | -9049 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
EIF1AX | -8383 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
EIF3L | -8255 |
RPL22L1 | -8202 |
EIF4B | -8190 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
EIF3H | -7091 |
EIF5B | -6867 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
EIF3M | -6817 |
RPS15 | -6703 |
EIF2B3 | -6649 |
RPL36AL | -6646 |
RPSA | -6629 |
EIF3J | -6448 |
RPL8 | -6101 |
RPLP1 | -6018 |
EIF2B5 | -5580 |
EIF3F | -5200 |
EIF3D | -5158 |
EIF3C | -4716 |
RPL28 | -3873 |
FAU | -3618 |
UBA52 | -3490 |
PABPC1 | -2991 |
EIF3G | -2746 |
EIF3I | -2580 |
EIF3K | -2369 |
EIF2B1 | -2228 |
RPL39L | -1661 |
EIF2S1 | -1649 |
EIF3A | -1276 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
EIF2S2 | 554 |
EIF4E | 1661 |
RPS9 | 1841 |
EIF2S3 | 2500 |
EIF4EBP1 | 2825 |
EIF5 | 2937 |
EIF2B4 | 4294 |
RPL3L | 5150 |
EIF4A1 | 5541 |
RPL26L1 | 6001 |
EIF2B2 | 7498 |
EIF4H | 7768 |
EIF4G1 | 10506 |
rRNA processing in the nucleus and cytosol
1353 | |
---|---|
set | rRNA processing in the nucleus and cytosol |
setSize | 190 |
pANOVA | 7.19e-52 |
s.dist | -0.636 |
p.adjustANOVA | 4.89e-49 |
Top enriched genes
GeneID | Gene Rank |
---|---|
DKC1 | -10139 |
RPP40 | -10069 |
NOP58 | -10031 |
RPL23A | -9979 |
GNL3 | -9960 |
RPL3 | -9957 |
FBL | -9942 |
NOL11 | -9932 |
RPL5 | -9881 |
RPS3A | -9834 |
NAT10 | -9828 |
WDR75 | -9823 |
THUMPD1 | -9782 |
RPL7 | -9765 |
EXOSC2 | -9753 |
TSR1 | -9724 |
RPS27A | -9723 |
UTP4 | -9700 |
RPS6 | -9699 |
RPL14 | -9698 |
GeneID | Gene Rank |
---|---|
DKC1 | -10139 |
RPP40 | -10069 |
NOP58 | -10031 |
RPL23A | -9979 |
GNL3 | -9960 |
RPL3 | -9957 |
FBL | -9942 |
NOL11 | -9932 |
RPL5 | -9881 |
RPS3A | -9834 |
NAT10 | -9828 |
WDR75 | -9823 |
THUMPD1 | -9782 |
RPL7 | -9765 |
EXOSC2 | -9753 |
TSR1 | -9724 |
RPS27A | -9723 |
UTP4 | -9700 |
RPS6 | -9699 |
RPL14 | -9698 |
LAS1L | -9679 |
RPS25 | -9664 |
RPL22 | -9659 |
DIMT1 | -9652 |
NOP14 | -9641 |
BMS1 | -9626 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
NOP56 | -9444 |
RPS20 | -9413 |
RPL13A | -9402 |
WDR43 | -9395 |
RPS23 | -9387 |
EXOSC8 | -9379 |
RPL32 | -9345 |
NCL | -9336 |
DDX47 | -9334 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
UTP15 | -9156 |
RPL11 | -9117 |
RPL17 | -9116 |
WDR46 | -9056 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
TEX10 | -8915 |
RPL36A | -8909 |
NOB1 | -8908 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
MPHOSPH10 | -8840 |
EXOSC9 | -8793 |
NOL9 | -8786 |
RPL31 | -8769 |
EMG1 | -8744 |
RPS13 | -8724 |
RPL26 | -8706 |
RPP25 | -8688 |
RPS4X | -8648 |
RPP30 | -8640 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
UTP6 | -8616 |
RRP9 | -8598 |
RPS16 | -8579 |
RPS14 | -8541 |
SNU13 | -8495 |
RPS10 | -8494 |
EXOSC7 | -8473 |
EXOSC5 | -8394 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
NOP2 | -8307 |
RPL7A | -8286 |
RPS17 | -8281 |
PELP1 | -8232 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RIOK2 | -8079 |
PNO1 | -8004 |
RPS11 | -7975 |
RPL38 | -7968 |
EBNA1BP2 | -7916 |
RPL37 | -7861 |
NOL6 | -7834 |
RPL27 | -7810 |
RPS19 | -7806 |
NIP7 | -7779 |
KRR1 | -7720 |
RCL1 | -7690 |
RPP38 | -7683 |
RPL13 | -7671 |
DCAF13 | -7564 |
RPL41 | -7561 |
RPL36 | -7493 |
EXOSC6 | -7458 |
UTP20 | -7427 |
GAR1 | -7407 |
HEATR1 | -7278 |
IMP4 | -7155 |
PES1 | -7148 |
LTV1 | -7119 |
WDR3 | -7016 |
IMP3 | -6912 |
RPL37A | -6833 |
EXOSC10 | -6829 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
BOP1 | -6593 |
PDCD11 | -6547 |
NHP2 | -6535 |
CSNK1E | -6526 |
RPL8 | -6101 |
RPLP1 | -6018 |
RBM28 | -5712 |
PWP2 | -5423 |
RRP7A | -5246 |
WDR36 | -5072 |
BYSL | -4898 |
RIOK1 | -4858 |
UTP3 | -4821 |
DHX37 | -4742 |
MTREX | -4495 |
RPP21 | -4260 |
DIS3 | -4140 |
RPL28 | -3873 |
WDR18 | -3817 |
FAU | -3618 |
UBA52 | -3490 |
UTP14A | -3323 |
MPHOSPH6 | -3194 |
RRP1 | -3051 |
UTP14C | -2415 |
TRMT112 | -2296 |
RPP14 | -2204 |
RPL39L | -1661 |
FTSJ3 | -1199 |
DDX21 | -1198 |
RPS26 | -1154 |
WDR12 | -731 |
RPS27L | -496 |
EXOSC1 | -493 |
RRP36 | -395 |
C1D | -325 |
EXOSC3 | -40 |
UTP11 | -37 |
SENP3 | 78 |
RPS4Y1 | 331 |
FCF1 | 453 |
TBL3 | 739 |
TSR3 | 1498 |
NOC4L | 1606 |
DDX52 | 1795 |
RPS9 | 1841 |
ISG20L2 | 3150 |
UTP18 | 3850 |
DDX49 | 4083 |
NOL12 | 4277 |
RPL3L | 5150 |
RPL26L1 | 6001 |
ERI1 | 6679 |
RIOK3 | 7088 |
CSNK1D | 8475 |
EXOSC4 | 10040 |
XRN2 | 10267 |
NOP10 | 10379 |
SNORD3A | 10596 |
Selenoamino acid metabolism
1057 | |
---|---|
set | Selenoamino acid metabolism |
setSize | 114 |
pANOVA | 2.44e-30 |
s.dist | -0.62 |
p.adjustANOVA | 1.58e-28 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
LARS1 | -9637 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
LARS1 | -9637 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
IARS1 | -8999 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
KARS1 | -8380 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
AIMP1 | -7990 |
RPS11 | -7975 |
RPL38 | -7968 |
SEPSECS | -7958 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
SCLY | -7645 |
RPL41 | -7561 |
RPL36 | -7493 |
SECISBP2 | -6992 |
DARS1 | -6939 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
EEFSEC | -6493 |
EPRS1 | -6350 |
RPL8 | -6101 |
SARS1 | -6044 |
RPLP1 | -6018 |
PSTK | -5710 |
RARS1 | -3944 |
RPL28 | -3873 |
QARS1 | -3758 |
FAU | -3618 |
UBA52 | -3490 |
AIMP2 | -3343 |
EEF1E1 | -2716 |
AHCY | -2510 |
RPL39L | -1661 |
RPS26 | -1154 |
CTH | -637 |
RPS27L | -496 |
INMT | -384 |
RPS4Y1 | 331 |
RPS9 | 1841 |
GNMT | 2920 |
RPL3L | 5150 |
RPL26L1 | 6001 |
HNMT | 6423 |
MARS1 | 7358 |
SEPHS2 | 8084 |
TXNRD1 | 9890 |
PAPSS1 | 10336 |
GSR | 11051 |
CBS | 11232 |
PAPSS2 | 11267 |
RHO GTPases Activate ROCKs
886 | |
---|---|
set | RHO GTPases Activate ROCKs |
setSize | 18 |
pANOVA | 6.3e-06 |
s.dist | 0.615 |
p.adjustANOVA | 8.41e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MYL6 | 10185 |
PAK1 | 10043 |
CFL1 | 9794 |
LIMK2 | 9689 |
RHOA | 9401 |
MYH9 | 9224 |
ROCK1 | 8695 |
MYH10 | 8632 |
PPP1R12B | 8489 |
LIMK1 | 8062 |
RHOB | 7921 |
PPP1R12A | 7801 |
PPP1CB | 6745 |
ROCK2 | 6611 |
MYL12B | 5703 |
RHOC | 4639 |
MYL9 | 1931 |
MYH11 | -2243 |
GeneID | Gene Rank |
---|---|
MYL6 | 10185 |
PAK1 | 10043 |
CFL1 | 9794 |
LIMK2 | 9689 |
RHOA | 9401 |
MYH9 | 9224 |
ROCK1 | 8695 |
MYH10 | 8632 |
PPP1R12B | 8489 |
LIMK1 | 8062 |
RHOB | 7921 |
PPP1R12A | 7801 |
PPP1CB | 6745 |
ROCK2 | 6611 |
MYL12B | 5703 |
RHOC | 4639 |
MYL9 | 1931 |
MYH11 | -2243 |
Uptake and function of anthrax toxins
1304 | |
---|---|
set | Uptake and function of anthrax toxins |
setSize | 10 |
pANOVA | 0.000817 |
s.dist | 0.611 |
p.adjustANOVA | 0.00492 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MAP2K6 | 10958 |
FURIN | 10905 |
MAP2K3 | 10377 |
MAP2K1 | 10148 |
PDCD6IP | 9293 |
MAP2K4 | 7754 |
MAP2K2 | 7222 |
ANTXR2 | 5636 |
MAP2K7 | 1550 |
CALM1 | -1245 |
GeneID | Gene Rank |
---|---|
MAP2K6 | 10958 |
FURIN | 10905 |
MAP2K3 | 10377 |
MAP2K1 | 10148 |
PDCD6IP | 9293 |
MAP2K4 | 7754 |
MAP2K2 | 7222 |
ANTXR2 | 5636 |
MAP2K7 | 1550 |
CALM1 | -1245 |
Activation of the pre-replicative complex
50 | |
---|---|
set | Activation of the pre-replicative complex |
setSize | 32 |
pANOVA | 2.71e-09 |
s.dist | -0.607 |
p.adjustANOVA | 6.59e-08 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MCM3 | -9943 |
POLA1 | -9841 |
RPA1 | -9799 |
MCM7 | -9325 |
POLE3 | -9287 |
RPA3 | -9220 |
PRIM1 | -9166 |
DBF4 | -8907 |
MCM6 | -8631 |
ORC5 | -8539 |
ORC2 | -8256 |
POLA2 | -7950 |
ORC3 | -7889 |
POLE2 | -7763 |
PRIM2 | -7112 |
MCM4 | -7086 |
MCM2 | -6880 |
ORC4 | -6267 |
MCM8 | -5713 |
CDC45 | -5132 |
GeneID | Gene Rank |
---|---|
MCM3 | -9943 |
POLA1 | -9841 |
RPA1 | -9799 |
MCM7 | -9325 |
POLE3 | -9287 |
RPA3 | -9220 |
PRIM1 | -9166 |
DBF4 | -8907 |
MCM6 | -8631 |
ORC5 | -8539 |
ORC2 | -8256 |
POLA2 | -7950 |
ORC3 | -7889 |
POLE2 | -7763 |
PRIM2 | -7112 |
MCM4 | -7086 |
MCM2 | -6880 |
ORC4 | -6267 |
MCM8 | -5713 |
CDC45 | -5132 |
RPA2 | -4811 |
MCM10 | -4587 |
CDC7 | -4493 |
POLE | -4081 |
CDK2 | -3614 |
CDT1 | -3436 |
ORC1 | -2973 |
MCM5 | -2327 |
POLE4 | -1856 |
CDC6 | -1597 |
GMNN | 2164 |
ORC6 | 5337 |
MET activates RAP1 and RAC1
618 | |
---|---|
set | MET activates RAP1 and RAC1 |
setSize | 10 |
pANOVA | 0.00102 |
s.dist | 0.6 |
p.adjustANOVA | 0.00589 |
Top enriched genes
GeneID | Gene Rank |
---|---|
GRB2 | 10733 |
RAC1 | 10624 |
HGF | 10417 |
CRK | 10387 |
GAB1 | 8670 |
RAP1A | 7335 |
RAP1B | 6962 |
CRKL | 5250 |
RAPGEF1 | 5102 |
DOCK7 | -4084 |
GeneID | Gene Rank |
---|---|
GRB2 | 10733 |
RAC1 | 10624 |
HGF | 10417 |
CRK | 10387 |
GAB1 | 8670 |
RAP1A | 7335 |
RAP1B | 6962 |
CRKL | 5250 |
RAPGEF1 | 5102 |
DOCK7 | -4084 |
rRNA processing
1351 | |
---|---|
set | rRNA processing |
setSize | 217 |
pANOVA | 2.08e-51 |
s.dist | -0.593 |
p.adjustANOVA | 9.44e-49 |
Top enriched genes
GeneID | Gene Rank |
---|---|
DKC1 | -10139 |
RPP40 | -10069 |
NOP58 | -10031 |
RPL23A | -9979 |
GNL3 | -9960 |
RPL3 | -9957 |
FBL | -9942 |
NOL11 | -9932 |
MTERF4 | -9917 |
RPL5 | -9881 |
RPS3A | -9834 |
NAT10 | -9828 |
WDR75 | -9823 |
THUMPD1 | -9782 |
RPL7 | -9765 |
EXOSC2 | -9753 |
TSR1 | -9724 |
RPS27A | -9723 |
UTP4 | -9700 |
RPS6 | -9699 |
GeneID | Gene Rank |
---|---|
DKC1 | -10139 |
RPP40 | -10069 |
NOP58 | -10031 |
RPL23A | -9979 |
GNL3 | -9960 |
RPL3 | -9957 |
FBL | -9942 |
NOL11 | -9932 |
MTERF4 | -9917 |
RPL5 | -9881 |
RPS3A | -9834 |
NAT10 | -9828 |
WDR75 | -9823 |
THUMPD1 | -9782 |
RPL7 | -9765 |
EXOSC2 | -9753 |
TSR1 | -9724 |
RPS27A | -9723 |
UTP4 | -9700 |
RPS6 | -9699 |
RPL14 | -9698 |
LAS1L | -9679 |
RPS25 | -9664 |
RPL22 | -9659 |
DIMT1 | -9652 |
NOP14 | -9641 |
BMS1 | -9626 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
NOP56 | -9444 |
RPS20 | -9413 |
RPL13A | -9402 |
WDR43 | -9395 |
RPS23 | -9387 |
EXOSC8 | -9379 |
RPL32 | -9345 |
NCL | -9336 |
DDX47 | -9334 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
UTP15 | -9156 |
RPL11 | -9117 |
RPL17 | -9116 |
WDR46 | -9056 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
TEX10 | -8915 |
RPL36A | -8909 |
NOB1 | -8908 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
MPHOSPH10 | -8840 |
EXOSC9 | -8793 |
NOL9 | -8786 |
RPL31 | -8769 |
EMG1 | -8744 |
RPS13 | -8724 |
RPL26 | -8706 |
RPP25 | -8688 |
RPS4X | -8648 |
RPP30 | -8640 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
UTP6 | -8616 |
RRP9 | -8598 |
RPS16 | -8579 |
RPS14 | -8541 |
MRM1 | -8526 |
SNU13 | -8495 |
RPS10 | -8494 |
EXOSC7 | -8473 |
EXOSC5 | -8394 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
NOP2 | -8307 |
TRMT10C | -8306 |
RPL7A | -8286 |
RPS17 | -8281 |
PELP1 | -8232 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RIOK2 | -8079 |
PNO1 | -8004 |
RPS11 | -7975 |
RPL38 | -7968 |
EBNA1BP2 | -7916 |
RPL37 | -7861 |
NOL6 | -7834 |
RPL27 | -7810 |
RPS19 | -7806 |
NIP7 | -7779 |
KRR1 | -7720 |
RCL1 | -7690 |
RPP38 | -7683 |
RPL13 | -7671 |
DCAF13 | -7564 |
RPL41 | -7561 |
RPL36 | -7493 |
EXOSC6 | -7458 |
UTP20 | -7427 |
GAR1 | -7407 |
HEATR1 | -7278 |
IMP4 | -7155 |
PES1 | -7148 |
LTV1 | -7119 |
WDR3 | -7016 |
IMP3 | -6912 |
TFB1M | -6859 |
RPL37A | -6833 |
EXOSC10 | -6829 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
BOP1 | -6593 |
PDCD11 | -6547 |
NHP2 | -6535 |
CSNK1E | -6526 |
RPL8 | -6101 |
MT-ND2 | -6095 |
RPLP1 | -6018 |
RBM28 | -5712 |
MRM3 | -5709 |
MT-ND3 | -5522 |
PWP2 | -5423 |
ELAC2 | -5385 |
RRP7A | -5246 |
MRM2 | -5169 |
MT-CO3 | -5157 |
MT-RNR1 | -5094 |
MT-ND1 | -5075 |
WDR36 | -5072 |
BYSL | -4898 |
RIOK1 | -4858 |
UTP3 | -4821 |
DHX37 | -4742 |
MTREX | -4495 |
RPP21 | -4260 |
DIS3 | -4140 |
RPL28 | -3873 |
WDR18 | -3817 |
FAU | -3618 |
UBA52 | -3490 |
UTP14A | -3323 |
MPHOSPH6 | -3194 |
RRP1 | -3051 |
MT-CO2 | -2523 |
UTP14C | -2415 |
TRMT112 | -2296 |
RPP14 | -2204 |
MT-ATP6 | -2202 |
MT-CYB | -2032 |
PRORP | -1720 |
RPL39L | -1661 |
FTSJ3 | -1199 |
DDX21 | -1198 |
RPS26 | -1154 |
MT-ND5 | -931 |
WDR12 | -731 |
RPS27L | -496 |
EXOSC1 | -493 |
MT-CO1 | -454 |
MT-RNR2 | -408 |
RRP36 | -395 |
C1D | -325 |
EXOSC3 | -40 |
UTP11 | -37 |
SENP3 | 78 |
MT-ATP8 | 189 |
RPS4Y1 | 331 |
FCF1 | 453 |
TBL3 | 739 |
TSR3 | 1498 |
NOC4L | 1606 |
DDX52 | 1795 |
RPS9 | 1841 |
MT-ND4L | 2323 |
NSUN4 | 2338 |
MT-TF | 2765 |
HSD17B10 | 2981 |
ISG20L2 | 3150 |
MT-TV | 3363 |
UTP18 | 3850 |
DDX49 | 4083 |
NOL12 | 4277 |
MT-ND4 | 4493 |
MT-TL1 | 4517 |
RPL3L | 5150 |
RPL26L1 | 6001 |
ERI1 | 6679 |
RIOK3 | 7088 |
CSNK1D | 8475 |
EXOSC4 | 10040 |
XRN2 | 10267 |
NOP10 | 10379 |
SNORD3A | 10596 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
741 | |
---|---|
set | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) |
setSize | 114 |
pANOVA | 1.63e-27 |
s.dist | -0.588 |
p.adjustANOVA | 9.23e-26 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
NCBP2 | -9631 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
NCBP2 | -9631 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
UPF3A | -8795 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RNPS1 | -8030 |
GSPT2 | -7995 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
MAGOHB | -6726 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
RPL8 | -6101 |
RPLP1 | -6018 |
UPF3B | -5843 |
DCP1A | -4839 |
MAGOH | -4678 |
RPL28 | -3873 |
PNRC2 | -3729 |
FAU | -3618 |
UBA52 | -3490 |
PABPC1 | -2991 |
GSPT1 | -2025 |
RPL39L | -1661 |
RBM8A | -1499 |
RPS26 | -1154 |
NCBP1 | -942 |
RPS27L | -496 |
SMG1 | -489 |
SMG6 | -480 |
RPS4Y1 | 331 |
UPF2 | 1281 |
EIF4A3 | 1507 |
PPP2R2A | 1788 |
RPS9 | 1841 |
SMG5 | 4864 |
SMG8 | 4994 |
RPL3L | 5150 |
PPP2R1A | 5189 |
RPL26L1 | 6001 |
SMG9 | 6262 |
PPP2CA | 6806 |
ETF1 | 6835 |
UPF1 | 9103 |
CASC3 | 9610 |
SMG7 | 10376 |
EIF4G1 | 10506 |
Nonsense-Mediated Decay (NMD)
743 | |
---|---|
set | Nonsense-Mediated Decay (NMD) |
setSize | 114 |
pANOVA | 1.63e-27 |
s.dist | -0.588 |
p.adjustANOVA | 9.23e-26 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
NCBP2 | -9631 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
NCBP2 | -9631 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
UPF3A | -8795 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RNPS1 | -8030 |
GSPT2 | -7995 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
RPL36 | -7493 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
MAGOHB | -6726 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
RPL8 | -6101 |
RPLP1 | -6018 |
UPF3B | -5843 |
DCP1A | -4839 |
MAGOH | -4678 |
RPL28 | -3873 |
PNRC2 | -3729 |
FAU | -3618 |
UBA52 | -3490 |
PABPC1 | -2991 |
GSPT1 | -2025 |
RPL39L | -1661 |
RBM8A | -1499 |
RPS26 | -1154 |
NCBP1 | -942 |
RPS27L | -496 |
SMG1 | -489 |
SMG6 | -480 |
RPS4Y1 | 331 |
UPF2 | 1281 |
EIF4A3 | 1507 |
PPP2R2A | 1788 |
RPS9 | 1841 |
SMG5 | 4864 |
SMG8 | 4994 |
RPL3L | 5150 |
PPP2R1A | 5189 |
RPL26L1 | 6001 |
SMG9 | 6262 |
PPP2CA | 6806 |
ETF1 | 6835 |
UPF1 | 9103 |
CASC3 | 9610 |
SMG7 | 10376 |
EIF4G1 | 10506 |
rRNA modification in the nucleus and cytosol
1350 | |
---|---|
set | rRNA modification in the nucleus and cytosol |
setSize | 59 |
pANOVA | 5.93e-15 |
s.dist | -0.587 |
p.adjustANOVA | 2.45e-13 |
Top enriched genes
GeneID | Gene Rank |
---|---|
DKC1 | -10139 |
NOP58 | -10031 |
FBL | -9942 |
NOL11 | -9932 |
NAT10 | -9828 |
WDR75 | -9823 |
THUMPD1 | -9782 |
UTP4 | -9700 |
RPS6 | -9699 |
DIMT1 | -9652 |
NOP14 | -9641 |
BMS1 | -9626 |
RPS2 | -9591 |
NOP56 | -9444 |
WDR43 | -9395 |
DDX47 | -9334 |
RPS7 | -9165 |
UTP15 | -9156 |
WDR46 | -9056 |
MPHOSPH10 | -8840 |
GeneID | Gene Rank |
---|---|
DKC1 | -10139 |
NOP58 | -10031 |
FBL | -9942 |
NOL11 | -9932 |
NAT10 | -9828 |
WDR75 | -9823 |
THUMPD1 | -9782 |
UTP4 | -9700 |
RPS6 | -9699 |
DIMT1 | -9652 |
NOP14 | -9641 |
BMS1 | -9626 |
RPS2 | -9591 |
NOP56 | -9444 |
WDR43 | -9395 |
DDX47 | -9334 |
RPS7 | -9165 |
UTP15 | -9156 |
WDR46 | -9056 |
MPHOSPH10 | -8840 |
EMG1 | -8744 |
UTP6 | -8616 |
RRP9 | -8598 |
RPS14 | -8541 |
SNU13 | -8495 |
NOP2 | -8307 |
PNO1 | -8004 |
NOL6 | -7834 |
KRR1 | -7720 |
RCL1 | -7690 |
DCAF13 | -7564 |
UTP20 | -7427 |
GAR1 | -7407 |
HEATR1 | -7278 |
IMP4 | -7155 |
WDR3 | -7016 |
IMP3 | -6912 |
PDCD11 | -6547 |
NHP2 | -6535 |
PWP2 | -5423 |
RRP7A | -5246 |
WDR36 | -5072 |
UTP3 | -4821 |
DHX37 | -4742 |
UTP14A | -3323 |
UTP14C | -2415 |
TRMT112 | -2296 |
RRP36 | -395 |
UTP11 | -37 |
FCF1 | 453 |
TBL3 | 739 |
TSR3 | 1498 |
NOC4L | 1606 |
DDX52 | 1795 |
RPS9 | 1841 |
UTP18 | 3850 |
DDX49 | 4083 |
NOP10 | 10379 |
SNORD3A | 10596 |
SRP-dependent cotranslational protein targeting to membrane
1038 | |
---|---|
set | SRP-dependent cotranslational protein targeting to membrane |
setSize | 111 |
pANOVA | 1.23e-26 |
s.dist | -0.586 |
p.adjustANOVA | 6.19e-25 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RPS11 | -7975 |
RPL38 | -7968 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
SRPRB | -7520 |
RPL36 | -7493 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
TRAM1 | -6480 |
RPL8 | -6101 |
SEC11C | -6046 |
RPLP1 | -6018 |
SEC61A2 | -5333 |
RPL28 | -3873 |
FAU | -3618 |
SRP72 | -3562 |
UBA52 | -3490 |
SRP9 | -3414 |
SEC61G | -3152 |
SSR2 | -2917 |
SPCS1 | -1700 |
RPL39L | -1661 |
RPS26 | -1154 |
SPCS2 | -977 |
SRP19 | -625 |
RPS27L | -496 |
RPS4Y1 | 331 |
SRP68 | 787 |
SSR1 | 1143 |
SSR4 | 1294 |
RPS9 | 1841 |
SPCS3 | 1967 |
SSR3 | 2510 |
SEC61B | 4322 |
SRP14 | 5022 |
RPL3L | 5150 |
RPL26L1 | 6001 |
SEC11A | 6634 |
RPN1 | 7151 |
SEC61A1 | 7486 |
SRP54 | 7912 |
SRPRA | 8301 |
DDOST | 8464 |
RPN2 | 8874 |
Translation initiation complex formation
1267 | |
---|---|
set | Translation initiation complex formation |
setSize | 58 |
pANOVA | 1.23e-14 |
s.dist | -0.585 |
p.adjustANOVA | 4.8e-13 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS3A | -9834 |
RPS27A | -9723 |
RPS6 | -9699 |
RPS25 | -9664 |
EIF4A2 | -9593 |
RPS2 | -9591 |
EIF3B | -9526 |
RPS20 | -9413 |
RPS23 | -9387 |
RPS3 | -9298 |
RPS12 | -9270 |
RPS27 | -9175 |
RPS7 | -9165 |
EIF3E | -9049 |
RPS5 | -9042 |
RPS15A | -8883 |
RPS8 | -8861 |
RPS13 | -8724 |
RPS4X | -8648 |
RPS29 | -8637 |
GeneID | Gene Rank |
---|---|
RPS3A | -9834 |
RPS27A | -9723 |
RPS6 | -9699 |
RPS25 | -9664 |
EIF4A2 | -9593 |
RPS2 | -9591 |
EIF3B | -9526 |
RPS20 | -9413 |
RPS23 | -9387 |
RPS3 | -9298 |
RPS12 | -9270 |
RPS27 | -9175 |
RPS7 | -9165 |
EIF3E | -9049 |
RPS5 | -9042 |
RPS15A | -8883 |
RPS8 | -8861 |
RPS13 | -8724 |
RPS4X | -8648 |
RPS29 | -8637 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
EIF1AX | -8383 |
RPS21 | -8330 |
RPS18 | -8321 |
RPS17 | -8281 |
EIF3L | -8255 |
EIF4B | -8190 |
RPS28 | -8083 |
RPS11 | -7975 |
RPS19 | -7806 |
EIF3H | -7091 |
RPS24 | -6818 |
EIF3M | -6817 |
RPS15 | -6703 |
RPSA | -6629 |
EIF3J | -6448 |
EIF3F | -5200 |
EIF3D | -5158 |
EIF3C | -4716 |
FAU | -3618 |
PABPC1 | -2991 |
EIF3G | -2746 |
EIF3I | -2580 |
EIF3K | -2369 |
EIF2S1 | -1649 |
EIF3A | -1276 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
EIF2S2 | 554 |
EIF4E | 1661 |
RPS9 | 1841 |
EIF2S3 | 2500 |
EIF4A1 | 5541 |
EIF4H | 7768 |
EIF4G1 | 10506 |
Nucleobase biosynthesis
753 | |
---|---|
set | Nucleobase biosynthesis |
setSize | 13 |
pANOVA | 0.000288 |
s.dist | -0.581 |
p.adjustANOVA | 0.00222 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IMPDH2 | -10126 |
ATIC | -10062 |
PPAT | -10019 |
UMPS | -9982 |
PAICS | -9454 |
PFAS | -9385 |
CAD | -8818 |
ADSL | -6382 |
DHODH | -5973 |
GMPS | -5196 |
LHPP | -3573 |
GART | 4563 |
IMPDH1 | 11303 |
GeneID | Gene Rank |
---|---|
IMPDH2 | -10126 |
ATIC | -10062 |
PPAT | -10019 |
UMPS | -9982 |
PAICS | -9454 |
PFAS | -9385 |
CAD | -8818 |
ADSL | -6382 |
DHODH | -5973 |
GMPS | -5196 |
LHPP | -3573 |
GART | 4563 |
IMPDH1 | 11303 |
Influenza Viral RNA Transcription and Replication
526 | |
---|---|
set | Influenza Viral RNA Transcription and Replication |
setSize | 135 |
pANOVA | 5.44e-31 |
s.dist | -0.576 |
p.adjustANOVA | 3.7e-29 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IPO5 | -10129 |
NDC1 | -10077 |
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
NUP35 | -9726 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
NUP88 | -9668 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
SEH1L | -9574 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
GeneID | Gene Rank |
---|---|
IPO5 | -10129 |
NDC1 | -10077 |
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
NUP35 | -9726 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
NUP88 | -9668 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
SEH1L | -9574 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
PARP1 | -8391 |
RPL23 | -8373 |
NUP43 | -8368 |
NUP160 | -8357 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
NUP107 | -8285 |
RPS17 | -8281 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RPS11 | -7975 |
RPL38 | -7968 |
NUP188 | -7953 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
NUP205 | -7516 |
RPL36 | -7493 |
NUP54 | -7131 |
NUP155 | -7061 |
POLR2D | -6856 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
NUP93 | -6458 |
POLR2H | -6200 |
RPL8 | -6101 |
RPLP1 | -6018 |
NUP133 | -5346 |
POLR2K | -4907 |
NUP42 | -4045 |
HSP90AA1 | -4016 |
NUP210 | -3949 |
POLR2I | -3929 |
RPL28 | -3873 |
TPR | -3744 |
FAU | -3618 |
UBA52 | -3490 |
NUP85 | -3427 |
POLR2B | -3384 |
AAAS | -3332 |
GRSF1 | -2923 |
NUP62 | -2410 |
NUP37 | -2275 |
POM121C | -1710 |
RPL39L | -1661 |
RPS26 | -1154 |
RANBP2 | -1141 |
RPS27L | -496 |
POLR2C | -494 |
POM121 | -142 |
NUP153 | 254 |
RPS4Y1 | 331 |
RPS9 | 1841 |
POLR2L | 2016 |
NUP50 | 2638 |
POLR2G | 4175 |
POLR2F | 4256 |
RAE1 | 5007 |
POLR2E | 5109 |
RPL3L | 5150 |
POLR2J | 5598 |
NUP98 | 5874 |
RPL26L1 | 6001 |
GTF2F2 | 6257 |
GTF2F1 | 6738 |
SEC13 | 7506 |
POLR2A | 7852 |
NUP58 | 9577 |
DNAJC3 | 9831 |
NUP214 | 10131 |
Ribosomal scanning and start codon recognition
1014 | |
---|---|
set | Ribosomal scanning and start codon recognition |
setSize | 58 |
pANOVA | 3.26e-14 |
s.dist | -0.576 |
p.adjustANOVA | 1.2e-12 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS3A | -9834 |
RPS27A | -9723 |
RPS6 | -9699 |
RPS25 | -9664 |
EIF4A2 | -9593 |
RPS2 | -9591 |
EIF3B | -9526 |
RPS20 | -9413 |
RPS23 | -9387 |
RPS3 | -9298 |
RPS12 | -9270 |
RPS27 | -9175 |
RPS7 | -9165 |
EIF3E | -9049 |
RPS5 | -9042 |
RPS15A | -8883 |
RPS8 | -8861 |
RPS13 | -8724 |
RPS4X | -8648 |
RPS29 | -8637 |
GeneID | Gene Rank |
---|---|
RPS3A | -9834 |
RPS27A | -9723 |
RPS6 | -9699 |
RPS25 | -9664 |
EIF4A2 | -9593 |
RPS2 | -9591 |
EIF3B | -9526 |
RPS20 | -9413 |
RPS23 | -9387 |
RPS3 | -9298 |
RPS12 | -9270 |
RPS27 | -9175 |
RPS7 | -9165 |
EIF3E | -9049 |
RPS5 | -9042 |
RPS15A | -8883 |
RPS8 | -8861 |
RPS13 | -8724 |
RPS4X | -8648 |
RPS29 | -8637 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
EIF1AX | -8383 |
RPS21 | -8330 |
RPS18 | -8321 |
RPS17 | -8281 |
EIF3L | -8255 |
EIF4B | -8190 |
RPS28 | -8083 |
RPS11 | -7975 |
RPS19 | -7806 |
EIF3H | -7091 |
RPS24 | -6818 |
EIF3M | -6817 |
RPS15 | -6703 |
RPSA | -6629 |
EIF3J | -6448 |
EIF3F | -5200 |
EIF3D | -5158 |
EIF3C | -4716 |
FAU | -3618 |
EIF3G | -2746 |
EIF3I | -2580 |
EIF3K | -2369 |
EIF2S1 | -1649 |
EIF3A | -1276 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
EIF2S2 | 554 |
EIF4E | 1661 |
RPS9 | 1841 |
EIF2S3 | 2500 |
EIF5 | 2937 |
EIF4A1 | 5541 |
EIF4H | 7768 |
EIF4G1 | 10506 |
Hyaluronan uptake and degradation
503 | |
---|---|
set | Hyaluronan uptake and degradation |
setSize | 12 |
pANOVA | 0.000572 |
s.dist | 0.574 |
p.adjustANOVA | 0.00374 |
Top enriched genes
GeneID | Gene Rank |
---|---|
SLC9A1 | 11350 |
HYAL2 | 11213 |
GUSB | 11175 |
LYVE1 | 10724 |
CHP1 | 10038 |
CD44 | 9255 |
HYAL1 | 8371 |
HEXB | 7695 |
STAB2 | 3499 |
HMMR | 1858 |
HYAL3 | -893 |
HEXA | -1967 |
GeneID | Gene Rank |
---|---|
SLC9A1 | 11350 |
HYAL2 | 11213 |
GUSB | 11175 |
LYVE1 | 10724 |
CHP1 | 10038 |
CD44 | 9255 |
HYAL1 | 8371 |
HEXB | 7695 |
STAB2 | 3499 |
HMMR | 1858 |
HYAL3 | -893 |
HEXA | -1967 |
Unwinding of DNA
1302 | |
---|---|
set | Unwinding of DNA |
setSize | 12 |
pANOVA | 0.000597 |
s.dist | -0.572 |
p.adjustANOVA | 0.00387 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MCM3 | -9943 |
MCM7 | -9325 |
MCM6 | -8631 |
GINS4 | -8275 |
MCM4 | -7086 |
MCM2 | -6880 |
MCM8 | -5713 |
CDC45 | -5132 |
GINS3 | -3875 |
GINS2 | -3476 |
MCM5 | -2327 |
GINS1 | 4263 |
GeneID | Gene Rank |
---|---|
MCM3 | -9943 |
MCM7 | -9325 |
MCM6 | -8631 |
GINS4 | -8275 |
MCM4 | -7086 |
MCM2 | -6880 |
MCM8 | -5713 |
CDC45 | -5132 |
GINS3 | -3875 |
GINS2 | -3476 |
MCM5 | -2327 |
GINS1 | 4263 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
49 | |
---|---|
set | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
setSize | 59 |
pANOVA | 2.93e-14 |
s.dist | -0.572 |
p.adjustANOVA | 1.11e-12 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS3A | -9834 |
RPS27A | -9723 |
RPS6 | -9699 |
RPS25 | -9664 |
EIF4A2 | -9593 |
RPS2 | -9591 |
EIF3B | -9526 |
RPS20 | -9413 |
RPS23 | -9387 |
RPS3 | -9298 |
RPS12 | -9270 |
RPS27 | -9175 |
RPS7 | -9165 |
EIF3E | -9049 |
RPS5 | -9042 |
RPS15A | -8883 |
RPS8 | -8861 |
RPS13 | -8724 |
RPS4X | -8648 |
RPS29 | -8637 |
GeneID | Gene Rank |
---|---|
RPS3A | -9834 |
RPS27A | -9723 |
RPS6 | -9699 |
RPS25 | -9664 |
EIF4A2 | -9593 |
RPS2 | -9591 |
EIF3B | -9526 |
RPS20 | -9413 |
RPS23 | -9387 |
RPS3 | -9298 |
RPS12 | -9270 |
RPS27 | -9175 |
RPS7 | -9165 |
EIF3E | -9049 |
RPS5 | -9042 |
RPS15A | -8883 |
RPS8 | -8861 |
RPS13 | -8724 |
RPS4X | -8648 |
RPS29 | -8637 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
EIF1AX | -8383 |
RPS21 | -8330 |
RPS18 | -8321 |
RPS17 | -8281 |
EIF3L | -8255 |
EIF4B | -8190 |
RPS28 | -8083 |
RPS11 | -7975 |
RPS19 | -7806 |
EIF3H | -7091 |
RPS24 | -6818 |
EIF3M | -6817 |
RPS15 | -6703 |
RPSA | -6629 |
EIF3J | -6448 |
EIF3F | -5200 |
EIF3D | -5158 |
EIF3C | -4716 |
FAU | -3618 |
PABPC1 | -2991 |
EIF3G | -2746 |
EIF3I | -2580 |
EIF3K | -2369 |
EIF2S1 | -1649 |
EIF3A | -1276 |
RPS26 | -1154 |
RPS27L | -496 |
RPS4Y1 | 331 |
EIF2S2 | 554 |
EIF4E | 1661 |
RPS9 | 1841 |
EIF2S3 | 2500 |
EIF4EBP1 | 2825 |
EIF4A1 | 5541 |
EIF4H | 7768 |
EIF4G1 | 10506 |
NOTCH4 Activation and Transmission of Signal to the Nucleus
705 | |
---|---|
set | NOTCH4 Activation and Transmission of Signal to the Nucleus |
setSize | 10 |
pANOVA | 0.00174 |
s.dist | 0.572 |
p.adjustANOVA | 0.00887 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NCSTN | 11452 |
PSEN1 | 10429 |
NOTCH4 | 10293 |
ADAM10 | 9992 |
APH1B | 9474 |
JAG1 | 8240 |
PSENEN | 7091 |
YWHAZ | 5202 |
APH1A | 2563 |
PSEN2 | -6393 |
GeneID | Gene Rank |
---|---|
NCSTN | 11452 |
PSEN1 | 10429 |
NOTCH4 | 10293 |
ADAM10 | 9992 |
APH1B | 9474 |
JAG1 | 8240 |
PSENEN | 7091 |
YWHAZ | 5202 |
APH1A | 2563 |
PSEN2 | -6393 |
VLDLR internalisation and degradation
1308 | |
---|---|
set | VLDLR internalisation and degradation |
setSize | 12 |
pANOVA | 0.000642 |
s.dist | 0.569 |
p.adjustANOVA | 0.00406 |
Top enriched genes
GeneID | Gene Rank |
---|---|
AP2A1 | 11340 |
PCSK9 | 11027 |
CLTC | 10304 |
AP2A2 | 10223 |
NR1H2 | 9521 |
AP2M1 | 8799 |
AP2S1 | 8045 |
CLTA | 7164 |
VLDLR | 6242 |
AP2B1 | 2910 |
NR1H3 | 954 |
MYLIP | -4888 |
GeneID | Gene Rank |
---|---|
AP2A1 | 11340 |
PCSK9 | 11027 |
CLTC | 10304 |
AP2A2 | 10223 |
NR1H2 | 9521 |
AP2M1 | 8799 |
AP2S1 | 8045 |
CLTA | 7164 |
VLDLR | 6242 |
AP2B1 | 2910 |
NR1H3 | 954 |
MYLIP | -4888 |
PD-1 signaling
777 | |
---|---|
set | PD-1 signaling |
setSize | 28 |
pANOVA | 2.24e-07 |
s.dist | -0.565 |
p.adjustANOVA | 4.12e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9971 |
TRAC | -9703 |
HLA-DQB2 | -9656 |
LCK | -9556 |
TRBC1 | -9303 |
TRAV29DV5 | -9278 |
CD3E | -9249 |
TRAV19 | -9248 |
HLA-DRA | -9006 |
HLA-DQA2 | -8774 |
CD247 | -8741 |
HLA-DPB1 | -8397 |
TRBV7-9 | -8303 |
CD3D | -8297 |
HLA-DPA1 | -8217 |
CD3G | -8111 |
CD274 | -7895 |
CD4 | -6881 |
HLA-DQA1 | -6389 |
PDCD1 | -5516 |
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9971 |
TRAC | -9703 |
HLA-DQB2 | -9656 |
LCK | -9556 |
TRBC1 | -9303 |
TRAV29DV5 | -9278 |
CD3E | -9249 |
TRAV19 | -9248 |
HLA-DRA | -9006 |
HLA-DQA2 | -8774 |
CD247 | -8741 |
HLA-DPB1 | -8397 |
TRBV7-9 | -8303 |
CD3D | -8297 |
HLA-DPA1 | -8217 |
CD3G | -8111 |
CD274 | -7895 |
CD4 | -6881 |
HLA-DQA1 | -6389 |
PDCD1 | -5516 |
TRAV8-4 | -4769 |
HLA-DQB1 | -4459 |
HLA-DRB1 | -334 |
PDCD1LG2 | 273 |
HLA-DRB5 | 748 |
PTPN11 | 6524 |
CSK | 9400 |
PTPN6 | 10446 |
Platelet sensitization by LDL
831 | |
---|---|
set | Platelet sensitization by LDL |
setSize | 16 |
pANOVA | 0.000104 |
s.dist | 0.56 |
p.adjustANOVA | 0.000947 |
Top enriched genes
GeneID | Gene Rank |
---|---|
FGR | 11323 |
MAPK14 | 11115 |
PTPN6 | 10446 |
PECAM1 | 10414 |
PPP2R5B | 9913 |
PPP2R5A | 9827 |
PLA2G4A | 9803 |
LRP8 | 9649 |
PPP2CB | 7451 |
PPP2CA | 6806 |
PPP2R5D | 6601 |
PTPN11 | 6524 |
PPP2R1A | 5189 |
PPP2R1B | 89 |
PPP2R5E | -2595 |
PPP2R5C | -5198 |
GeneID | Gene Rank |
---|---|
FGR | 11323 |
MAPK14 | 11115 |
PTPN6 | 10446 |
PECAM1 | 10414 |
PPP2R5B | 9913 |
PPP2R5A | 9827 |
PLA2G4A | 9803 |
LRP8 | 9649 |
PPP2CB | 7451 |
PPP2CA | 6806 |
PPP2R5D | 6601 |
PTPN11 | 6524 |
PPP2R1A | 5189 |
PPP2R1B | 89 |
PPP2R5E | -2595 |
PPP2R5C | -5198 |
DNA strand elongation
245 | |
---|---|
set | DNA strand elongation |
setSize | 32 |
pANOVA | 4.6e-08 |
s.dist | -0.558 |
p.adjustANOVA | 1.01e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
MCM3 | -9943 |
POLA1 | -9841 |
RPA1 | -9799 |
LIG1 | -9469 |
RFC3 | -9405 |
MCM7 | -9325 |
RPA3 | -9220 |
PRIM1 | -9166 |
RFC4 | -8897 |
MCM6 | -8631 |
GINS4 | -8275 |
POLA2 | -7950 |
RFC5 | -7574 |
PRIM2 | -7112 |
PCNA | -7101 |
MCM4 | -7086 |
MCM2 | -6880 |
FEN1 | -6485 |
DNA2 | -6307 |
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
MCM3 | -9943 |
POLA1 | -9841 |
RPA1 | -9799 |
LIG1 | -9469 |
RFC3 | -9405 |
MCM7 | -9325 |
RPA3 | -9220 |
PRIM1 | -9166 |
RFC4 | -8897 |
MCM6 | -8631 |
GINS4 | -8275 |
POLA2 | -7950 |
RFC5 | -7574 |
PRIM2 | -7112 |
PCNA | -7101 |
MCM4 | -7086 |
MCM2 | -6880 |
FEN1 | -6485 |
DNA2 | -6307 |
MCM8 | -5713 |
CDC45 | -5132 |
RFC1 | -5080 |
RPA2 | -4811 |
GINS3 | -3875 |
GINS2 | -3476 |
POLD1 | -2573 |
MCM5 | -2327 |
GINS1 | 4263 |
RFC2 | 5478 |
POLD4 | 9079 |
POLD3 | 10698 |
Processive synthesis on the lagging strand
858 | |
---|---|
set | Processive synthesis on the lagging strand |
setSize | 15 |
pANOVA | 2e-04 |
s.dist | -0.555 |
p.adjustANOVA | 0.00167 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
POLA1 | -9841 |
RPA1 | -9799 |
LIG1 | -9469 |
RPA3 | -9220 |
PRIM1 | -9166 |
POLA2 | -7950 |
PRIM2 | -7112 |
PCNA | -7101 |
FEN1 | -6485 |
DNA2 | -6307 |
RPA2 | -4811 |
POLD1 | -2573 |
POLD4 | 9079 |
POLD3 | 10698 |
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
POLA1 | -9841 |
RPA1 | -9799 |
LIG1 | -9469 |
RPA3 | -9220 |
PRIM1 | -9166 |
POLA2 | -7950 |
PRIM2 | -7112 |
PCNA | -7101 |
FEN1 | -6485 |
DNA2 | -6307 |
RPA2 | -4811 |
POLD1 | -2573 |
POLD4 | 9079 |
POLD3 | 10698 |
Lagging Strand Synthesis
590 | |
---|---|
set | Lagging Strand Synthesis |
setSize | 20 |
pANOVA | 2.12e-05 |
s.dist | -0.549 |
p.adjustANOVA | 0.000241 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
POLA1 | -9841 |
RPA1 | -9799 |
LIG1 | -9469 |
RFC3 | -9405 |
RPA3 | -9220 |
PRIM1 | -9166 |
RFC4 | -8897 |
POLA2 | -7950 |
RFC5 | -7574 |
PRIM2 | -7112 |
PCNA | -7101 |
FEN1 | -6485 |
DNA2 | -6307 |
RFC1 | -5080 |
RPA2 | -4811 |
POLD1 | -2573 |
RFC2 | 5478 |
POLD4 | 9079 |
POLD3 | 10698 |
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
POLA1 | -9841 |
RPA1 | -9799 |
LIG1 | -9469 |
RFC3 | -9405 |
RPA3 | -9220 |
PRIM1 | -9166 |
RFC4 | -8897 |
POLA2 | -7950 |
RFC5 | -7574 |
PRIM2 | -7112 |
PCNA | -7101 |
FEN1 | -6485 |
DNA2 | -6307 |
RFC1 | -5080 |
RPA2 | -4811 |
POLD1 | -2573 |
RFC2 | 5478 |
POLD4 | 9079 |
POLD3 | 10698 |
Gap junction trafficking
435 | |
---|---|
set | Gap junction trafficking |
setSize | 13 |
pANOVA | 0.00064 |
s.dist | 0.547 |
p.adjustANOVA | 0.00406 |
Top enriched genes
GeneID | Gene Rank |
---|---|
DAB2 | 10645 |
GJD3 | 10584 |
DNM2 | 10373 |
CLTC | 10304 |
CLTCL1 | 9201 |
AP2M1 | 8799 |
CLTB | 7968 |
CLTA | 7164 |
DNM1 | 5998 |
GJC1 | 4969 |
GJB6 | 3533 |
GJC2 | -694 |
MYO6 | -3522 |
GeneID | Gene Rank |
---|---|
DAB2 | 10645 |
GJD3 | 10584 |
DNM2 | 10373 |
CLTC | 10304 |
CLTCL1 | 9201 |
AP2M1 | 8799 |
CLTB | 7968 |
CLTA | 7164 |
DNM1 | 5998 |
GJC1 | 4969 |
GJB6 | 3533 |
GJC2 | -694 |
MYO6 | -3522 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
344 | |
---|---|
set | Erythropoietin activates Phosphoinositide-3-kinase (PI3K) |
setSize | 11 |
pANOVA | 0.00179 |
s.dist | 0.544 |
p.adjustANOVA | 0.00907 |
Top enriched genes
GeneID | Gene Rank |
---|---|
LYN | 10810 |
EPOR | 10409 |
IRS2 | 9427 |
PIK3CG | 9128 |
PIK3CB | 9126 |
PIK3CD | 8956 |
GAB1 | 8670 |
PIK3R5 | 7579 |
JAK2 | 4428 |
PIK3CA | 2133 |
PIK3R1 | -8831 |
GeneID | Gene Rank |
---|---|
LYN | 10810 |
EPOR | 10409 |
IRS2 | 9427 |
PIK3CG | 9128 |
PIK3CB | 9126 |
PIK3CD | 8956 |
GAB1 | 8670 |
PIK3R5 | 7579 |
JAK2 | 4428 |
PIK3CA | 2133 |
PIK3R1 | -8831 |
RHO GTPases Activate WASPs and WAVEs
887 | |
---|---|
set | RHO GTPases Activate WASPs and WAVEs |
setSize | 35 |
pANOVA | 3.78e-08 |
s.dist | 0.537 |
p.adjustANOVA | 8.44e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
WASF1 | 11328 |
NCKAP1L | 11304 |
MAPK1 | 11193 |
ARPC1A | 10981 |
BTK | 10849 |
WASF2 | 10807 |
ARPC1B | 10781 |
WAS | 10777 |
GRB2 | 10733 |
RAC1 | 10624 |
ACTB | 10606 |
CYFIP1 | 10420 |
ARPC5 | 10102 |
MAPK3 | 9750 |
ACTG1 | 9678 |
ARPC4 | 9592 |
ABI1 | 9373 |
ARPC2 | 9016 |
ACTR2 | 8895 |
ACTR3 | 8873 |
GeneID | Gene Rank |
---|---|
WASF1 | 11328 |
NCKAP1L | 11304 |
MAPK1 | 11193 |
ARPC1A | 10981 |
BTK | 10849 |
WASF2 | 10807 |
ARPC1B | 10781 |
WAS | 10777 |
GRB2 | 10733 |
RAC1 | 10624 |
ACTB | 10606 |
CYFIP1 | 10420 |
ARPC5 | 10102 |
MAPK3 | 9750 |
ACTG1 | 9678 |
ARPC4 | 9592 |
ABI1 | 9373 |
ARPC2 | 9016 |
ACTR2 | 8895 |
ACTR3 | 8873 |
NCKAP1 | 8861 |
ARPC3 | 8726 |
WIPF2 | 8699 |
CDC42 | 8342 |
ABL1 | 6127 |
WASL | 3297 |
WIPF1 | 3137 |
PTK2 | 388 |
CYFIP2 | -775 |
WASF3 | -1364 |
BAIAP2 | -1877 |
BRK1 | -2561 |
NCKIPSD | -3692 |
ABI2 | -8174 |
NCK1 | -8975 |
Advanced glycosylation endproduct receptor signaling
60 | |
---|---|
set | Advanced glycosylation endproduct receptor signaling |
setSize | 12 |
pANOVA | 0.00128 |
s.dist | 0.537 |
p.adjustANOVA | 0.00701 |
Top enriched genes
GeneID | Gene Rank |
---|---|
S100A12 | 11206 |
MAPK1 | 11193 |
MAPK3 | 9750 |
CAPZA1 | 9530 |
LGALS3 | 9180 |
DDOST | 8464 |
CAPZA2 | 8225 |
PRKCSH | 6831 |
APP | 6245 |
AGER | 4895 |
S100B | -1351 |
HMGB1 | -6699 |
GeneID | Gene Rank |
---|---|
S100A12 | 11206 |
MAPK1 | 11193 |
MAPK3 | 9750 |
CAPZA1 | 9530 |
LGALS3 | 9180 |
DDOST | 8464 |
CAPZA2 | 8225 |
PRKCSH | 6831 |
APP | 6245 |
AGER | 4895 |
S100B | -1351 |
HMGB1 | -6699 |
PCNA-Dependent Long Patch Base Excision Repair
775 | |
---|---|
set | PCNA-Dependent Long Patch Base Excision Repair |
setSize | 21 |
pANOVA | 2.52e-05 |
s.dist | -0.531 |
p.adjustANOVA | 0.000277 |
Top enriched genes
GeneID | Gene Rank |
---|---|
APEX1 | -10111 |
POLD2 | -10054 |
RPA1 | -9799 |
LIG1 | -9469 |
RFC3 | -9405 |
POLE3 | -9287 |
RPA3 | -9220 |
RFC4 | -8897 |
POLB | -8449 |
POLE2 | -7763 |
RFC5 | -7574 |
PCNA | -7101 |
FEN1 | -6485 |
RFC1 | -5080 |
RPA2 | -4811 |
POLE | -4081 |
POLD1 | -2573 |
POLE4 | -1856 |
RFC2 | 5478 |
POLD4 | 9079 |
GeneID | Gene Rank |
---|---|
APEX1 | -10111 |
POLD2 | -10054 |
RPA1 | -9799 |
LIG1 | -9469 |
RFC3 | -9405 |
POLE3 | -9287 |
RPA3 | -9220 |
RFC4 | -8897 |
POLB | -8449 |
POLE2 | -7763 |
RFC5 | -7574 |
PCNA | -7101 |
FEN1 | -6485 |
RFC1 | -5080 |
RPA2 | -4811 |
POLE | -4081 |
POLD1 | -2573 |
POLE4 | -1856 |
RFC2 | 5478 |
POLD4 | 9079 |
POLD3 | 10698 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
799 | |
---|---|
set | PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases |
setSize | 13 |
pANOVA | 0.000951 |
s.dist | 0.529 |
p.adjustANOVA | 0.00558 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RAC1 | 10624 |
CRK | 10387 |
ELMO2 | 10190 |
PXN | 10135 |
RHOA | 9401 |
PTK6 | 9263 |
DOCK1 | 7594 |
RASA1 | 6250 |
KRAS | 6132 |
ELMO1 | 5455 |
NRAS | 4907 |
ARHGAP35 | -2201 |
HRAS | -5273 |
GeneID | Gene Rank |
---|---|
RAC1 | 10624 |
CRK | 10387 |
ELMO2 | 10190 |
PXN | 10135 |
RHOA | 9401 |
PTK6 | 9263 |
DOCK1 | 7594 |
RASA1 | 6250 |
KRAS | 6132 |
ELMO1 | 5455 |
NRAS | 4907 |
ARHGAP35 | -2201 |
HRAS | -5273 |
Removal of the Flap Intermediate
993 | |
---|---|
set | Removal of the Flap Intermediate |
setSize | 14 |
pANOVA | 0.000635 |
s.dist | -0.527 |
p.adjustANOVA | 0.00406 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
POLA1 | -9841 |
RPA1 | -9799 |
RPA3 | -9220 |
PRIM1 | -9166 |
POLA2 | -7950 |
PRIM2 | -7112 |
PCNA | -7101 |
FEN1 | -6485 |
DNA2 | -6307 |
RPA2 | -4811 |
POLD1 | -2573 |
POLD4 | 9079 |
POLD3 | 10698 |
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
POLA1 | -9841 |
RPA1 | -9799 |
RPA3 | -9220 |
PRIM1 | -9166 |
POLA2 | -7950 |
PRIM2 | -7112 |
PCNA | -7101 |
FEN1 | -6485 |
DNA2 | -6307 |
RPA2 | -4811 |
POLD1 | -2573 |
POLD4 | 9079 |
POLD3 | 10698 |
Erythrocytes take up carbon dioxide and release oxygen
343 | |
---|---|
set | Erythrocytes take up carbon dioxide and release oxygen |
setSize | 12 |
pANOVA | 0.00158 |
s.dist | 0.527 |
p.adjustANOVA | 0.00815 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CYB5R1 | 11052 |
CA4 | 10997 |
CYB5R4 | 8995 |
CYB5R2 | 8743 |
CA1 | 8217 |
AQP1 | 7985 |
SLC4A1 | 7532 |
RHAG | 7023 |
HBB | 6697 |
HBA1 | 6237 |
CA2 | 42 |
CYB5RL | -7366 |
GeneID | Gene Rank |
---|---|
CYB5R1 | 11052 |
CA4 | 10997 |
CYB5R4 | 8995 |
CYB5R2 | 8743 |
CA1 | 8217 |
AQP1 | 7985 |
SLC4A1 | 7532 |
RHAG | 7023 |
HBB | 6697 |
HBA1 | 6237 |
CA2 | 42 |
CYB5RL | -7366 |
O2/CO2 exchange in erythrocytes
763 | |
---|---|
set | O2/CO2 exchange in erythrocytes |
setSize | 12 |
pANOVA | 0.00158 |
s.dist | 0.527 |
p.adjustANOVA | 0.00815 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CYB5R1 | 11052 |
CA4 | 10997 |
CYB5R4 | 8995 |
CYB5R2 | 8743 |
CA1 | 8217 |
AQP1 | 7985 |
SLC4A1 | 7532 |
RHAG | 7023 |
HBB | 6697 |
HBA1 | 6237 |
CA2 | 42 |
CYB5RL | -7366 |
GeneID | Gene Rank |
---|---|
CYB5R1 | 11052 |
CA4 | 10997 |
CYB5R4 | 8995 |
CYB5R2 | 8743 |
CA1 | 8217 |
AQP1 | 7985 |
SLC4A1 | 7532 |
RHAG | 7023 |
HBB | 6697 |
HBA1 | 6237 |
CA2 | 42 |
CYB5RL | -7366 |
SLBP independent Processing of Histone Pre-mRNAs
1034 | |
---|---|
set | SLBP independent Processing of Histone Pre-mRNAs |
setSize | 10 |
pANOVA | 0.00433 |
s.dist | -0.521 |
p.adjustANOVA | 0.0178 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NCBP2 | -9631 |
ZNF473 | -9381 |
LSM11 | -9085 |
SNRPF | -8687 |
SNRPE | -8564 |
SNRPD3 | -6352 |
SNRPB | -4187 |
NCBP1 | -942 |
SNRPG | 560 |
LSM10 | 6472 |
GeneID | Gene Rank |
---|---|
NCBP2 | -9631 |
ZNF473 | -9381 |
LSM11 | -9085 |
SNRPF | -8687 |
SNRPE | -8564 |
SNRPD3 | -6352 |
SNRPB | -4187 |
NCBP1 | -942 |
SNRPG | 560 |
LSM10 | 6472 |
WNT5A-dependent internalization of FZD4
1322 | |
---|---|
set | WNT5A-dependent internalization of FZD4 |
setSize | 13 |
pANOVA | 0.00118 |
s.dist | 0.519 |
p.adjustANOVA | 0.0066 |
Top enriched genes
GeneID | Gene Rank |
---|---|
AP2A1 | 11340 |
ARRB2 | 10688 |
CLTC | 10304 |
AP2A2 | 10223 |
AP2M1 | 8799 |
PRKCB | 8577 |
AP2S1 | 8045 |
CLTB | 7968 |
CLTA | 7164 |
FZD4 | 3498 |
AP2B1 | 2910 |
PRKCA | -2408 |
DVL2 | -5637 |
GeneID | Gene Rank |
---|---|
AP2A1 | 11340 |
ARRB2 | 10688 |
CLTC | 10304 |
AP2A2 | 10223 |
AP2M1 | 8799 |
PRKCB | 8577 |
AP2S1 | 8045 |
CLTB | 7968 |
CLTA | 7164 |
FZD4 | 3498 |
AP2B1 | 2910 |
PRKCA | -2408 |
DVL2 | -5637 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway
997 | |
---|---|
set | Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
setSize | 24 |
pANOVA | 1.17e-05 |
s.dist | -0.517 |
p.adjustANOVA | 0.000147 |
Top enriched genes
GeneID | Gene Rank |
---|---|
APEX1 | -10111 |
POLD2 | -10054 |
RPA1 | -9799 |
LIG1 | -9469 |
RFC3 | -9405 |
POLE3 | -9287 |
RPA3 | -9220 |
RFC4 | -8897 |
POLB | -8449 |
PARP1 | -8391 |
POLE2 | -7763 |
RFC5 | -7574 |
PCNA | -7101 |
FEN1 | -6485 |
PARP2 | -6040 |
RFC1 | -5080 |
RPA2 | -4811 |
POLE | -4081 |
POLD1 | -2573 |
POLE4 | -1856 |
GeneID | Gene Rank |
---|---|
APEX1 | -10111 |
POLD2 | -10054 |
RPA1 | -9799 |
LIG1 | -9469 |
RFC3 | -9405 |
POLE3 | -9287 |
RPA3 | -9220 |
RFC4 | -8897 |
POLB | -8449 |
PARP1 | -8391 |
POLE2 | -7763 |
RFC5 | -7574 |
PCNA | -7101 |
FEN1 | -6485 |
PARP2 | -6040 |
RFC1 | -5080 |
RPA2 | -4811 |
POLE | -4081 |
POLD1 | -2573 |
POLE4 | -1856 |
PARG | 2874 |
RFC2 | 5478 |
POLD4 | 9079 |
POLD3 | 10698 |
Retrograde neurotrophin signalling
1010 | |
---|---|
set | Retrograde neurotrophin signalling |
setSize | 12 |
pANOVA | 0.00217 |
s.dist | 0.511 |
p.adjustANOVA | 0.0106 |
Top enriched genes
GeneID | Gene Rank |
---|---|
AP2A1 | 11340 |
DNM2 | 10373 |
CLTC | 10304 |
AP2A2 | 10223 |
AP2M1 | 8799 |
AP2S1 | 8045 |
CLTA | 7164 |
DNM1 | 5998 |
DNM3 | 3523 |
AP2B1 | 2910 |
DNAL4 | -764 |
NTRK1 | -3793 |
GeneID | Gene Rank |
---|---|
AP2A1 | 11340 |
DNM2 | 10373 |
CLTC | 10304 |
AP2A2 | 10223 |
AP2M1 | 8799 |
AP2S1 | 8045 |
CLTA | 7164 |
DNM1 | 5998 |
DNM3 | 3523 |
AP2B1 | 2910 |
DNAL4 | -764 |
NTRK1 | -3793 |
Prolonged ERK activation events
861 | |
---|---|
set | Prolonged ERK activation events |
setSize | 13 |
pANOVA | 0.00151 |
s.dist | 0.508 |
p.adjustANOVA | 0.00799 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MAPK1 | 11193 |
CRK | 10387 |
MAP2K1 | 10148 |
MAPK3 | 9750 |
KIDINS220 | 9339 |
RAP1A | 7335 |
MAP2K2 | 7222 |
CRKL | 5250 |
RAPGEF1 | 5102 |
YWHAB | 4721 |
BRAF | 4367 |
FRS2 | -1144 |
NTRK1 | -3793 |
GeneID | Gene Rank |
---|---|
MAPK1 | 11193 |
CRK | 10387 |
MAP2K1 | 10148 |
MAPK3 | 9750 |
KIDINS220 | 9339 |
RAP1A | 7335 |
MAP2K2 | 7222 |
CRKL | 5250 |
RAPGEF1 | 5102 |
YWHAB | 4721 |
BRAF | 4367 |
FRS2 | -1144 |
NTRK1 | -3793 |
Purine ribonucleoside monophosphate biosynthesis
869 | |
---|---|
set | Purine ribonucleoside monophosphate biosynthesis |
setSize | 10 |
pANOVA | 0.00545 |
s.dist | -0.507 |
p.adjustANOVA | 0.0219 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IMPDH2 | -10126 |
ATIC | -10062 |
PPAT | -10019 |
PAICS | -9454 |
PFAS | -9385 |
ADSL | -6382 |
GMPS | -5196 |
LHPP | -3573 |
GART | 4563 |
IMPDH1 | 11303 |
GeneID | Gene Rank |
---|---|
IMPDH2 | -10126 |
ATIC | -10062 |
PPAT | -10019 |
PAICS | -9454 |
PFAS | -9385 |
ADSL | -6382 |
GMPS | -5196 |
LHPP | -3573 |
GART | 4563 |
IMPDH1 | 11303 |
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
1033 | |
---|---|
set | SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
setSize | 11 |
pANOVA | 0.00387 |
s.dist | -0.503 |
p.adjustANOVA | 0.0164 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NCBP2 | -9631 |
ZNF473 | -9381 |
LSM11 | -9085 |
SNRPF | -8687 |
SNRPE | -8564 |
SNRPD3 | -6352 |
SNRPB | -4187 |
SLBP | -2817 |
NCBP1 | -942 |
SNRPG | 560 |
LSM10 | 6472 |
GeneID | Gene Rank |
---|---|
NCBP2 | -9631 |
ZNF473 | -9381 |
LSM11 | -9085 |
SNRPF | -8687 |
SNRPE | -8564 |
SNRPD3 | -6352 |
SNRPB | -4187 |
SLBP | -2817 |
NCBP1 | -942 |
SNRPG | 560 |
LSM10 | 6472 |
Influenza Infection
525 | |
---|---|
set | Influenza Infection |
setSize | 154 |
pANOVA | 4.36e-27 |
s.dist | -0.503 |
p.adjustANOVA | 2.28e-25 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IPO5 | -10129 |
NDC1 | -10077 |
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
NUP35 | -9726 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
NUP88 | -9668 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
SEH1L | -9574 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
GeneID | Gene Rank |
---|---|
IPO5 | -10129 |
NDC1 | -10077 |
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
RPS3A | -9834 |
RPL7 | -9765 |
NUP35 | -9726 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
NUP88 | -9668 |
RPS25 | -9664 |
RPL22 | -9659 |
RPS2 | -9591 |
SEH1L | -9574 |
RPL4 | -9549 |
RPL21 | -9511 |
RPL34 | -9492 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
RPS3 | -9298 |
RPL35A | -9291 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
RPL11 | -9117 |
RPL17 | -9116 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
KPNA5 | -9017 |
RPL30 | -8930 |
RPL10A | -8928 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
RPS16 | -8579 |
RPS14 | -8541 |
RPS10 | -8494 |
RAN | -8475 |
PARP1 | -8391 |
RPL23 | -8373 |
NUP43 | -8368 |
NUP160 | -8357 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
NUP107 | -8285 |
RPS17 | -8281 |
RPL22L1 | -8202 |
RPL35 | -8183 |
RPL15 | -8169 |
RPS28 | -8083 |
RPS11 | -7975 |
RPL38 | -7968 |
NUP188 | -7953 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
RPL41 | -7561 |
NUP205 | -7516 |
RPL36 | -7493 |
NUP54 | -7131 |
NUP155 | -7061 |
POLR2D | -6856 |
RPL37A | -6833 |
RPL9 | -6821 |
RPS24 | -6818 |
RPS15 | -6703 |
RPL36AL | -6646 |
RPSA | -6629 |
NUP93 | -6458 |
POLR2H | -6200 |
RPL8 | -6101 |
RPLP1 | -6018 |
SLC25A6 | -5588 |
NUP133 | -5346 |
ISG15 | -5074 |
POLR2K | -4907 |
NUP42 | -4045 |
CPSF4 | -4025 |
HSP90AA1 | -4016 |
NUP210 | -3949 |
POLR2I | -3929 |
RPL28 | -3873 |
TPR | -3744 |
FAU | -3618 |
UBA52 | -3490 |
NUP85 | -3427 |
POLR2B | -3384 |
AAAS | -3332 |
XPO1 | -3214 |
GRSF1 | -2923 |
KPNA2 | -2535 |
NUP62 | -2410 |
NUP37 | -2275 |
KPNA3 | -1964 |
PABPN1 | -1789 |
POM121C | -1710 |
RPL39L | -1661 |
KPNA1 | -1312 |
RPS26 | -1154 |
RANBP2 | -1141 |
RPS27L | -496 |
POLR2C | -494 |
POM121 | -142 |
NUP153 | 254 |
RPS4Y1 | 331 |
RPS9 | 1841 |
POLR2L | 2016 |
NUP50 | 2638 |
CANX | 3332 |
POLR2G | 4175 |
POLR2F | 4256 |
RAE1 | 5007 |
POLR2E | 5109 |
RPL3L | 5150 |
TGFB1 | 5504 |
EIF2AK2 | 5594 |
POLR2J | 5598 |
KPNB1 | 5604 |
KPNA4 | 5698 |
NUP98 | 5874 |
RPL26L1 | 6001 |
GTF2F2 | 6257 |
GTF2F1 | 6738 |
CLTA | 7164 |
SEC13 | 7506 |
CALR | 7713 |
POLR2A | 7852 |
HSPA1A | 9341 |
NUP58 | 9577 |
DNAJC3 | 9831 |
NUP214 | 10131 |
CLTC | 10304 |
Signal transduction by L1
1070 | |
---|---|
set | Signal transduction by L1 |
setSize | 20 |
pANOVA | 0.000105 |
s.dist | 0.501 |
p.adjustANOVA | 0.000953 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MAPK1 | 11193 |
RAC1 | 10624 |
MAP2K1 | 10148 |
PAK1 | 10043 |
ITGA5 | 9848 |
MAPK3 | 9750 |
CSNK2A1 | 9040 |
ITGAV | 7847 |
ITGA9 | 7807 |
ITGA2B | 7387 |
CSNK2A2 | 7341 |
MAP2K2 | 7222 |
FGFR1 | 6607 |
NRP1 | 6221 |
CSNK2B | 5876 |
ITGB3 | 2944 |
VAV2 | 2755 |
ITGB1 | -3073 |
L1CAM | -3125 |
NCAM1 | -5143 |
GeneID | Gene Rank |
---|---|
MAPK1 | 11193 |
RAC1 | 10624 |
MAP2K1 | 10148 |
PAK1 | 10043 |
ITGA5 | 9848 |
MAPK3 | 9750 |
CSNK2A1 | 9040 |
ITGAV | 7847 |
ITGA9 | 7807 |
ITGA2B | 7387 |
CSNK2A2 | 7341 |
MAP2K2 | 7222 |
FGFR1 | 6607 |
NRP1 | 6221 |
CSNK2B | 5876 |
ITGB3 | 2944 |
VAV2 | 2755 |
ITGB1 | -3073 |
L1CAM | -3125 |
NCAM1 | -5143 |
Erythropoietin activates RAS
345 | |
---|---|
set | Erythropoietin activates RAS |
setSize | 13 |
pANOVA | 0.00181 |
s.dist | 0.5 |
p.adjustANOVA | 0.00912 |
Top enriched genes
GeneID | Gene Rank |
---|---|
LYN | 10810 |
GRB2 | 10733 |
EPOR | 10409 |
VAV1 | 10226 |
SHC1 | 9541 |
IRS2 | 9427 |
KRAS | 6132 |
CRKL | 5250 |
RAPGEF1 | 5102 |
NRAS | 4907 |
JAK2 | 4428 |
SOS1 | -2983 |
HRAS | -5273 |
GeneID | Gene Rank |
---|---|
LYN | 10810 |
GRB2 | 10733 |
EPOR | 10409 |
VAV1 | 10226 |
SHC1 | 9541 |
IRS2 | 9427 |
KRAS | 6132 |
CRKL | 5250 |
RAPGEF1 | 5102 |
NRAS | 4907 |
JAK2 | 4428 |
SOS1 | -2983 |
HRAS | -5273 |
Synthesis of Leukotrienes (LT) and Eoxins (EX)
1164 | |
---|---|
set | Synthesis of Leukotrienes (LT) and Eoxins (EX) |
setSize | 15 |
pANOVA | 0.000851 |
s.dist | 0.497 |
p.adjustANOVA | 0.00508 |
Top enriched genes
GeneID | Gene Rank |
---|---|
GGT1 | 11459 |
ALOX5 | 11178 |
PTGR1 | 10862 |
CYP4F8 | 10561 |
LTA4H | 10541 |
ALOX5AP | 9860 |
MAPKAPK2 | 8852 |
CYP4F3 | 7797 |
ABCC1 | 5410 |
GGT5 | 5204 |
CYP4F22 | 4727 |
DPEP2 | 2213 |
DPEP3 | 1876 |
LTC4S | -624 |
ALOX15 | -9484 |
GeneID | Gene Rank |
---|---|
GGT1 | 11459 |
ALOX5 | 11178 |
PTGR1 | 10862 |
CYP4F8 | 10561 |
LTA4H | 10541 |
ALOX5AP | 9860 |
MAPKAPK2 | 8852 |
CYP4F3 | 7797 |
ABCC1 | 5410 |
GGT5 | 5204 |
CYP4F22 | 4727 |
DPEP2 | 2213 |
DPEP3 | 1876 |
LTC4S | -624 |
ALOX15 | -9484 |
Activation of ATR in response to replication stress
33 | |
---|---|
set | Activation of ATR in response to replication stress |
setSize | 37 |
pANOVA | 2.01e-07 |
s.dist | -0.494 |
p.adjustANOVA | 3.75e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MCM3 | -9943 |
RAD1 | -9896 |
RPA1 | -9799 |
RFC3 | -9405 |
MCM7 | -9325 |
RPA3 | -9220 |
DBF4 | -8907 |
RFC4 | -8897 |
MCM6 | -8631 |
ORC5 | -8539 |
RAD17 | -8493 |
ORC2 | -8256 |
ORC3 | -7889 |
RFC5 | -7574 |
RAD9A | -7462 |
MCM4 | -7086 |
MCM2 | -6880 |
ORC4 | -6267 |
CHEK1 | -6143 |
MCM8 | -5713 |
GeneID | Gene Rank |
---|---|
MCM3 | -9943 |
RAD1 | -9896 |
RPA1 | -9799 |
RFC3 | -9405 |
MCM7 | -9325 |
RPA3 | -9220 |
DBF4 | -8907 |
RFC4 | -8897 |
MCM6 | -8631 |
ORC5 | -8539 |
RAD17 | -8493 |
ORC2 | -8256 |
ORC3 | -7889 |
RFC5 | -7574 |
RAD9A | -7462 |
MCM4 | -7086 |
MCM2 | -6880 |
ORC4 | -6267 |
CHEK1 | -6143 |
MCM8 | -5713 |
ATR | -5340 |
CDC45 | -5132 |
RPA2 | -4811 |
MCM10 | -4587 |
CDC7 | -4493 |
CDK2 | -3614 |
ATRIP | -3603 |
ORC1 | -2973 |
MCM5 | -2327 |
CDC6 | -1597 |
CDC25A | 317 |
CLSPN | 1968 |
HUS1 | 4236 |
ORC6 | 5337 |
RFC2 | 5478 |
CDC25C | 5800 |
RAD9B | 6597 |
Telomere C-strand (Lagging Strand) Synthesis
1217 | |
---|---|
set | Telomere C-strand (Lagging Strand) Synthesis |
setSize | 34 |
pANOVA | 6.34e-07 |
s.dist | -0.493 |
p.adjustANOVA | 1.04e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
STN1 | -9859 |
POLA1 | -9841 |
RPA1 | -9799 |
CHTF18 | -9602 |
WRN | -9501 |
LIG1 | -9469 |
RFC3 | -9405 |
RPA3 | -9220 |
PRIM1 | -9166 |
RFC4 | -8897 |
CTC1 | -8852 |
POLA2 | -7950 |
RFC5 | -7574 |
PRIM2 | -7112 |
PCNA | -7101 |
FEN1 | -6485 |
DNA2 | -6307 |
DSCC1 | -5837 |
ACD | -5673 |
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
STN1 | -9859 |
POLA1 | -9841 |
RPA1 | -9799 |
CHTF18 | -9602 |
WRN | -9501 |
LIG1 | -9469 |
RFC3 | -9405 |
RPA3 | -9220 |
PRIM1 | -9166 |
RFC4 | -8897 |
CTC1 | -8852 |
POLA2 | -7950 |
RFC5 | -7574 |
PRIM2 | -7112 |
PCNA | -7101 |
FEN1 | -6485 |
DNA2 | -6307 |
DSCC1 | -5837 |
ACD | -5673 |
BLM | -5151 |
RFC1 | -5080 |
RPA2 | -4811 |
POT1 | -4708 |
TERF2 | -4421 |
TERF1 | -2831 |
POLD1 | -2573 |
CHTF8 | -124 |
TEN1 | 624 |
TERF2IP | 4065 |
RFC2 | 5478 |
TINF2 | 8502 |
POLD4 | 9079 |
POLD3 | 10698 |
Phosphorylation of CD3 and TCR zeta chains
819 | |
---|---|
set | Phosphorylation of CD3 and TCR zeta chains |
setSize | 27 |
pANOVA | 1.07e-05 |
s.dist | -0.489 |
p.adjustANOVA | 0.000138 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9971 |
TRAC | -9703 |
HLA-DQB2 | -9656 |
LCK | -9556 |
TRBC1 | -9303 |
TRAV29DV5 | -9278 |
CD3E | -9249 |
TRAV19 | -9248 |
HLA-DRA | -9006 |
HLA-DQA2 | -8774 |
CD247 | -8741 |
HLA-DPB1 | -8397 |
TRBV7-9 | -8303 |
CD3D | -8297 |
HLA-DPA1 | -8217 |
CD3G | -8111 |
CD4 | -6881 |
HLA-DQA1 | -6389 |
TRAV8-4 | -4769 |
HLA-DQB1 | -4459 |
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9971 |
TRAC | -9703 |
HLA-DQB2 | -9656 |
LCK | -9556 |
TRBC1 | -9303 |
TRAV29DV5 | -9278 |
CD3E | -9249 |
TRAV19 | -9248 |
HLA-DRA | -9006 |
HLA-DQA2 | -8774 |
CD247 | -8741 |
HLA-DPB1 | -8397 |
TRBV7-9 | -8303 |
CD3D | -8297 |
HLA-DPA1 | -8217 |
CD3G | -8111 |
CD4 | -6881 |
HLA-DQA1 | -6389 |
TRAV8-4 | -4769 |
HLA-DQB1 | -4459 |
HLA-DRB1 | -334 |
HLA-DRB5 | 748 |
PAG1 | 6054 |
PTPN22 | 6966 |
PTPRC | 8021 |
CSK | 9400 |
PTPRJ | 10340 |
RHO GTPases activate CIT
888 | |
---|---|
set | RHO GTPases activate CIT |
setSize | 18 |
pANOVA | 0.000325 |
s.dist | 0.489 |
p.adjustANOVA | 0.00245 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RAC1 | 10624 |
MYL6 | 10185 |
DLG4 | 9813 |
RHOA | 9401 |
MYH9 | 9224 |
MYH10 | 8632 |
PPP1R12B | 8489 |
RHOB | 7921 |
PPP1R12A | 7801 |
PPP1CB | 6745 |
KIF14 | 5707 |
MYL12B | 5703 |
RHOC | 4639 |
CIT | 3097 |
PRC1 | 2399 |
MYL9 | 1931 |
MYH11 | -2243 |
CDKN1B | -3127 |
GeneID | Gene Rank |
---|---|
RAC1 | 10624 |
MYL6 | 10185 |
DLG4 | 9813 |
RHOA | 9401 |
MYH9 | 9224 |
MYH10 | 8632 |
PPP1R12B | 8489 |
RHOB | 7921 |
PPP1R12A | 7801 |
PPP1CB | 6745 |
KIF14 | 5707 |
MYL12B | 5703 |
RHOC | 4639 |
CIT | 3097 |
PRC1 | 2399 |
MYL9 | 1931 |
MYH11 | -2243 |
CDKN1B | -3127 |
Generation of second messenger molecules
443 | |
---|---|
set | Generation of second messenger molecules |
setSize | 38 |
pANOVA | 2.64e-07 |
s.dist | -0.482 |
p.adjustANOVA | 4.67e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9971 |
TRAC | -9703 |
ITK | -9674 |
HLA-DQB2 | -9656 |
EVL | -9560 |
LCK | -9556 |
LAT | -9470 |
PLCG1 | -9412 |
TRBC1 | -9303 |
TRAV29DV5 | -9278 |
CD3E | -9249 |
TRAV19 | -9248 |
HLA-DRA | -9006 |
NCK1 | -8975 |
HLA-DQA2 | -8774 |
ZAP70 | -8755 |
CD247 | -8741 |
HLA-DPB1 | -8397 |
TRBV7-9 | -8303 |
CD3D | -8297 |
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9971 |
TRAC | -9703 |
ITK | -9674 |
HLA-DQB2 | -9656 |
EVL | -9560 |
LCK | -9556 |
LAT | -9470 |
PLCG1 | -9412 |
TRBC1 | -9303 |
TRAV29DV5 | -9278 |
CD3E | -9249 |
TRAV19 | -9248 |
HLA-DRA | -9006 |
NCK1 | -8975 |
HLA-DQA2 | -8774 |
ZAP70 | -8755 |
CD247 | -8741 |
HLA-DPB1 | -8397 |
TRBV7-9 | -8303 |
CD3D | -8297 |
HLA-DPA1 | -8217 |
CD3G | -8111 |
CD4 | -6881 |
HLA-DQA1 | -6389 |
PAK3 | -5908 |
TRAV8-4 | -4769 |
HLA-DQB1 | -4459 |
GRAP2 | -2088 |
CD101 | -1089 |
HLA-DRB1 | -334 |
HLA-DRB5 | 748 |
ENAH | 3578 |
LCP2 | 3759 |
PAK2 | 9042 |
PAK1 | 10043 |
PLCG2 | 10244 |
VASP | 10286 |
WAS | 10777 |
Pre-NOTCH Processing in Golgi
845 | |
---|---|
set | Pre-NOTCH Processing in Golgi |
setSize | 18 |
pANOVA | 0.000408 |
s.dist | 0.481 |
p.adjustANOVA | 0.00289 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NOTCH3 | 11420 |
FURIN | 10905 |
ATP2A2 | 10359 |
NOTCH4 | 10293 |
ST3GAL4 | 10218 |
RAB6A | 9958 |
NOTCH1 | 9499 |
NOTCH2 | 8400 |
SEL1L | 7883 |
B4GALT1 | 7763 |
TMED2 | 5345 |
RFNG | 4095 |
ATP2A1 | 3981 |
ATP2A3 | 3651 |
ST3GAL6 | 3223 |
LFNG | 1213 |
ST3GAL3 | -5250 |
MFNG | -7604 |
GeneID | Gene Rank |
---|---|
NOTCH3 | 11420 |
FURIN | 10905 |
ATP2A2 | 10359 |
NOTCH4 | 10293 |
ST3GAL4 | 10218 |
RAB6A | 9958 |
NOTCH1 | 9499 |
NOTCH2 | 8400 |
SEL1L | 7883 |
B4GALT1 | 7763 |
TMED2 | 5345 |
RFNG | 4095 |
ATP2A1 | 3981 |
ATP2A3 | 3651 |
ST3GAL6 | 3223 |
LFNG | 1213 |
ST3GAL3 | -5250 |
MFNG | -7604 |
Heme degradation
493 | |
---|---|
set | Heme degradation |
setSize | 10 |
pANOVA | 0.00889 |
s.dist | 0.478 |
p.adjustANOVA | 0.032 |
Top enriched genes
GeneID | Gene Rank |
---|---|
GUSB | 11175 |
HMOX1 | 11030 |
SLCO2B1 | 10681 |
BLVRB | 9359 |
ALB | 8630 |
BLVRA | 7999 |
ABCC1 | 5410 |
ABCG2 | 1372 |
ABCC2 | 1314 |
HMOX2 | -8794 |
GeneID | Gene Rank |
---|---|
GUSB | 11175 |
HMOX1 | 11030 |
SLCO2B1 | 10681 |
BLVRB | 9359 |
ALB | 8630 |
BLVRA | 7999 |
ABCC1 | 5410 |
ABCG2 | 1372 |
ABCC2 | 1314 |
HMOX2 | -8794 |
BBSome-mediated cargo-targeting to cilium
98 | |
---|---|
set | BBSome-mediated cargo-targeting to cilium |
setSize | 22 |
pANOVA | 0.000114 |
s.dist | -0.475 |
p.adjustANOVA | 0.00102 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CCT2 | -10024 |
LZTFL1 | -8558 |
BBS9 | -8390 |
BBS2 | -8123 |
BBS5 | -7994 |
MKKS | -7647 |
BBS1 | -7348 |
ARL6 | -7121 |
CCT3 | -6877 |
CCT4 | -6795 |
BBIP1 | -5342 |
SSTR3 | -5020 |
TCP1 | -4240 |
BBS4 | -3211 |
CCT8 | -2751 |
BBS10 | -2726 |
BBS12 | -1657 |
BBS7 | -934 |
MCHR1 | -651 |
RAB3IP | -569 |
GeneID | Gene Rank |
---|---|
CCT2 | -10024 |
LZTFL1 | -8558 |
BBS9 | -8390 |
BBS2 | -8123 |
BBS5 | -7994 |
MKKS | -7647 |
BBS1 | -7348 |
ARL6 | -7121 |
CCT3 | -6877 |
CCT4 | -6795 |
BBIP1 | -5342 |
SSTR3 | -5020 |
TCP1 | -4240 |
BBS4 | -3211 |
CCT8 | -2751 |
BBS10 | -2726 |
BBS12 | -1657 |
BBS7 | -934 |
MCHR1 | -651 |
RAB3IP | -569 |
CCT5 | 3205 |
TTC8 | 4167 |
Golgi Cisternae Pericentriolar Stack Reorganization
466 | |
---|---|
set | Golgi Cisternae Pericentriolar Stack Reorganization |
setSize | 14 |
pANOVA | 0.00208 |
s.dist | 0.475 |
p.adjustANOVA | 0.0103 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MAPK1 | 11193 |
RAB1B | 10055 |
RAB1A | 9971 |
MAPK3 | 9750 |
GORASP1 | 9633 |
RAB2A | 9581 |
GOLGA2 | 9412 |
CCNB2 | 7285 |
PLK1 | 5400 |
BLZF1 | 3737 |
USO1 | 2424 |
CCNB1 | 735 |
CDK1 | -2593 |
GORASP2 | -5545 |
GeneID | Gene Rank |
---|---|
MAPK1 | 11193 |
RAB1B | 10055 |
RAB1A | 9971 |
MAPK3 | 9750 |
GORASP1 | 9633 |
RAB2A | 9581 |
GOLGA2 | 9412 |
CCNB2 | 7285 |
PLK1 | 5400 |
BLZF1 | 3737 |
USO1 | 2424 |
CCNB1 | 735 |
CDK1 | -2593 |
GORASP2 | -5545 |
Diseases associated with the TLR signaling cascade
287 | |
---|---|
set | Diseases associated with the TLR signaling cascade |
setSize | 23 |
pANOVA | 7.99e-05 |
s.dist | 0.475 |
p.adjustANOVA | 0.000755 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MYD88 | 11331 |
TLR5 | 11191 |
CD36 | 10947 |
BTK | 10849 |
TLR2 | 10535 |
UNC93B1 | 10526 |
TLR1 | 10059 |
TLR4 | 9549 |
CD14 | 9466 |
IKBKG | 9441 |
LY96 | 9322 |
TLR6 | 9070 |
TICAM1 | 8878 |
TIRAP | 8858 |
CHUK | 8723 |
NFKBIA | 5457 |
NFKB1 | 2860 |
IKBKB | 1759 |
RELA | -204 |
NFKB2 | -3527 |
GeneID | Gene Rank |
---|---|
MYD88 | 11331 |
TLR5 | 11191 |
CD36 | 10947 |
BTK | 10849 |
TLR2 | 10535 |
UNC93B1 | 10526 |
TLR1 | 10059 |
TLR4 | 9549 |
CD14 | 9466 |
IKBKG | 9441 |
LY96 | 9322 |
TLR6 | 9070 |
TICAM1 | 8878 |
TIRAP | 8858 |
CHUK | 8723 |
NFKBIA | 5457 |
NFKB1 | 2860 |
IKBKB | 1759 |
RELA | -204 |
NFKB2 | -3527 |
TLR10 | -7067 |
TLR3 | -7411 |
TRAF3 | -7539 |
Diseases of Immune System
289 | |
---|---|
set | Diseases of Immune System |
setSize | 23 |
pANOVA | 7.99e-05 |
s.dist | 0.475 |
p.adjustANOVA | 0.000755 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MYD88 | 11331 |
TLR5 | 11191 |
CD36 | 10947 |
BTK | 10849 |
TLR2 | 10535 |
UNC93B1 | 10526 |
TLR1 | 10059 |
TLR4 | 9549 |
CD14 | 9466 |
IKBKG | 9441 |
LY96 | 9322 |
TLR6 | 9070 |
TICAM1 | 8878 |
TIRAP | 8858 |
CHUK | 8723 |
NFKBIA | 5457 |
NFKB1 | 2860 |
IKBKB | 1759 |
RELA | -204 |
NFKB2 | -3527 |
GeneID | Gene Rank |
---|---|
MYD88 | 11331 |
TLR5 | 11191 |
CD36 | 10947 |
BTK | 10849 |
TLR2 | 10535 |
UNC93B1 | 10526 |
TLR1 | 10059 |
TLR4 | 9549 |
CD14 | 9466 |
IKBKG | 9441 |
LY96 | 9322 |
TLR6 | 9070 |
TICAM1 | 8878 |
TIRAP | 8858 |
CHUK | 8723 |
NFKBIA | 5457 |
NFKB1 | 2860 |
IKBKB | 1759 |
RELA | -204 |
NFKB2 | -3527 |
TLR10 | -7067 |
TLR3 | -7411 |
TRAF3 | -7539 |
RHO GTPases activate IQGAPs
889 | |
---|---|
set | RHO GTPases activate IQGAPs |
setSize | 11 |
pANOVA | 0.0068 |
s.dist | 0.471 |
p.adjustANOVA | 0.0258 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CTNNA1 | 11326 |
CLIP1 | 10646 |
RAC1 | 10624 |
IQGAP1 | 10037 |
CTNNB1 | 9670 |
IQGAP2 | 8437 |
CDC42 | 8342 |
IQGAP3 | 1051 |
CDH1 | -307 |
CALM1 | -1245 |
MEN1 | -5364 |
GeneID | Gene Rank |
---|---|
CTNNA1 | 11326 |
CLIP1 | 10646 |
RAC1 | 10624 |
IQGAP1 | 10037 |
CTNNB1 | 9670 |
IQGAP2 | 8437 |
CDC42 | 8342 |
IQGAP3 | 1051 |
CDH1 | -307 |
CALM1 | -1245 |
MEN1 | -5364 |
EPHB-mediated forward signaling
323 | |
---|---|
set | EPHB-mediated forward signaling |
setSize | 32 |
pANOVA | 4.14e-06 |
s.dist | 0.47 |
p.adjustANOVA | 5.69e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ARPC1A | 10981 |
LYN | 10810 |
ARPC1B | 10781 |
ITSN1 | 10737 |
RAC1 | 10624 |
ACTB | 10606 |
ARPC5 | 10102 |
PAK1 | 10043 |
CFL1 | 9794 |
LIMK2 | 9689 |
ACTG1 | 9678 |
ARPC4 | 9592 |
RHOA | 9401 |
ARPC2 | 9016 |
ACTR2 | 8895 |
ACTR3 | 8873 |
ARPC3 | 8726 |
ROCK1 | 8695 |
CDC42 | 8342 |
LIMK1 | 8062 |
GeneID | Gene Rank |
---|---|
ARPC1A | 10981 |
LYN | 10810 |
ARPC1B | 10781 |
ITSN1 | 10737 |
RAC1 | 10624 |
ACTB | 10606 |
ARPC5 | 10102 |
PAK1 | 10043 |
CFL1 | 9794 |
LIMK2 | 9689 |
ACTG1 | 9678 |
ARPC4 | 9592 |
RHOA | 9401 |
ARPC2 | 9016 |
ACTR2 | 8895 |
ACTR3 | 8873 |
ARPC3 | 8726 |
ROCK1 | 8695 |
CDC42 | 8342 |
LIMK1 | 8062 |
ROCK2 | 6611 |
RASA1 | 6250 |
WASL | 3297 |
ARHGEF28 | 2384 |
SDC2 | 2325 |
PTK2 | 388 |
YES1 | -2846 |
TIAM1 | -3517 |
FYN | -5211 |
HRAS | -5273 |
SRC | -6396 |
KALRN | -8077 |
RHO GTPases Activate NADPH Oxidases
885 | |
---|---|
set | RHO GTPases Activate NADPH Oxidases |
setSize | 21 |
pANOVA | 0.000204 |
s.dist | 0.468 |
p.adjustANOVA | 0.00168 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MAPK1 | 11193 |
S100A8 | 11184 |
PRKCD | 11168 |
MAPK14 | 11115 |
NCF4 | 10813 |
NCF2 | 10793 |
RAC1 | 10624 |
S100A9 | 10613 |
CYBA | 10173 |
MAPK3 | 9750 |
CYBB | 9660 |
PRKCB | 8577 |
RAC2 | 8237 |
NCF1 | 7245 |
PIN1 | 577 |
PIK3C3 | -1718 |
PIK3R4 | -2097 |
PRKCA | -2408 |
MAPK11 | -4641 |
NOXA1 | -4914 |
GeneID | Gene Rank |
---|---|
MAPK1 | 11193 |
S100A8 | 11184 |
PRKCD | 11168 |
MAPK14 | 11115 |
NCF4 | 10813 |
NCF2 | 10793 |
RAC1 | 10624 |
S100A9 | 10613 |
CYBA | 10173 |
MAPK3 | 9750 |
CYBB | 9660 |
PRKCB | 8577 |
RAC2 | 8237 |
NCF1 | 7245 |
PIN1 | 577 |
PIK3C3 | -1718 |
PIK3R4 | -2097 |
PRKCA | -2408 |
MAPK11 | -4641 |
NOXA1 | -4914 |
PRKCZ | -6016 |
Telomere C-strand synthesis initiation
1218 | |
---|---|
set | Telomere C-strand synthesis initiation |
setSize | 13 |
pANOVA | 0.0035 |
s.dist | -0.468 |
p.adjustANOVA | 0.0151 |
Top enriched genes
GeneID | Gene Rank |
---|---|
STN1 | -9859 |
POLA1 | -9841 |
PRIM1 | -9166 |
CTC1 | -8852 |
POLA2 | -7950 |
PRIM2 | -7112 |
ACD | -5673 |
POT1 | -4708 |
TERF2 | -4421 |
TERF1 | -2831 |
TEN1 | 624 |
TERF2IP | 4065 |
TINF2 | 8502 |
GeneID | Gene Rank |
---|---|
STN1 | -9859 |
POLA1 | -9841 |
PRIM1 | -9166 |
CTC1 | -8852 |
POLA2 | -7950 |
PRIM2 | -7112 |
ACD | -5673 |
POT1 | -4708 |
TERF2 | -4421 |
TERF1 | -2831 |
TEN1 | 624 |
TERF2IP | 4065 |
TINF2 | 8502 |
Sema4D in semaphorin signaling
1060 | |
---|---|
set | Sema4D in semaphorin signaling |
setSize | 22 |
pANOVA | 0.000152 |
s.dist | 0.466 |
p.adjustANOVA | 0.00132 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ARHGEF11 | 11412 |
RRAS | 10835 |
RAC1 | 10624 |
MYL6 | 10185 |
LIMK2 | 9689 |
RHOA | 9401 |
MYH9 | 9224 |
ROCK1 | 8695 |
MYH10 | 8632 |
LIMK1 | 8062 |
RHOB | 7921 |
ROCK2 | 6611 |
MYL12B | 5703 |
PLXNB1 | 5405 |
RHOC | 4639 |
ARHGEF12 | 4165 |
RND1 | 3716 |
MYL9 | 1931 |
SEMA4D | -1019 |
ARHGAP35 | -2201 |
GeneID | Gene Rank |
---|---|
ARHGEF11 | 11412 |
RRAS | 10835 |
RAC1 | 10624 |
MYL6 | 10185 |
LIMK2 | 9689 |
RHOA | 9401 |
MYH9 | 9224 |
ROCK1 | 8695 |
MYH10 | 8632 |
LIMK1 | 8062 |
RHOB | 7921 |
ROCK2 | 6611 |
MYL12B | 5703 |
PLXNB1 | 5405 |
RHOC | 4639 |
ARHGEF12 | 4165 |
RND1 | 3716 |
MYL9 | 1931 |
SEMA4D | -1019 |
ARHGAP35 | -2201 |
MYH11 | -2243 |
ERBB2 | -6142 |
COPI-independent Golgi-to-ER retrograde traffic
131 | |
---|---|
set | COPI-independent Golgi-to-ER retrograde traffic |
setSize | 33 |
pANOVA | 5.41e-06 |
s.dist | 0.457 |
p.adjustANOVA | 7.29e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
GALNT2 | 10885 |
DCTN4 | 10682 |
DCTN2 | 10412 |
ACTR1A | 10310 |
RAB6A | 9958 |
PLA2G4A | 9803 |
BICD2 | 9707 |
CAPZB | 9575 |
DCTN1 | 9558 |
CAPZA1 | 9530 |
DYNC1LI1 | 8276 |
CAPZA2 | 8225 |
AGPAT3 | 7932 |
PAFAH1B1 | 7857 |
DYNC1LI2 | 7644 |
DCTN6 | 7540 |
RAB18 | 7038 |
DYNC1I2 | 6705 |
DCTN3 | 6625 |
RAB3GAP2 | 6599 |
GeneID | Gene Rank |
---|---|
GALNT2 | 10885 |
DCTN4 | 10682 |
DCTN2 | 10412 |
ACTR1A | 10310 |
RAB6A | 9958 |
PLA2G4A | 9803 |
BICD2 | 9707 |
CAPZB | 9575 |
DCTN1 | 9558 |
CAPZA1 | 9530 |
DYNC1LI1 | 8276 |
CAPZA2 | 8225 |
AGPAT3 | 7932 |
PAFAH1B1 | 7857 |
DYNC1LI2 | 7644 |
DCTN6 | 7540 |
RAB18 | 7038 |
DYNC1I2 | 6705 |
DCTN3 | 6625 |
RAB3GAP2 | 6599 |
GALNT1 | 6495 |
PAFAH1B2 | 5996 |
ACTR10 | 5886 |
RAB3GAP1 | 5167 |
DYNC1I1 | 2879 |
DYNC1H1 | 1705 |
DYNLL1 | 1530 |
DCTN5 | 297 |
RAB6B | -1849 |
BICD1 | -2303 |
PAFAH1B3 | -4044 |
DYNLL2 | -4904 |
PLA2G6 | -7168 |
Cargo concentration in the ER
145 | |
---|---|
set | Cargo concentration in the ER |
setSize | 30 |
pANOVA | 1.48e-05 |
s.dist | 0.457 |
p.adjustANOVA | 0.000179 |
Top enriched genes
GeneID | Gene Rank |
---|---|
F5 | 11434 |
SERPINA1 | 11407 |
TGFA | 10983 |
SEC24D | 10803 |
PREB | 10364 |
CTSZ | 9943 |
LMAN2 | 9480 |
SEC24A | 9414 |
CTSC | 9276 |
SEC24C | 8993 |
STX5 | 8547 |
MIA2 | 8200 |
F8 | 8026 |
COL7A1 | 7971 |
SEC24B | 7352 |
SEC23A | 7129 |
SAR1B | 6893 |
SEC22B | 6272 |
GOSR2 | 5986 |
TMED2 | 5345 |
GeneID | Gene Rank |
---|---|
F5 | 11434 |
SERPINA1 | 11407 |
TGFA | 10983 |
SEC24D | 10803 |
PREB | 10364 |
CTSZ | 9943 |
LMAN2 | 9480 |
SEC24A | 9414 |
CTSC | 9276 |
SEC24C | 8993 |
STX5 | 8547 |
MIA2 | 8200 |
F8 | 8026 |
COL7A1 | 7971 |
SEC24B | 7352 |
SEC23A | 7129 |
SAR1B | 6893 |
SEC22B | 6272 |
GOSR2 | 5986 |
TMED2 | 5345 |
MCFD2 | 5134 |
CD59 | 4252 |
CNIH2 | 4186 |
AREG | 2386 |
LMAN2L | 1586 |
CNIH1 | -2698 |
MIA3 | -3686 |
TMED10 | -4413 |
CNIH3 | -4435 |
LMAN1 | -8522 |
Sema4D induced cell migration and growth-cone collapse
1061 | |
---|---|
set | Sema4D induced cell migration and growth-cone collapse |
setSize | 19 |
pANOVA | 0.000582 |
s.dist | 0.456 |
p.adjustANOVA | 0.00379 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ARHGEF11 | 11412 |
MYL6 | 10185 |
LIMK2 | 9689 |
RHOA | 9401 |
MYH9 | 9224 |
ROCK1 | 8695 |
MYH10 | 8632 |
LIMK1 | 8062 |
RHOB | 7921 |
ROCK2 | 6611 |
MYL12B | 5703 |
PLXNB1 | 5405 |
RHOC | 4639 |
ARHGEF12 | 4165 |
RND1 | 3716 |
MYL9 | 1931 |
SEMA4D | -1019 |
MYH11 | -2243 |
ERBB2 | -6142 |
GeneID | Gene Rank |
---|---|
ARHGEF11 | 11412 |
MYL6 | 10185 |
LIMK2 | 9689 |
RHOA | 9401 |
MYH9 | 9224 |
ROCK1 | 8695 |
MYH10 | 8632 |
LIMK1 | 8062 |
RHOB | 7921 |
ROCK2 | 6611 |
MYL12B | 5703 |
PLXNB1 | 5405 |
RHOC | 4639 |
ARHGEF12 | 4165 |
RND1 | 3716 |
MYL9 | 1931 |
SEMA4D | -1019 |
MYH11 | -2243 |
ERBB2 | -6142 |
Leading Strand Synthesis
594 | |
---|---|
set | Leading Strand Synthesis |
setSize | 14 |
pANOVA | 0.00329 |
s.dist | -0.454 |
p.adjustANOVA | 0.0145 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
POLA1 | -9841 |
RFC3 | -9405 |
PRIM1 | -9166 |
RFC4 | -8897 |
POLA2 | -7950 |
RFC5 | -7574 |
PRIM2 | -7112 |
PCNA | -7101 |
RFC1 | -5080 |
POLD1 | -2573 |
RFC2 | 5478 |
POLD4 | 9079 |
POLD3 | 10698 |
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
POLA1 | -9841 |
RFC3 | -9405 |
PRIM1 | -9166 |
RFC4 | -8897 |
POLA2 | -7950 |
RFC5 | -7574 |
PRIM2 | -7112 |
PCNA | -7101 |
RFC1 | -5080 |
POLD1 | -2573 |
RFC2 | 5478 |
POLD4 | 9079 |
POLD3 | 10698 |
Polymerase switching
833 | |
---|---|
set | Polymerase switching |
setSize | 14 |
pANOVA | 0.00329 |
s.dist | -0.454 |
p.adjustANOVA | 0.0145 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
POLA1 | -9841 |
RFC3 | -9405 |
PRIM1 | -9166 |
RFC4 | -8897 |
POLA2 | -7950 |
RFC5 | -7574 |
PRIM2 | -7112 |
PCNA | -7101 |
RFC1 | -5080 |
POLD1 | -2573 |
RFC2 | 5478 |
POLD4 | 9079 |
POLD3 | 10698 |
GeneID | Gene Rank |
---|---|
POLD2 | -10054 |
POLA1 | -9841 |
RFC3 | -9405 |
PRIM1 | -9166 |
RFC4 | -8897 |
POLA2 | -7950 |
RFC5 | -7574 |
PRIM2 | -7112 |
PCNA | -7101 |
RFC1 | -5080 |
POLD1 | -2573 |
RFC2 | 5478 |
POLD4 | 9079 |
POLD3 | 10698 |
Signaling by Erythropoietin
1083 | |
---|---|
set | Signaling by Erythropoietin |
setSize | 24 |
pANOVA | 0.000126 |
s.dist | 0.452 |
p.adjustANOVA | 0.00113 |
Top enriched genes
GeneID | Gene Rank |
---|---|
LYN | 10810 |
GRB2 | 10733 |
EPOR | 10409 |
PLCG2 | 10244 |
VAV1 | 10226 |
SHC1 | 9541 |
IRS2 | 9427 |
PIK3CG | 9128 |
PIK3CB | 9126 |
PIK3CD | 8956 |
STAT5B | 8742 |
GAB1 | 8670 |
STAT5A | 7833 |
PIK3R5 | 7579 |
KRAS | 6132 |
CRKL | 5250 |
RAPGEF1 | 5102 |
NRAS | 4907 |
JAK2 | 4428 |
PIK3CA | 2133 |
GeneID | Gene Rank |
---|---|
LYN | 10810 |
GRB2 | 10733 |
EPOR | 10409 |
PLCG2 | 10244 |
VAV1 | 10226 |
SHC1 | 9541 |
IRS2 | 9427 |
PIK3CG | 9128 |
PIK3CB | 9126 |
PIK3CD | 8956 |
STAT5B | 8742 |
GAB1 | 8670 |
STAT5A | 7833 |
PIK3R5 | 7579 |
KRAS | 6132 |
CRKL | 5250 |
RAPGEF1 | 5102 |
NRAS | 4907 |
JAK2 | 4428 |
PIK3CA | 2133 |
SOS1 | -2983 |
HRAS | -5273 |
PIK3R1 | -8831 |
PLCG1 | -9412 |
GPVI-mediated activation cascade
429 | |
---|---|
set | GPVI-mediated activation cascade |
setSize | 31 |
pANOVA | 1.49e-05 |
s.dist | 0.449 |
p.adjustANOVA | 0.000179 |
Top enriched genes
GeneID | Gene Rank |
---|---|
FCER1G | 11216 |
LYN | 10810 |
RHOG | 10635 |
RAC1 | 10624 |
PTPN6 | 10446 |
SYK | 10256 |
PLCG2 | 10244 |
VAV1 | 10226 |
PIK3R6 | 10025 |
RHOA | 9401 |
PIK3CG | 9128 |
PIK3CB | 9126 |
PDPK1 | 8710 |
VAV3 | 8413 |
CLEC1B | 8373 |
CDC42 | 8342 |
RAC2 | 8237 |
RHOB | 7921 |
PIK3R5 | 7579 |
PTPN11 | 6524 |
GeneID | Gene Rank |
---|---|
FCER1G | 11216 |
LYN | 10810 |
RHOG | 10635 |
RAC1 | 10624 |
PTPN6 | 10446 |
SYK | 10256 |
PLCG2 | 10244 |
VAV1 | 10226 |
PIK3R6 | 10025 |
RHOA | 9401 |
PIK3CG | 9128 |
PIK3CB | 9126 |
PDPK1 | 8710 |
VAV3 | 8413 |
CLEC1B | 8373 |
CDC42 | 8342 |
RAC2 | 8237 |
RHOB | 7921 |
PIK3R5 | 7579 |
PTPN11 | 6524 |
PIK3R2 | 6511 |
GP6 | 5660 |
LCP2 | 3759 |
VAV2 | 2755 |
PIK3R3 | 2676 |
PIK3CA | 2133 |
FYN | -5211 |
PRKCZ | -6016 |
PIK3R1 | -8831 |
LAT | -9470 |
LCK | -9556 |
Neutrophil degranulation
734 | |
---|---|
set | Neutrophil degranulation |
setSize | 458 |
pANOVA | 3.16e-61 |
s.dist | 0.449 |
p.adjustANOVA | 4.3e-58 |
Top enriched genes
GeneID | Gene Rank |
---|---|
SLC11A1 | 11464 |
NCSTN | 11452 |
DOK3 | 11443 |
P2RX1 | 11442 |
LILRB2 | 11437 |
HK3 | 11430 |
OSCAR | 11425 |
IDH1 | 11418 |
SIRPA | 11414 |
GNS | 11410 |
SERPINA1 | 11407 |
CR1 | 11401 |
DNASE1L1 | 11385 |
SIGLEC9 | 11381 |
QSOX1 | 11369 |
CD63 | 11355 |
MCEMP1 | 11349 |
FGR | 11323 |
HP | 11312 |
NCKAP1L | 11304 |
GeneID | Gene Rank |
---|---|
SLC11A1 | 11464 |
NCSTN | 11452 |
DOK3 | 11443 |
P2RX1 | 11442 |
LILRB2 | 11437 |
HK3 | 11430 |
OSCAR | 11425 |
IDH1 | 11418 |
SIRPA | 11414 |
GNS | 11410 |
SERPINA1 | 11407 |
CR1 | 11401 |
DNASE1L1 | 11385 |
SIGLEC9 | 11381 |
QSOX1 | 11369 |
CD63 | 11355 |
MCEMP1 | 11349 |
FGR | 11323 |
HP | 11312 |
NCKAP1L | 11304 |
IMPDH1 | 11303 |
CTSD | 11297 |
C3AR1 | 11294 |
ATP6V0A1 | 11283 |
LAIR1 | 11276 |
ITGAM | 11269 |
UNC13D | 11266 |
CTSB | 11250 |
ITGAX | 11231 |
ANPEP | 11227 |
FPR1 | 11221 |
FCER1G | 11216 |
TIMP2 | 11214 |
S100A12 | 11206 |
MAPK1 | 11193 |
RNASE2 | 11192 |
S100A8 | 11184 |
ALOX5 | 11178 |
GUSB | 11175 |
PRKCD | 11168 |
TCIRG1 | 11138 |
TRPM2 | 11134 |
PGAM1 | 11128 |
PLAC8 | 11120 |
MAPK14 | 11115 |
PLD1 | 11091 |
NEU1 | 11082 |
SERPINB1 | 11081 |
ACAA1 | 11076 |
CD177 | 11068 |
ALDH3B1 | 11063 |
C5AR1 | 11061 |
MMP25 | 11057 |
AGPAT2 | 11054 |
PLEKHO2 | 11053 |
ADGRG3 | 11019 |
VNN1 | 11000 |
GCA | 10999 |
ATP6V0C | 10995 |
VAT1 | 10971 |
BRI3 | 10962 |
RAB10 | 10956 |
PYGL | 10952 |
MGAM | 10950 |
CD36 | 10947 |
CD93 | 10937 |
MOSPD2 | 10933 |
CEACAM3 | 10932 |
MMP9 | 10920 |
CD55 | 10914 |
S100A11 | 10910 |
NFAM1 | 10890 |
FPR2 | 10883 |
GYG1 | 10873 |
ALDOA | 10868 |
ITGB2 | 10861 |
CDA | 10859 |
GM2A | 10846 |
CTSA | 10842 |
GRN | 10837 |
CKAP4 | 10819 |
CRISPLD2 | 10814 |
ASAH1 | 10796 |
ATP11A | 10791 |
LRG1 | 10785 |
CYB5R3 | 10775 |
TSPAN14 | 10759 |
NBEAL2 | 10743 |
RETN | 10732 |
SLC2A3 | 10714 |
ANXA2 | 10704 |
QPCT | 10700 |
SLC15A4 | 10684 |
RAB3D | 10677 |
RAB31 | 10661 |
BST1 | 10647 |
RHOG | 10635 |
GPR84 | 10632 |
RAC1 | 10624 |
S100A9 | 10613 |
CYSTM1 | 10605 |
GLA | 10595 |
TOM1 | 10594 |
CAPN1 | 10570 |
GSN | 10558 |
TNFAIP6 | 10555 |
CD68 | 10546 |
LTA4H | 10541 |
PYCARD | 10540 |
TLR2 | 10535 |
PKM | 10523 |
IGF2R | 10494 |
PLAUR | 10490 |
FCGR2A | 10470 |
ALAD | 10449 |
PTPN6 | 10446 |
LILRB3 | 10433 |
PSEN1 | 10429 |
CYFIP1 | 10420 |
PECAM1 | 10414 |
CLEC4D | 10398 |
PGM2 | 10380 |
DNAJC5 | 10371 |
CD300A | 10362 |
PTPRJ | 10340 |
COTL1 | 10333 |
CD53 | 10308 |
ACLY | 10268 |
PADI2 | 10252 |
AP2A2 | 10223 |
FCAR | 10219 |
GLB1 | 10217 |
TMBIM1 | 10197 |
PTAFR | 10188 |
AMPD3 | 10183 |
CYBA | 10173 |
DOCK2 | 10155 |
NAPRT | 10133 |
RAB7A | 10115 |
CAT | 10103 |
ARPC5 | 10102 |
FTL | 10101 |
TNFRSF1B | 10079 |
ARG1 | 10061 |
ARL8A | 10056 |
ARSB | 10041 |
IQGAP1 | 10037 |
ADAM10 | 9992 |
CPPED1 | 9991 |
ATP6V1D | 9982 |
SELL | 9974 |
RAB6A | 9958 |
SDCBP | 9947 |
CTSZ | 9943 |
CAP1 | 9934 |
DNAJC13 | 9921 |
S100P | 9918 |
RAB5C | 9864 |
MGST1 | 9847 |
DNAJC3 | 9831 |
DBNL | 9815 |
BIN2 | 9720 |
LAMP1 | 9712 |
ARHGAP9 | 9702 |
CD58 | 9688 |
TOLLIP | 9682 |
HSPA6 | 9675 |
CYBB | 9660 |
TYROBP | 9637 |
VAPA | 9635 |
RAB24 | 9634 |
RAB27A | 9628 |
AP1M1 | 9595 |
CSTB | 9479 |
CD14 | 9466 |
GMFG | 9443 |
RHOA | 9401 |
CAB39 | 9379 |
DERA | 9344 |
HSPA1A | 9341 |
CXCR1 | 9335 |
VPS35L | 9320 |
CTSC | 9276 |
LAMTOR1 | 9265 |
CANT1 | 9259 |
CD44 | 9255 |
SIGLEC5 | 9235 |
LGALS3 | 9180 |
SNAP29 | 9157 |
CNN2 | 9140 |
TRAPPC1 | 9087 |
CEACAM1 | 9052 |
GALNS | 9046 |
LAMP2 | 9034 |
PDAP1 | 9011 |
IST1 | 8994 |
STK10 | 8992 |
CMTM6 | 8960 |
ADAM8 | 8938 |
ADGRE5 | 8937 |
ACTR2 | 8895 |
PSAP | 8894 |
MNDA | 8892 |
CFP | 8875 |
STK11IP | 8872 |
HPSE | 8832 |
APAF1 | 8822 |
HSPA1B | 8806 |
MMP8 | 8706 |
ROCK1 | 8695 |
CREG1 | 8692 |
GAA | 8625 |
MVP | 8603 |
HEBP2 | 8559 |
ATP11B | 8523 |
PRCP | 8518 |
CLEC5A | 8487 |
SLCO4C1 | 8486 |
DDOST | 8464 |
PSMB7 | 8460 |
ARSA | 8456 |
RAB4B | 8449 |
TUBB4B | 8440 |
IQGAP2 | 8437 |
KCMF1 | 8403 |
OSTF1 | 8338 |
SURF4 | 8306 |
DYNC1LI1 | 8276 |
PDXK | 8267 |
RAB5B | 8258 |
PSMD1 | 8184 |
PSMD2 | 8139 |
PNP | 8043 |
PTPRC | 8021 |
LAMTOR2 | 8006 |
COPB1 | 7997 |
STOM | 7990 |
RNASET2 | 7961 |
FCN1 | 7954 |
FABP5 | 7903 |
ITGAV | 7847 |
VCP | 7804 |
PSMD11 | 7775 |
B4GALT1 | 7763 |
LPCAT1 | 7696 |
HEXB | 7695 |
MANBA | 7689 |
OLFM4 | 7638 |
RAP2C | 7598 |
FAF2 | 7588 |
SNAP23 | 7530 |
RAP1A | 7335 |
PSMD6 | 7307 |
YPEL5 | 7288 |
PGM1 | 7238 |
GGH | 7233 |
COMMD9 | 7156 |
SIRPB1 | 7136 |
DIAPH1 | 7128 |
GPI | 7117 |
CXCL1 | 7072 |
RAB18 | 7038 |
TMEM30A | 7030 |
RAP1B | 6962 |
GDI2 | 6949 |
CD33 | 6932 |
DYNLT1 | 6926 |
FTH1 | 6883 |
C6orf120 | 6840 |
PSMD12 | 6820 |
CXCR2 | 6720 |
METTL7A | 6718 |
HBB | 6697 |
UBR4 | 6594 |
CTSS | 6504 |
FUCA1 | 6469 |
KCNAB2 | 6369 |
PIGR | 6337 |
RAB3A | 6284 |
VCL | 6193 |
LRMP | 6184 |
ATG7 | 6082 |
FUCA2 | 6028 |
PAFAH1B2 | 5996 |
NDUFC2 | 5943 |
ACTR10 | 5886 |
CSNK2B | 5876 |
MAN2B1 | 5768 |
STBD1 | 5663 |
SIGLEC14 | 5662 |
SERPINB10 | 5629 |
KPNB1 | 5604 |
RAB14 | 5469 |
LAMTOR3 | 5383 |
SERPINB6 | 5280 |
ATP8B4 | 5252 |
SLC44A2 | 5180 |
DGAT1 | 5173 |
PRDX6 | 5085 |
SRP14 | 5022 |
NHLRC3 | 5010 |
CTSH | 4985 |
APEH | 4945 |
ATP6AP2 | 4915 |
PGLYRP1 | 4910 |
NRAS | 4907 |
PTPRN2 | 4854 |
ERP44 | 4818 |
GLIPR1 | 4675 |
ARMC8 | 4598 |
PSMC2 | 4543 |
NFASC | 4356 |
MAGT1 | 4339 |
PSMD3 | 4297 |
TICAM2 | 4262 |
CD59 | 4252 |
TARM1 | 3952 |
RAP2B | 3915 |
PLAU | 3907 |
PSMD13 | 3766 |
ITGAL | 3647 |
ANO6 | 3404 |
NPC2 | 3326 |
DEGS1 | 3135 |
CPNE3 | 2985 |
HLA-C | 2969 |
NFKB1 | 2860 |
FOLR3 | 2736 |
FRK | 2672 |
AOC1 | 2506 |
CLEC12A | 2330 |
LCN2 | 2300 |
CLEC4C | 2219 |
CDK13 | 2118 |
PSMD7 | 2084 |
ORM1 | 2075 |
GHDC | 1853 |
XRCC5 | 1832 |
CST3 | 1747 |
DYNC1H1 | 1705 |
DDX3X | 1692 |
PTX3 | 1567 |
DYNLL1 | 1530 |
CRISP3 | 1416 |
FCGR3B | 1391 |
ADGRE3 | 1240 |
HUWE1 | 1218 |
CRACR2A | 1215 |
PSMD14 | 941 |
PSMC3 | 916 |
SYNGR1 | 852 |
MLEC | 796 |
MME | 695 |
ORM2 | 565 |
CFD | 461 |
GSDMD | 370 |
AGL | 316 |
STING1 | 94 |
GOLGA7 | 14 |
PGRMC1 | -59 |
HLA-B | -98 |
VAMP8 | -139 |
HVCN1 | -250 |
ENPP4 | -308 |
LRRC7 | -340 |
RNASE3 | -371 |
PYGB | -418 |
FRMPD3 | -550 |
DSP | -573 |
HGSNAT | -737 |
GSTP1 | -759 |
BST2 | -782 |
NME2 | -791 |
PRDX4 | -834 |
RAB37 | -1057 |
LYZ | -1067 |
A1BG | -1468 |
CPNE1 | -1632 |
TMEM179B | -1671 |
TUBB | -1675 |
TCN1 | -1708 |
CHIT1 | -1890 |
PPBP | -1960 |
TXNDC5 | -2141 |
COMMD3 | -2657 |
JUP | -2668 |
HLA-H | -2741 |
CCT8 | -2751 |
PSMA2 | -2823 |
SVIP | -3052 |
SLPI | -3392 |
C3 | -3394 |
RAB44 | -3423 |
PFKL | -3512 |
PSMB1 | -3610 |
HSP90AA1 | -4016 |
RAB9B | -4177 |
PTPRB | -4321 |
ILF2 | -4378 |
LTF | -4464 |
EPX | -4781 |
HRNR | -5086 |
PA2G4 | -5255 |
KRT1 | -5265 |
DSN1 | -5307 |
BPI | -5410 |
PTGES2 | -5466 |
ALDOC | -5613 |
CHI3L1 | -5761 |
ACTR1B | -5952 |
HLA-A | -5985 |
DPP7 | -6012 |
FGL2 | -6015 |
ORMDL3 | -6182 |
SLC27A2 | -6278 |
EEF2 | -6279 |
PPIE | -6341 |
SLC2A5 | -6479 |
PPIA | -6498 |
TMC6 | -6551 |
HMGB1 | -6699 |
ABCA13 | -6934 |
B2M | -6943 |
MS4A3 | -7001 |
CAND1 | -7058 |
MIF | -7102 |
SCAMP1 | -7313 |
PSMA5 | -7476 |
CEACAM8 | -7546 |
APRT | -7580 |
TBC1D10C | -7608 |
OLR1 | -7621 |
AGA | -7674 |
DEFA1 | -7680 |
DEFA4 | -7723 |
TMEM63A | -7978 |
XRCC6 | -8146 |
CEP290 | -8156 |
MPO | -8263 |
CEACAM6 | -8277 |
ATAD3B | -8354 |
ELANE | -8371 |
CAMP | -8417 |
RHOF | -8679 |
HMOX2 | -8794 |
HSPA8 | -9129 |
NIT2 | -9152 |
CD47 | -9164 |
HSP90AB1 | -9172 |
ATP8A1 | -9218 |
PRTN3 | -9350 |
AZU1 | -9380 |
SPTAN1 | -9461 |
CTSG | -9503 |
DSC1 | -9630 |
EEF1A1 | -9751 |
CCT2 | -10024 |
IMPDH2 | -10126 |
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism
981 | |
---|---|
set | Regulation of glycolysis by fructose 2,6-bisphosphate metabolism |
setSize | 11 |
pANOVA | 0.0102 |
s.dist | 0.447 |
p.adjustANOVA | 0.0363 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PFKFB4 | 11413 |
PRKACA | 11363 |
PFKFB3 | 11033 |
PFKFB2 | 10694 |
PPP2CB | 7451 |
PPP2CA | 6806 |
PPP2R5D | 6601 |
PPP2R1A | 5189 |
PPP2R1B | 89 |
PFKFB1 | -427 |
PRKACB | -9863 |
GeneID | Gene Rank |
---|---|
PFKFB4 | 11413 |
PRKACA | 11363 |
PFKFB3 | 11033 |
PFKFB2 | 10694 |
PPP2CB | 7451 |
PPP2CA | 6806 |
PPP2R5D | 6601 |
PPP2R1A | 5189 |
PPP2R1B | 89 |
PFKFB1 | -427 |
PRKACB | -9863 |
RHO GTPases activate PAKs
891 | |
---|---|
set | RHO GTPases activate PAKs |
setSize | 20 |
pANOVA | 0.000538 |
s.dist | 0.447 |
p.adjustANOVA | 0.00359 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RAC1 | 10624 |
MYL6 | 10185 |
PAK1 | 10043 |
MYH9 | 9224 |
PAK2 | 9042 |
MYH10 | 8632 |
PPP1R12B | 8489 |
CDC42 | 8342 |
FLNA | 8318 |
LIMK1 | 8062 |
PPP1R12A | 7801 |
PPP1CB | 6745 |
MYL12B | 5703 |
NF2 | 4139 |
MYL9 | 1931 |
MYLK | 1267 |
CTTN | 514 |
CALM1 | -1245 |
MYH11 | -2243 |
PAK3 | -5908 |
GeneID | Gene Rank |
---|---|
RAC1 | 10624 |
MYL6 | 10185 |
PAK1 | 10043 |
MYH9 | 9224 |
PAK2 | 9042 |
MYH10 | 8632 |
PPP1R12B | 8489 |
CDC42 | 8342 |
FLNA | 8318 |
LIMK1 | 8062 |
PPP1R12A | 7801 |
PPP1CB | 6745 |
MYL12B | 5703 |
NF2 | 4139 |
MYL9 | 1931 |
MYLK | 1267 |
CTTN | 514 |
CALM1 | -1245 |
MYH11 | -2243 |
PAK3 | -5908 |
Hyaluronan metabolism
502 | |
---|---|
set | Hyaluronan metabolism |
setSize | 15 |
pANOVA | 0.00274 |
s.dist | 0.447 |
p.adjustANOVA | 0.0124 |
Top enriched genes
GeneID | Gene Rank |
---|---|
SLC9A1 | 11350 |
HYAL2 | 11213 |
GUSB | 11175 |
LYVE1 | 10724 |
CHP1 | 10038 |
CD44 | 9255 |
HYAL1 | 8371 |
HEXB | 7695 |
STAB2 | 3499 |
HAS3 | 3339 |
HMMR | 1858 |
ABCC5 | 1588 |
HYAL3 | -893 |
HEXA | -1967 |
CEMIP | -5033 |
GeneID | Gene Rank |
---|---|
SLC9A1 | 11350 |
HYAL2 | 11213 |
GUSB | 11175 |
LYVE1 | 10724 |
CHP1 | 10038 |
CD44 | 9255 |
HYAL1 | 8371 |
HEXB | 7695 |
STAB2 | 3499 |
HAS3 | 3339 |
HMMR | 1858 |
ABCC5 | 1588 |
HYAL3 | -893 |
HEXA | -1967 |
CEMIP | -5033 |
Translation
1266 | |
---|---|
set | Translation |
setSize | 295 |
pANOVA | 9.42e-40 |
s.dist | -0.446 |
p.adjustANOVA | 2.14e-37 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
MRPS6 | -9838 |
RPS3A | -9834 |
RPL7 | -9765 |
EEF1A1 | -9751 |
NARS2 | -9738 |
EEF1B2 | -9732 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
LARS1 | -9637 |
EIF4A2 | -9593 |
RPS2 | -9591 |
FARS2 | -9569 |
RPL4 | -9549 |
EIF3B | -9526 |
GeneID | Gene Rank |
---|---|
RPL23A | -9979 |
RPL3 | -9957 |
RPL5 | -9881 |
MRPS6 | -9838 |
RPS3A | -9834 |
RPL7 | -9765 |
EEF1A1 | -9751 |
NARS2 | -9738 |
EEF1B2 | -9732 |
RPS27A | -9723 |
RPS6 | -9699 |
RPL14 | -9698 |
RPS25 | -9664 |
RPL22 | -9659 |
LARS1 | -9637 |
EIF4A2 | -9593 |
RPS2 | -9591 |
FARS2 | -9569 |
RPL4 | -9549 |
EIF3B | -9526 |
RPL21 | -9511 |
RPL34 | -9492 |
GFM1 | -9467 |
MRPS33 | -9440 |
RPS20 | -9413 |
RPL13A | -9402 |
RPS23 | -9387 |
RPL32 | -9345 |
RPL6 | -9309 |
MRPL50 | -9302 |
RPS3 | -9298 |
EEF1G | -9293 |
RPL35A | -9291 |
N6AMT1 | -9282 |
MRPS25 | -9279 |
RPS12 | -9270 |
RPLP0 | -9227 |
RPL12 | -9177 |
RPS27 | -9175 |
RPS7 | -9165 |
RPLP2 | -9163 |
MRPS27 | -9147 |
RPL11 | -9117 |
RPL17 | -9116 |
EIF3E | -9049 |
RPL27A | -9048 |
RPS5 | -9042 |
RPL10 | -9031 |
IARS1 | -8999 |
RPL30 | -8930 |
RPL10A | -8928 |
MRPS9 | -8917 |
RPL36A | -8909 |
RPL24 | -8901 |
RPL18A | -8896 |
RPS15A | -8883 |
RPL18 | -8863 |
RPS8 | -8861 |
MRPL48 | -8859 |
RPL31 | -8769 |
RPS13 | -8724 |
RPL26 | -8706 |
MRPL24 | -8692 |
RPS4X | -8648 |
RPS29 | -8637 |
RPL39 | -8635 |
RPL29 | -8621 |
FARSB | -8580 |
RPS16 | -8579 |
EARS2 | -8562 |
RPS14 | -8541 |
RPS10 | -8494 |
MRPL46 | -8479 |
EIF1AX | -8383 |
KARS1 | -8380 |
RPL23 | -8373 |
RPL19 | -8338 |
RPS21 | -8330 |
RPS18 | -8321 |
RPL7A | -8286 |
RPS17 | -8281 |
MRPS30 | -8262 |
EIF3L | -8255 |
AARS2 | -8248 |
RPL22L1 | -8202 |
EIF4B | -8190 |
RPL35 | -8183 |
RPL15 | -8169 |
MRPS18B | -8125 |
RPS28 | -8083 |
MRPL17 | -8047 |
GSPT2 | -7995 |
MRPL32 | -7992 |
AIMP1 | -7990 |
RPS11 | -7975 |
RPL38 | -7968 |
MARS2 | -7955 |
MRPL39 | -7936 |
SARS2 | -7925 |
RPL37 | -7861 |
RPL27 | -7810 |
RPS19 | -7806 |
RPL13 | -7671 |
WARS2 | -7615 |
MRPL1 | -7594 |
RPL41 | -7561 |
SRPRB | -7520 |
MRPL38 | -7496 |
RPL36 | -7493 |
MRPS2 | -7237 |
MRPL42 | -7224 |
MRPL9 | -7188 |
EIF3H | -7091 |
DAP3 | -7087 |
MRPL45 | -6990 |
DARS1 | -6939 |
MRPS17 | -6909 |
EIF5B | -6867 |
RPL37A | -6833 |
HARS1 | -6831 |
RPL9 | -6821 |
RPS24 | -6818 |
EIF3M | -6817 |
AARS1 | -6785 |
MRPL14 | -6728 |
MRPS14 | -6718 |
RPS15 | -6703 |
MRPS7 | -6677 |
EIF2B3 | -6649 |
RPL36AL | -6646 |
RPSA | -6629 |
PTCD3 | -6500 |
TRAM1 | -6480 |
EIF3J | -6448 |
EPRS1 | -6350 |
MRPS21 | -6319 |
EEF2 | -6279 |
LARS2 | -6268 |
MRPS28 | -6255 |
RPL8 | -6101 |
TSFM | -6082 |
SEC11C | -6046 |
SARS1 | -6044 |
RPLP1 | -6018 |
PPA1 | -5970 |
MRPL35 | -5957 |
MRPL3 | -5916 |
EEF1A1P5 | -5877 |
EEF1D | -5664 |
MRPS12 | -5654 |
MRPL49 | -5619 |
MRPL54 | -5616 |
EIF2B5 | -5580 |
MRRF | -5487 |
MRPL11 | -5474 |
MRPS26 | -5430 |
SEC61A2 | -5333 |
EIF3F | -5200 |
EIF3D | -5158 |
MT-RNR1 | -5094 |
MRPL57 | -5039 |
YARS2 | -5018 |
MRPL34 | -4765 |
EIF3C | -4716 |
MRPL43 | -4449 |
MRPL27 | -4262 |
MRPS23 | -4230 |
MRPL19 | -4123 |
VARS1 | -4083 |
MRPL58 | -3985 |
RARS1 | -3944 |
RPL28 | -3873 |
MRPS31 | -3868 |
MRPL12 | -3819 |
RARS2 | -3810 |
QARS1 | -3758 |
WARS1 | -3717 |
VARS2 | -3646 |
FAU | -3618 |
SRP72 | -3562 |
MRPL55 | -3524 |
UBA52 | -3490 |
MRPL41 | -3438 |
SRP9 | -3414 |
AIMP2 | -3343 |
MRPS35 | -3315 |
MRPL18 | -3314 |
EEF1A2 | -3246 |
SEC61G | -3152 |
MTIF2 | -3020 |
PABPC1 | -2991 |
MRPL40 | -2981 |
MRPL15 | -2975 |
SSR2 | -2917 |
GADD45GIP1 | -2813 |
EIF3G | -2746 |
MRPS10 | -2725 |
EEF1E1 | -2716 |
EIF3I | -2580 |
MRPL21 | -2473 |
PPA2 | -2453 |
MRPL2 | -2449 |
MRPL30 | -2421 |
MRPS22 | -2388 |
EIF3K | -2369 |
TRMT112 | -2296 |
EIF2B1 | -2228 |
MRPS34 | -2208 |
MRPS18C | -2145 |
MRPL47 | -2119 |
GSPT1 | -2025 |
MRPL4 | -1924 |
MRPL16 | -1832 |
SPCS1 | -1700 |
RPL39L | -1661 |
EIF2S1 | -1649 |
MRPL20 | -1647 |
IARS2 | -1595 |
ERAL1 | -1389 |
EIF3A | -1276 |
NARS1 | -1189 |
RPS26 | -1154 |
SPCS2 | -977 |
MRPS15 | -924 |
SRP19 | -625 |
FARSA | -514 |
RPS27L | -496 |
MRPS36 | -492 |
MRPL22 | -462 |
MT-RNR2 | -408 |
MRPL13 | -237 |
MRPL37 | 177 |
MTIF3 | 221 |
RPS4Y1 | 331 |
MRPS16 | 350 |
EIF2S2 | 554 |
SRP68 | 787 |
TARS2 | 801 |
PARS2 | 910 |
MRPS24 | 1048 |
SSR1 | 1143 |
SSR4 | 1294 |
MRPS18A | 1407 |
GFM2 | 1540 |
MRPL36 | 1646 |
EIF4E | 1661 |
YARS1 | 1707 |
TARS1 | 1786 |
OXA1L | 1825 |
RPS9 | 1841 |
MRPL44 | 1847 |
SPCS3 | 1967 |
MRPS11 | 2087 |
MRPS5 | 2484 |
EIF2S3 | 2500 |
SSR3 | 2510 |
MRPL51 | 2595 |
MRPL33 | 2637 |
HARS2 | 2776 |
EIF4EBP1 | 2825 |
EIF5 | 2937 |
DARS2 | 2971 |
MT-TV | 3363 |
TUFM | 3457 |
CHCHD1 | 3643 |
MRPL52 | 4004 |
MRPL10 | 4156 |
EIF2B4 | 4294 |
SEC61B | 4322 |
MTFMT | 4587 |
MRPL23 | 4865 |
APEH | 4945 |
SRP14 | 5022 |
RPL3L | 5150 |
MTRF1L | 5386 |
EIF4A1 | 5541 |
AURKAIP1 | 5758 |
RPL26L1 | 6001 |
MRPL53 | 6626 |
SEC11A | 6634 |
GARS1 | 6727 |
ETF1 | 6835 |
RPN1 | 7151 |
MARS1 | 7358 |
SEC61A1 | 7486 |
EIF2B2 | 7498 |
EIF4H | 7768 |
SRP54 | 7912 |
SRPRA | 8301 |
DDOST | 8464 |
CARS2 | 8664 |
RPN2 | 8874 |
MRPL28 | 9785 |
EIF4G1 | 10506 |
CARS1 | 10656 |
Frs2-mediated activation
399 | |
---|---|
set | Frs2-mediated activation |
setSize | 11 |
pANOVA | 0.0105 |
s.dist | 0.445 |
p.adjustANOVA | 0.0369 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MAPK1 | 11193 |
MAP2K1 | 10148 |
MAPK3 | 9750 |
RAP1A | 7335 |
MAP2K2 | 7222 |
CRKL | 5250 |
RAPGEF1 | 5102 |
YWHAB | 4721 |
BRAF | 4367 |
FRS2 | -1144 |
NTRK1 | -3793 |
GeneID | Gene Rank |
---|---|
MAPK1 | 11193 |
MAP2K1 | 10148 |
MAPK3 | 9750 |
RAP1A | 7335 |
MAP2K2 | 7222 |
CRKL | 5250 |
RAPGEF1 | 5102 |
YWHAB | 4721 |
BRAF | 4367 |
FRS2 | -1144 |
NTRK1 | -3793 |
Regulated proteolysis of p75NTR
944 | |
---|---|
set | Regulated proteolysis of p75NTR |
setSize | 11 |
pANOVA | 0.0109 |
s.dist | 0.443 |
p.adjustANOVA | 0.0378 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NCSTN | 11452 |
ADAM17 | 10964 |
PSEN1 | 10429 |
APH1B | 9474 |
PSENEN | 7091 |
NGFR | 7009 |
TRAF6 | 4673 |
NFKB1 | 2860 |
APH1A | 2563 |
RELA | -204 |
PSEN2 | -6393 |
GeneID | Gene Rank |
---|---|
NCSTN | 11452 |
ADAM17 | 10964 |
PSEN1 | 10429 |
APH1B | 9474 |
PSENEN | 7091 |
NGFR | 7009 |
TRAF6 | 4673 |
NFKB1 | 2860 |
APH1A | 2563 |
RELA | -204 |
PSEN2 | -6393 |
Translesion synthesis by REV1
1273 | |
---|---|
set | Translesion synthesis by REV1 |
setSize | 16 |
pANOVA | 0.00221 |
s.dist | -0.442 |
p.adjustANOVA | 0.0107 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPA1 | -9799 |
RPS27A | -9723 |
RFC3 | -9405 |
RPA3 | -9220 |
RFC4 | -8897 |
RFC5 | -7574 |
REV1 | -7478 |
PCNA | -7101 |
REV3L | -5347 |
RFC1 | -5080 |
RPA2 | -4811 |
UBA52 | -3490 |
UBB | 1026 |
RFC2 | 5478 |
UBC | 6135 |
MAD2L2 | 9324 |
GeneID | Gene Rank |
---|---|
RPA1 | -9799 |
RPS27A | -9723 |
RFC3 | -9405 |
RPA3 | -9220 |
RFC4 | -8897 |
RFC5 | -7574 |
REV1 | -7478 |
PCNA | -7101 |
REV3L | -5347 |
RFC1 | -5080 |
RPA2 | -4811 |
UBA52 | -3490 |
UBB | 1026 |
RFC2 | 5478 |
UBC | 6135 |
MAD2L2 | 9324 |
Trafficking of GluR2-containing AMPA receptors
1246 | |
---|---|
set | Trafficking of GluR2-containing AMPA receptors |
setSize | 12 |
pANOVA | 0.00828 |
s.dist | 0.44 |
p.adjustANOVA | 0.0301 |
Top enriched genes
GeneID | Gene Rank |
---|---|
AP2A1 | 11340 |
AP2A2 | 10223 |
NSF | 9870 |
AP2M1 | 8799 |
PRKCB | 8577 |
AP2S1 | 8045 |
PICK1 | 6735 |
GRIA4 | 5498 |
TSPAN7 | 5060 |
AP2B1 | 2910 |
PRKCA | -2408 |
GRIP1 | -9719 |
GeneID | Gene Rank |
---|---|
AP2A1 | 11340 |
AP2A2 | 10223 |
NSF | 9870 |
AP2M1 | 8799 |
PRKCB | 8577 |
AP2S1 | 8045 |
PICK1 | 6735 |
GRIA4 | 5498 |
TSPAN7 | 5060 |
AP2B1 | 2910 |
PRKCA | -2408 |
GRIP1 | -9719 |
AKT phosphorylates targets in the cytosol
8 | |
---|---|
set | AKT phosphorylates targets in the cytosol |
setSize | 14 |
pANOVA | 0.00465 |
s.dist | 0.437 |
p.adjustANOVA | 0.0189 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CASP9 | 11186 |
GSK3A | 9979 |
CHUK | 8723 |
AKT1S1 | 8410 |
BAD | 7263 |
GSK3B | 7147 |
MKRN1 | 6583 |
AKT1 | 6498 |
MDM2 | 6043 |
CDKN1A | 5537 |
AKT2 | 5502 |
TSC2 | 4311 |
CDKN1B | -3127 |
AKT3 | -8810 |
GeneID | Gene Rank |
---|---|
CASP9 | 11186 |
GSK3A | 9979 |
CHUK | 8723 |
AKT1S1 | 8410 |
BAD | 7263 |
GSK3B | 7147 |
MKRN1 | 6583 |
AKT1 | 6498 |
MDM2 | 6043 |
CDKN1A | 5537 |
AKT2 | 5502 |
TSC2 | 4311 |
CDKN1B | -3127 |
AKT3 | -8810 |
Mucopolysaccharidoses
681 | |
---|---|
set | Mucopolysaccharidoses |
setSize | 11 |
pANOVA | 0.0122 |
s.dist | 0.437 |
p.adjustANOVA | 0.0412 |
Top enriched genes
GeneID | Gene Rank |
---|---|
GNS | 11410 |
GUSB | 11175 |
GLB1 | 10217 |
ARSB | 10041 |
GALNS | 9046 |
HYAL1 | 8371 |
SGSH | 2887 |
NAGLU | 1714 |
IDS | 1338 |
HGSNAT | -737 |
IDUA | -6370 |
GeneID | Gene Rank |
---|---|
GNS | 11410 |
GUSB | 11175 |
GLB1 | 10217 |
ARSB | 10041 |
GALNS | 9046 |
HYAL1 | 8371 |
SGSH | 2887 |
NAGLU | 1714 |
IDS | 1338 |
HGSNAT | -737 |
IDUA | -6370 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.0.2 (2020-06-22)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 18.04.5 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.7.1
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.7.1
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.1.0 GGally_2.0.0
## [3] beeswarm_0.2.3 gtools_3.8.2
## [5] echarts4r_0.3.2 mitch_1.0.6
## [7] MASS_7.3-52 fgsea_1.14.0
## [9] gplots_3.0.3 DESeq2_1.28.1
## [11] SummarizedExperiment_1.18.1 DelayedArray_0.14.0
## [13] matrixStats_0.56.0 Biobase_2.48.0
## [15] GenomicRanges_1.40.0 GenomeInfoDb_1.24.2
## [17] IRanges_2.22.2 S4Vectors_0.26.1
## [19] BiocGenerics_0.34.0 reshape2_1.4.4
## [21] forcats_0.5.0 stringr_1.4.0
## [23] dplyr_1.0.0 purrr_0.3.4
## [25] readr_1.3.1 tidyr_1.1.0
## [27] tibble_3.0.1 ggplot2_3.3.2
## [29] tidyverse_1.3.0
##
## loaded via a namespace (and not attached):
## [1] colorspace_1.4-1 ellipsis_0.3.1 rprojroot_1.3-2
## [4] XVector_0.28.0 fs_1.4.2 rstudioapi_0.11
## [7] bit64_0.9-7 AnnotationDbi_1.50.1 fansi_0.4.1
## [10] lubridate_1.7.9 xml2_1.3.2 splines_4.0.2
## [13] geneplotter_1.66.0 knitr_1.29 jsonlite_1.7.0
## [16] broom_0.5.6 annotate_1.66.0 dbplyr_1.4.4
## [19] shiny_1.5.0 compiler_4.0.2 httr_1.4.1
## [22] backports_1.1.8 assertthat_0.2.1 Matrix_1.2-18
## [25] fastmap_1.0.1 cli_2.0.2 later_1.1.0.1
## [28] htmltools_0.5.0 tools_4.0.2 gtable_0.3.0
## [31] glue_1.4.1 GenomeInfoDbData_1.2.3 fastmatch_1.1-0
## [34] Rcpp_1.0.4.6 cellranger_1.1.0 vctrs_0.3.1
## [37] gdata_2.18.0 nlme_3.1-148 xfun_0.15
## [40] testthat_2.3.2 rvest_0.3.5 mime_0.9
## [43] lifecycle_0.2.0 XML_3.99-0.3 zlibbioc_1.34.0
## [46] scales_1.1.1 hms_0.5.3 promises_1.1.1
## [49] RColorBrewer_1.1-2 yaml_2.2.1 memoise_1.1.0
## [52] gridExtra_2.3 reshape_0.8.8 stringi_1.4.6
## [55] RSQLite_2.2.0 highr_0.8 genefilter_1.70.0
## [58] desc_1.2.0 caTools_1.18.0 BiocParallel_1.22.0
## [61] rlang_0.4.6 pkgconfig_2.0.3 bitops_1.0-6
## [64] evaluate_0.14 lattice_0.20-41 htmlwidgets_1.5.1
## [67] bit_1.1-15.2 tidyselect_1.1.0 plyr_1.8.6
## [70] magrittr_1.5 R6_2.4.1 generics_0.0.2
## [73] DBI_1.1.0 pillar_1.4.4 haven_2.3.1
## [76] withr_2.2.0 survival_3.2-3 RCurl_1.98-1.2
## [79] modelr_0.1.8 crayon_1.3.4 KernSmooth_2.23-17
## [82] rmarkdown_2.3 locfit_1.5-9.4 grid_4.0.2
## [85] readxl_1.3.1 data.table_1.12.8 blob_1.2.1
## [88] reprex_0.3.0 digest_0.6.25 pbmcapply_1.5.0
## [91] xtable_1.8-4 httpuv_1.5.4 munsell_0.5.0
END of report